BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15:409-425. [PMID: 26105538 DOI: 10.1038/nrc3958] [Cited by in Crossref: 783] [Cited by in F6Publishing: 769] [Article Influence: 111.9] [Reference Citation Analysis]
Number Citing Articles
1 Yan C, Luo L, Goto S, Urata Y, Guo CY, Doi H, Kitazato K, Li TS. Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance. Oncotarget 2016;7:45112-21. [PMID: 27129175 DOI: 10.18632/oncotarget.8972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Camacho A, Jerez S. Bone metastasis treatment modeling via optimal control. J Math Biol 2019;78:497-526. [DOI: 10.1007/s00285-018-1281-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zhang Y, Xu J, Zhang N, Chen M, Wang H, Zhu D. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019;458:123-35. [DOI: 10.1016/j.canlet.2019.05.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Johnson MB, Pang B, Gardner DJ, Niknam-Benia S, Soundarajan V, Bramos A, Perrault DP, Banks K, Lee GK, Baker RY, Kim GH, Lee S, Chai Y, Chen M, Li W, Kwong L, Hong YK, Wong AK. Topical Fibronectin Improves Wound Healing of Irradiated Skin. Sci Rep 2017;7:3876. [PMID: 28634413 DOI: 10.1038/s41598-017-03614-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
5 Park JH, Kim HY, Lee A, Seo YK, Kim IH, Park ET, Kang MS, Park SJ, Park S. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1. Int J Radiat Oncol Biol Phys 2021;110:510-20. [PMID: 33383126 DOI: 10.1016/j.ijrobp.2020.12.031] [Reference Citation Analysis]
6 Ristescu AI, Tiron CE, Tiron A, Grigoras I. Exploring Hyperoxia Effects in Cancer-From Perioperative Clinical Data to Potential Molecular Mechanisms. Biomedicines 2021;9:1213. [PMID: 34572400 DOI: 10.3390/biomedicines9091213] [Reference Citation Analysis]
7 Wu CE, Zhuang YW, Zhou JY, Liu SL, Wang RP, Shu P. Cinnamaldehyde enhances apoptotic effect of oxaliplatin and reverses epithelial-mesenchymal transition and stemnness in hypoxic colorectal cancer cells. Exp Cell Res 2019;383:111500. [PMID: 31306656 DOI: 10.1016/j.yexcr.2019.111500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 2017;16:10. [PMID: 28137309 DOI: 10.1186/s12943-016-0577-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 176] [Article Influence: 32.6] [Reference Citation Analysis]
9 He Z, Yan H, Zeng W, Yang K, Rong P. Tumor microenvironment-responsive multifunctional nanoplatform based on MnFe2O4-PEG for enhanced magnetic resonance imaging-guided hypoxic cancer radiotherapy. J Mater Chem B 2021;9:1625-37. [PMID: 33475658 DOI: 10.1039/d0tb02631j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hickey RM, Kulik LM, Nimeiri H, Kalyan A, Kircher S, Desai K, Riaz A, Lewandowski RJ, Salem R. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures. J Vasc Interv Radiol 2017;28:1487-94. [PMID: 28912090 DOI: 10.1016/j.jvir.2017.07.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
11 Han X, Nie G. Say No to Tumors: NO Matters. Matter 2019;1:794-6. [DOI: 10.1016/j.matt.2019.08.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Amaoui B, Lalya I, Safini F, Semghouli S. Combination of immunotherapy-radiotherapy in non-small cell lung cancer: Reality and perspective. Radiation Medicine and Protection 2021;2:160-4. [DOI: 10.1016/j.radmp.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Attaran S, Bissell MJ. The Role of Tumor Microenvironment and Exosomes in Dormancy and Relapse. Semin Cancer Biol 2021:S1044-579X(21)00232-7. [PMID: 34757184 DOI: 10.1016/j.semcancer.2021.09.008] [Reference Citation Analysis]
14 Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther 2022;7:121. [PMID: 35418578 DOI: 10.1038/s41392-022-00975-3] [Reference Citation Analysis]
15 Liu T, Yang Y, Chiang W, Hung C, Tsai Y, Chiang C, Lo C, Chiu H. Radiotherapy-Controllable Chemotherapy from Reactive Oxygen Species-Responsive Polymeric Nanoparticles for Effective Local Dual Modality Treatment of Malignant Tumors. Biomacromolecules 2018;19:3825-39. [DOI: 10.1021/acs.biomac.8b00942] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
16 Wu C, Zhuang Y, Jiang S, Tian F, Teng Y, Chen X, Zheng P, Liu S, Zhou J, Wu J, Wang R, Zou X. Cinnamaldehyde induces apoptosis and reverses epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in non-small cell lung cancer. The International Journal of Biochemistry & Cell Biology 2017;84:58-74. [DOI: 10.1016/j.biocel.2017.01.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
17 Asperud J, Arous D, Edin NFJ, Malinen E. Spatially fractionated radiotherapy: tumor response modelling including immunomodulation. Phys Med Biol 2021;66:175012. [DOI: 10.1088/1361-6560/ac176b] [Reference Citation Analysis]
18 Song X, Shi X, Li W, Zhang F, Cai Z. The RNA-Binding Protein HuR in Digestive System Tumors. Biomed Res Int 2020;2020:9656051. [PMID: 32775456 DOI: 10.1155/2020/9656051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mccuaig R, Wu F, Dunn J, Rao S, Dahlstrom JE. The biological and clinical significance of stromal-epithelial interactions in breast cancer. Pathology 2017;49:133-40. [DOI: 10.1016/j.pathol.2016.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
20 Carreira-Barbosa F, Nunes SC. Wnt Signaling: Paths for Cancer Progression. Adv Exp Med Biol. 2020;1219:189-202. [PMID: 32130700 DOI: 10.1007/978-3-030-34025-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kim JS, Jeong SK, Oh SJ, Lee CG, Kang YR, Jo WS, Jeong MH. The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth. Int J Oncol 2020;56:1405-16. [PMID: 32236622 DOI: 10.3892/ijo.2020.5017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yi X, Zhou H, Zhang Z, Xiong S, Yang K. X-rays-optimized delivery of radiolabeled albumin for cancer theranostics. Biomaterials 2020;233:119764. [PMID: 31927252 DOI: 10.1016/j.biomaterials.2020.119764] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Perillo A, Agbaje Olufemi MV, De Robbio J, Mancuso RM, Roscigno A, Tirozzi M, Scognamiglio IR. Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00038] [Reference Citation Analysis]
24 Du J, Zhang P, Zhao H, Dong S, Yang Y, Cui J, Gao F, Cai J, Liu C. The mechanism for the radioprotective effects of zymosan-A in mice. J Cell Mol Med 2018;22:2413-21. [PMID: 29411511 DOI: 10.1111/jcmm.13538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
25 Liang S, Li C, Gao Z, Li J, Zhao H, Yu J, Meng X. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma. Int Immunopharmacol 2021;90:107178. [PMID: 33218939 DOI: 10.1016/j.intimp.2020.107178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Samuel E, Lie G, Balasubramanian A, Hiong A, So Y, Voskoboynik M, Moore M, Shackleton M, Haydon A, John T, Mitchell PLR, Markman B, Briggs P, Parakh S. Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC. Clin Lung Cancer 2021;22:e425-30. [PMID: 32778511 DOI: 10.1016/j.cllc.2020.06.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Li A, Barsoumian HB, Schoenhals JE, Caetano MS, Wang X, Menon H, Valdecanas DR, Niknam S, Younes AI, Cortez MA, Welsh JW. IDO1 Inhibition Overcomes Radiation-Induced “Rebound Immune Suppression” by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. International Journal of Radiation Oncology*Biology*Physics 2019;104:903-12. [DOI: 10.1016/j.ijrobp.2019.03.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
28 Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, Lydiatt WM, Smith RB, Ganti AK, Jones DT, Batra SK, Jain M. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells. Oncotarget 2017;8:20961-73. [PMID: 28423495 DOI: 10.18632/oncotarget.15468] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
29 Li G, Zhong X, Wang X, Gong F, Lei H, Zhou Y, Li C, Xiao Z, Ren G, Zhang L, Dong Z, Liu Z, Cheng L. Titanium carbide nanosheets with defect structure for photothermal-enhanced sonodynamic therapy. Bioact Mater 2022;8:409-19. [PMID: 34541410 DOI: 10.1016/j.bioactmat.2021.06.021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang C, Wang X, Du J, Gu Z, Zhao Y. Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment. Adv Sci (Weinh) 2021;8:2002797. [PMID: 33552863 DOI: 10.1002/advs.202002797] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
31 Nicolas AM, Pesic M, Engel E, Ziegler PK, Diefenhardt M, Kennel KB, Buettner F, Conche C, Petrocelli V, Elwakeel E, Weigert A, Zinoveva A, Fleischmann M, Häupl B, Karakütük C, Bohnenberger H, Mosa MH, Kaderali L, Gaedcke J, Ghadimi M, Rödel F, Arkan MC, Oellerich T, Rödel C, Fokas E, Greten FR. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell 2022:S1535-6108(22)00006-X. [PMID: 35120600 DOI: 10.1016/j.ccell.2022.01.004] [Reference Citation Analysis]
32 Maia A, Wiemann S. Cancer-Associated Fibroblasts: Implications for Cancer Therapy. Cancers (Basel) 2021;13:3526. [PMID: 34298736 DOI: 10.3390/cancers13143526] [Reference Citation Analysis]
33 Wu Q, Cheng H, Chang A, Xu W, Lu F, Wu W. Glucose-mediated catalysis of Au nanoparticles in microgels. Chem Commun 2015;51:16068-71. [DOI: 10.1039/c5cc06386h] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zhang J, Yang M, Fan X, Zhu M, Yin Y, Li H, Chen J, Qin S, Zhang H, Zhang K, Yu F. Biomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis. J Nanobiotechnology 2022;20:103. [PMID: 35246159 DOI: 10.1186/s12951-022-01324-w] [Reference Citation Analysis]
35 Zhu L, Yu X, Wang L, Liu J, Qu Z, Zhang H, Li L, Chen J, Zhou Q. Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges. Oncogenesis 2021;10:47. [PMID: 34247198 DOI: 10.1038/s41389-021-00335-w] [Reference Citation Analysis]
36 Aghamiri S, Jafarpour A, Zandsalimi F, Aghemiri M, Shoja M. Effect of resveratrol on the radiosensitivity of 5‐FU in human breast cancer MCF‐7 cells. J Cell Biochem 2019;120:15671-7. [DOI: 10.1002/jcb.28836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Shao L, Peng Q, Du K, He J, Dong Y, Lin X, Li J, Wu J. Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy. Cancer Manag Res 2017;9:249-58. [PMID: 28721097 DOI: 10.2147/CMAR.S139889] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
38 Liang R, Li Y, Huo M, Lin H, Chen Y. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy. ACS Appl Mater Interfaces 2019;11:42917-31. [DOI: 10.1021/acsami.9b13598] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
39 Shinde-Jadhav S, Mansure JJ, Rayes RF, Marcq G, Ayoub M, Skowronski R, Kool R, Bourdeau F, Brimo F, Spicer J, Kassouf W. Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. Nat Commun 2021;12:2776. [PMID: 33986291 DOI: 10.1038/s41467-021-23086-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Tripathy J, Chowdhury AR, Prusty M, Muduli K, Priyadarshini N, Reddy KS, Banerjee B, Elangovan S. α-Lipoic acid prevents the ionizing radiation-induced epithelial-mesenchymal transition and enhances the radiosensitivity in breast cancer cells. Eur J Pharmacol 2020;871:172938. [PMID: 31958458 DOI: 10.1016/j.ejphar.2020.172938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
41 Dai D, Zhou H, Yin L, Ye F, Yuan X, You T, Zhao X, Long W, Wang D, He X, Feng J, Chen D. PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF-κB in esophageal squamous cancer. Mol Oncol 2021. [PMID: 34738714 DOI: 10.1002/1878-0261.13134] [Reference Citation Analysis]
42 Kim ES, Choi JY, Hwang SJ, Bae IH. Hypermethylation of miR-205-5p by IR Governs Aggressiveness and Metastasis via Regulating Bcl-w and Src. Mol Ther Nucleic Acids 2019;14:450-64. [PMID: 30743214 DOI: 10.1016/j.omtn.2018.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
43 Aydin O, Chandran P, Lorsung RR, Cohen G, Burks SR, Frank JA. The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models. Ultrasound Med Biol 2019;45:3232-45. [PMID: 31530419 DOI: 10.1016/j.ultrasmedbio.2019.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
44 Akkari L, Bowman RL, Tessier J, Klemm F, Handgraaf SM, de Groot M, Quail DF, Tillard L, Gadiot J, Huse JT, Brandsma D, Westerga J, Watts C, Joyce JA. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci Transl Med 2020;12:eaaw7843. [PMID: 32669424 DOI: 10.1126/scitranslmed.aaw7843] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 31.0] [Reference Citation Analysis]
45 Kooreman ES, van Houdt PJ, Keesman R, van Pelt VWJ, Nowee ME, Pos F, Sikorska K, Wetscherek A, Müller AC, Thorwarth D, Tree AC, van der Heide UA. Daily Intravoxel Incoherent Motion (IVIM) In Prostate Cancer Patients During MR-Guided Radiotherapy-A Multicenter Study. Front Oncol 2021;11:705964. [PMID: 34485138 DOI: 10.3389/fonc.2021.705964] [Reference Citation Analysis]
46 Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271-285. [PMID: 28303904 DOI: 10.1038/nrc.2017.13] [Cited by in Crossref: 370] [Cited by in F6Publishing: 348] [Article Influence: 74.0] [Reference Citation Analysis]
47 Elbanna M, Chowdhury NN, Rhome R, Fishel ML. Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy. Front Oncol 2021;11:749496. [PMID: 34733787 DOI: 10.3389/fonc.2021.749496] [Reference Citation Analysis]
48 Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines. Cancers (Basel) 2020;12:E3356. [PMID: 33202734 DOI: 10.3390/cancers12113356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bleve A, Durante B, Sica A, Consonni FM. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad. Int J Mol Sci 2020;21:E5845. [PMID: 32823961 DOI: 10.3390/ijms21165845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Li M, Zha X, Wang S. The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochim Biophys Acta Rev Cancer 2021;1875:188522. [PMID: 33545295 DOI: 10.1016/j.bbcan.2021.188522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
51 Amin S, Baine M, Meza J, Alam M, Lin C. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor. Clin Transl Radiat Oncol 2020;24:34-40. [PMID: 32613090 DOI: 10.1016/j.ctro.2020.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Tong J, Yu H, Li J, Zhou J, Ma X, Yang J. Short-term recurrence and distant metastasis following robotic-assisted radical hysterectomy with pelvic lymphadenectomy and chemoradiotherapy for a stage IB1 cervical adenocarcinoma: A case report and literature review. Medicine (Baltimore) 2019;98:e15387. [PMID: 31027131 DOI: 10.1097/MD.0000000000015387] [Reference Citation Analysis]
53 Guo D, Xu S, Huang Y, Jiang H, Yasen W, Wang N, Su Y, Qian J, Li J, Zhang C, Zhu X. Platinum(IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy. Biomaterials 2018;177:67-77. [PMID: 29885587 DOI: 10.1016/j.biomaterials.2018.05.052] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
54 Liu Y, He D, Xiao M, Zhu Y, Zhou J, Cao K. Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma. Cell Death Dis 2021;12:245. [PMID: 33664256 DOI: 10.1038/s41419-021-03523-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Wang H, Chen Y, Shang J, Wang H, Pan M, Liu X, Zhou X, Wang F. Multifunctional Hypoxia-Involved Gene Silencing Nanoplatform for Sensitizing Photochemotherapy. ACS Appl Mater Interfaces 2020;12:34588-98. [DOI: 10.1021/acsami.0c08315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
56 Hillman GG, Reich LA, Rothstein SE, Abernathy LM, Fountain MD, Hankerd K, Yunker CK, Rakowski JT, Quemeneur E, Slos P. Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen. J Immunother Cancer 2017;5:4. [PMID: 28116088 DOI: 10.1186/s40425-016-0204-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Huang W, He L, Ouyang J, Chen Q, Liu C, Tao W, Chen T. Triangle-Shaped Tellurium Nanostars Potentiate Radiotherapy by Boosting Checkpoint Blockade Immunotherapy. Matter 2020;3:1725-53. [DOI: 10.1016/j.matt.2020.08.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
58 Wang J, Xu Y, Huang Z, Lu X. T cell exhaustion in cancer: Mechanisms and clinical implications. J Cell Biochem 2018;119:4279-86. [DOI: 10.1002/jcb.26645] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
59 Li JJ, Tsang JY, Tse GM. Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment. Cancers (Basel) 2021;13:4233. [PMID: 34439387 DOI: 10.3390/cancers13164233] [Reference Citation Analysis]
60 Shnaider PV, Ivanova OM, Malyants IK, Anufrieva KS, Semenov IA, Pavlyukov MS, Lagarkova MA, Govorun VM, Shender VO. New Insights into Therapy-Induced Progression of Cancer. Int J Mol Sci 2020;21:E7872. [PMID: 33114182 DOI: 10.3390/ijms21217872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Chao Y, Xu L, Liang C, Feng L, Xu J, Dong Z, Tian L, Yi X, Yang K, Liu Z. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses. Nat Biomed Eng 2018;2:611-21. [PMID: 31015634 DOI: 10.1038/s41551-018-0262-6] [Cited by in Crossref: 164] [Cited by in F6Publishing: 154] [Article Influence: 41.0] [Reference Citation Analysis]
62 Levy A, Doyen J. Metformin for non-small cell lung cancer patients: Opportunities and pitfalls. Crit Rev Oncol Hematol 2018;125:41-7. [PMID: 29650275 DOI: 10.1016/j.critrevonc.2018.03.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
63 Kadioglu O, Saeed MEM, Mahmoud N, Azawi S, Mrasek K, Liehr T, Efferth T. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR. Life Sci 2021;:119601. [PMID: 33991550 DOI: 10.1016/j.lfs.2021.119601] [Reference Citation Analysis]
64 Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Immune Priming of the Tumor Microenvironment by Radiation. Trends Cancer. 2016;2:638-645. [PMID: 28741502 DOI: 10.1016/j.trecan.2016.09.007] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
65 Yuan D, Xu J, Wang J, Pan Y, Fu J, Bai Y, Zhang J, Shao C. Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget 2016;7:32707-22. [PMID: 27129166 DOI: 10.18632/oncotarget.9017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 10.6] [Reference Citation Analysis]
66 Lu H, Shi T, Wang M, Li X, Gu Y, Zhang X, Zhang G, Chen W. B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells. Oncoimmunology 2020;9:1748991. [PMID: 32363121 DOI: 10.1080/2162402X.2020.1748991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
67 Lotti LV, Vespa S, Pantalone MR, Perconti S, Esposito DL, Visone R, Veronese A, Paties CT, Sanna M, Verginelli F, Nauclér CS, Mariani-Costantini R. A Developmental Perspective on Paragangliar Tumorigenesis. Cancers (Basel) 2019;11:E273. [PMID: 30813557 DOI: 10.3390/cancers11030273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
68 Bertorello J, Sesen J, Gilhodes J, Evrard S, Courtade-Saïdi M, Augustus M, Uro-Coste E, Toulas C, Moyal EC, Seva C, Dassi E, Cammas A, Skuli N, Millevoi S. Translation reprogramming by eIF3 linked to glioblastoma resistance. NAR Cancer 2020;2:zcaa020. [PMID: 34316689 DOI: 10.1093/narcan/zcaa020] [Reference Citation Analysis]
69 Li L, Huang S, Yao Y, Chen J, Li J, Xiang X, Deng J, Xiong J. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. World J Surg Oncol 2020;18:324. [PMID: 33292276 DOI: 10.1186/s12957-020-02070-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
70 Bonavita E, Pelly VS, Zelenay S. Resolving the dark side of therapy-driven cancer cell death. J Exp Med 2018;215:9-11. [PMID: 29263217 DOI: 10.1084/jem.20172044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
71 Bright S, Kadhim M. The future impacts of non-targeted effects. International Journal of Radiation Biology 2018;94:727-36. [DOI: 10.1080/09553002.2018.1454617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
72 Wang L, Jiang W, Xiao L, Li H, Chen Z, Liu Y, Dou J, Li S, Wang Q, Han W, Wang Y, Liu H. Self-Reporting and Splitting Nanopomegranates Potentiate Deep Tissue Cancer Radiotherapy via Elevated Diffusion and Transcytosis. ACS Nano 2020;14:8459-72. [DOI: 10.1021/acsnano.0c02674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
73 Bosma SC, Hoogstraat M, van der Leij F, de Maaker M, Wesseling J, Lips E, Loo CE, Rutgers EJ, Elkhuizen PH, Bartelink H, van de Vijver MJ. Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer Patients. International Journal of Radiation Oncology*Biology*Physics 2020;106:174-81. [DOI: 10.1016/j.ijrobp.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
74 Xiang H, Wu Y, Zhu X, She M, An Q, Zhou R, Xu P, Zhao F, Yan L, Zhao Y. Highly Stable Silica-Coated Bismuth Nanoparticles Deliver Tumor Microenvironment-Responsive Prodrugs to Enhance Tumor-Specific Photoradiotherapy. J Am Chem Soc 2021;143:11449-61. [PMID: 34292717 DOI: 10.1021/jacs.1c03303] [Reference Citation Analysis]
75 Wu CT, Chen WC, Chen MF. The Response of Prostate Cancer to Androgen Deprivation and Irradiation Due to Immune Modulation. Cancers (Basel) 2018;11:E20. [PMID: 30587810 DOI: 10.3390/cancers11010020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Mouawad M, Biernaski H, Brackstone M, Lock M, Yaremko B, Shmuilovich O, Kornecki A, Ben Nachum I, Muscedere G, Lynn K, Prato FS, Thompson RT, Gaede S, Gelman N. DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR. Clin Transl Radiat Oncol 2020;21:25-31. [PMID: 32021911 DOI: 10.1016/j.ctro.2019.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
77 Chung E, Mulhall J. Practical Considerations in Inflatable Penile Implant Surgery. J Sex Med 2021;18:1320-7. [PMID: 34247953 DOI: 10.1016/j.jsxm.2021.05.017] [Reference Citation Analysis]
78 Brown NF, Carter TJ, Ottaviani D, Mulholland P. Harnessing the immune system in glioblastoma. Br J Cancer 2018;119:1171-81. [PMID: 30393372 DOI: 10.1038/s41416-018-0258-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 16.5] [Reference Citation Analysis]
79 Timaner M, Kotsofruk R, Raviv Z, Magidey K, Shechter D, Kan T, Nevelsky A, Daniel S, de Vries EGE, Zhang T, Kaidar-Person O, Kerbel RS, Shaked Y. Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene 2020;39:187-203. [PMID: 31467431 DOI: 10.1038/s41388-019-0971-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
80 Sang W, Zhang Z, Dai Y, Chen X. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chem Soc Rev 2019;48:3771-810. [DOI: 10.1039/c8cs00896e] [Cited by in Crossref: 126] [Cited by in F6Publishing: 30] [Article Influence: 42.0] [Reference Citation Analysis]
81 Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance. Onco Targets Ther 2020;13:6037-50. [PMID: 32606809 DOI: 10.2147/OTT.S256708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
82 Sreepadmanabh M, Toley BJ. Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics. Biotechnology Advances 2018;36:1094-110. [DOI: 10.1016/j.biotechadv.2018.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
83 Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 2021:gutjnl-2020-321175. [PMID: 33487592 DOI: 10.1136/gutjnl-2020-321175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Rodrigues CF, Alves CG, Lima-sousa R, Moreira AF, de Melo-diogo D, Correia IJ. Inorganic-based drug delivery systems for cancer therapy. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Elsevier; 2020. pp. 283-316. [DOI: 10.1016/b978-0-12-819666-3.00010-9] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887-904. [PMID: 30361552 DOI: 10.1038/nrd.2018.169] [Cited by in Crossref: 427] [Cited by in F6Publishing: 408] [Article Influence: 106.8] [Reference Citation Analysis]
86 Xu Q, Zhang H, Liu H, Han Y, Qiu W, Li Z. Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma. Biomaterials 2022;280:121287. [PMID: 34864449 DOI: 10.1016/j.biomaterials.2021.121287] [Reference Citation Analysis]
87 Byrne NM, Tambe P, Coulter JA. Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives. J Pers Med 2021;11:53. [PMID: 33467153 DOI: 10.3390/jpm11010053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Keam SP, Gulati T, Gamell C, Caramia F, Huang C, Schittenhelm RB, Kleifeld O, Neeson PJ, Haupt Y, Williams SG. Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry. Prostate 2018;78:563-75. [PMID: 29520850 DOI: 10.1002/pros.23500] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
89 Wang X, Zhang C, Du J, Dong X, Jian S, Yan L, Gu Z, Zhao Y. Enhanced Generation of Non-Oxygen Dependent Free Radicals by Schottky-type Heterostructures of Au-Bi2S3 Nanoparticles via X-ray-Induced Catalytic Reaction for Radiosensitization. ACS Nano 2019;13:5947-58. [PMID: 30969747 DOI: 10.1021/acsnano.9b01818] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 18.0] [Reference Citation Analysis]
90 Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol 2019;10:193. [PMID: 30828330 DOI: 10.3389/fimmu.2019.00193] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
91 Mo J, Leung N, Gupta P, Zhu B, Velliou E, Sui T. Novel in situ multi-level analysis of structural-mechanical relations in a bioinspired polyurethane-based tissue model. Materials Today Advances 2021;12:100184. [DOI: 10.1016/j.mtadv.2021.100184] [Reference Citation Analysis]
92 Li J, Luo Y, Pu K. Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy. Angew Chem Int Ed 2021;60:12682-705. [DOI: 10.1002/anie.202008386] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
93 Thomas RP, Nagpal S, Iv M, Soltys SG, Bertrand S, Pelpola JS, Ball R, Yang J, Sundaram V, Lavezo J, Born D, Vogel H, Brown JM, Recht LD. Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. Clin Cancer Res 2019;25:6948-57. [PMID: 31537527 DOI: 10.1158/1078-0432.CCR-19-1421] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
94 Zhou Z, Deng H, Yang W, Wang Z, Lin L, Munasinghe J, Jacobson O, Liu Y, Tang L, Ni Q, Kang F, Liu Y, Niu G, Bai R, Qian C, Song J, Chen X. Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging. Nat Commun 2020;11:3032. [PMID: 32541769 DOI: 10.1038/s41467-020-16771-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
95 Yang W, Zhu G, Wang S, Yu G, Yang Z, Lin L, Zhou Z, Liu Y, Dai Y, Zhang F, Shen Z, Liu Y, He Z, Lau J, Niu G, Kiesewetter DO, Hu S, Chen X. In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy. ACS Nano 2019;13:3083-94. [PMID: 30835435 DOI: 10.1021/acsnano.8b08346] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 23.7] [Reference Citation Analysis]
96 Yi X, Shen M, Liu X, Gu J. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. Nanoscale 2021;13:13943-61. [PMID: 34477676 DOI: 10.1039/d1nr03034e] [Reference Citation Analysis]
97 Ilicic K, Combs SE, Schmid TE. New insights in the relative radiobiological effectiveness of proton irradiation. Radiat Oncol. 2018;13:6. [PMID: 29338744 DOI: 10.1186/s13014-018-0954-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
98 Zhao G, Wu H, Feng R, Wang D, Xu P, Jiang P, Yang K, Wang H, Guo Z, Chen Q. Novel Metal Polyphenol Framework for MR Imaging-Guided Photothermal Therapy. ACS Appl Mater Interfaces 2018;10:3295-304. [PMID: 29300453 DOI: 10.1021/acsami.7b16222] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
99 Yan S, Fang J, Chen Y, Xie Y, Zhang S, Zhu X, Fang F. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer. BMC Cancer 2020;20:1205. [PMID: 33287740 DOI: 10.1186/s12885-020-07695-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 [DOI: 10.1101/564724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Ma Q, Liu Y, Zhu H, Zhang L, Liao X. Nanozymes in Tumor Theranostics. Front Oncol 2021;11:666017. [PMID: 34737942 DOI: 10.3389/fonc.2021.666017] [Reference Citation Analysis]
102 Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019;234:17187-204. [DOI: 10.1002/jcp.28504] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
103 Wang J, Xu Z, Wang Z, Du G, Lun L. TGF-beta signaling in cancer radiotherapy. Cytokine 2021;148:155709. [PMID: 34597918 DOI: 10.1016/j.cyto.2021.155709] [Reference Citation Analysis]
104 Ma J, Lu Y, Zhang S, Li Y, Huang J, Yin Z, Ren J, Huang K, Liu L, Yang K, Wu G, Xu S. β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer. Cell Death Differ 2018;25:1473-85. [PMID: 29396548 DOI: 10.1038/s41418-017-0055-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
105 Yi X, Chen L, Zhong X, Gao R, Qian Y, Wu F, Song G, Chai Z, Liu Z, Yang K. Core–shell Au@MnO2 nanoparticles for enhanced radiotherapy via improving the tumor oxygenation. Nano Res 2016;9:3267-78. [DOI: 10.1007/s12274-016-1205-8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 80] [Article Influence: 17.2] [Reference Citation Analysis]
106 Bolli E, D'Huyvetter M, Murgaski A, Berus D, Stangé G, Clappaert EJ, Arnouk S, Pombo Antunes AR, Krasniqi A, Lahoutte T, Gonçalves A, Vuylsteke M, Raes G, Devoogdt N, Movahedi K, Van Ginderachter JA. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors. J Control Release 2019;314:1-11. [PMID: 31626860 DOI: 10.1016/j.jconrel.2019.10.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
107 Neshastehriz A, Amini SM, Mohammadi A, Mahdavi SR, Mahabadi VP, Akbari A. In-vitro investigation of green synthesized gold nanoparticle’s role in combined photodynamic and radiation therapy of cancerous cells. Adv Nat Sci: Nanosci Nanotechnol 2020;11:045006. [DOI: 10.1088/2043-6254/abb8c7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
108 Zhang J, Yang L, Huang F, Zhao C, Liu J, Zhang Y, Liu J. Multifunctional Hybrid Hydrogel Enhanced Antitumor Therapy through Multiple Destroying DNA Functions by a Triple-Combination Synergistic Therapy. Adv Healthc Mater 2021;:e2101190. [PMID: 34382378 DOI: 10.1002/adhm.202101190] [Reference Citation Analysis]
109 Mikhalkevich N, O'Carroll IP, Tkavc R, Lund K, Sukumar G, Dalgard CL, Johnson KR, Li W, Wang T, Nath A, Iordanskiy S. Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses. PLoS Pathog 2021;17:e1009305. [PMID: 33556144 DOI: 10.1371/journal.ppat.1009305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
110 Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel) 2019;11:E1618. [PMID: 31652660 DOI: 10.3390/cancers11101618] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 44.7] [Reference Citation Analysis]
111 Barbarisi M, Iaffaioli RV, Armenia E, Schiavo L, De Sena G, Tafuto S, Barbarisi A, Quagliariello V. Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. J Cell Physiol 2018;233:6550-64. [PMID: 29030990 DOI: 10.1002/jcp.26238] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
112 Yu J, Lee SH, Jeung TS, Chang H. Expression of vascular endothelial growth factor as a predictor of complete response for preoperative chemoradiotherapy in rectal cancer. Medicine (Baltimore) 2019;98:e16190. [PMID: 31261557 DOI: 10.1097/MD.0000000000016190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
113 Feng M, Xiong G, Cao Z, Yang G, Zheng S, Song X, You L, Zheng L, Zhang T, Zhao Y. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017;407:57-65. [PMID: 28826722 DOI: 10.1016/j.canlet.2017.08.006] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 22.6] [Reference Citation Analysis]
114 Choi C, Son A, Lee HS, Lee YJ, Park HC. Radiosensitization by Marine Sponge Agelas sp. Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction. Sci Rep 2018;8:6317. [PMID: 29679028 DOI: 10.1038/s41598-018-24745-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
115 Wu CT, Huang YC, Chen WC, Chen MF. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling. Front Oncol 2021;11:619365. [PMID: 34109109 DOI: 10.3389/fonc.2021.619365] [Reference Citation Analysis]
116 Ishii G. Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in the Tumor Microenvironment After Radiotherapy. EBioMedicine 2017;17:7-8. [PMID: 28274806 DOI: 10.1016/j.ebiom.2017.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
117 Fan Y, Zhang J, Shi M, Li D, Lu C, Cao X, Peng C, Mignani S, Majoral JP, Shi X. Poly(amidoamine) Dendrimer-Coordinated Copper(II) Complexes as a Theranostic Nanoplatform for the Radiotherapy-Enhanced Magnetic Resonance Imaging and Chemotherapy of Tumors and Tumor Metastasis. Nano Lett 2019;19:1216-26. [PMID: 30698017 DOI: 10.1021/acs.nanolett.8b04757] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 14.7] [Reference Citation Analysis]
118 Zhou X, Meng Z, She J, Zhang Y, Yi X, Zhou H, Zhong J, Dong Z, Han X, Chen M, Fan Q, Yang K, Wang C. Near-Infrared Light-Responsive Nitric Oxide Delivery Platform for Enhanced Radioimmunotherapy. Nanomicro Lett 2020;12:100. [PMID: 34138094 DOI: 10.1007/s40820-020-00431-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
119 Huang Y, Fan J, Li Y, Fu S, Chen Y, Wu J. Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET. Front Oncol 2021;11:731503. [PMID: 34557414 DOI: 10.3389/fonc.2021.731503] [Reference Citation Analysis]
120 Mi Z, Feng ZC, Li C, Yang X, Ma MT, Rong PF. Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy. J Cancer 2019;10:4765-76. [PMID: 31598148 DOI: 10.7150/jca.32650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
121 Herrscher H, Sauer B, Truntzer P, Robert C. Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019. Eur J Cancer 2021;149:91-3. [PMID: 33839589 DOI: 10.1016/j.ejca.2021.03.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Chen H, Luan X, Paholak HJ, Burnett JP, Stevers NO, Sansanaphongpricha K, He M, Chang AE, Li Q, Sun D. Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy. Nanomedicine (Lond) 2020;15:77-92. [PMID: 31868112 DOI: 10.2217/nnm-2019-0190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
123 Zhi X, Jiang K, Shen Y, Su X, Wang K, Ma Y, Zhou L. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non-surgical esophageal squamous cell carcinoma patients treated with radiotherapy. J Clin Lab Anal 2020;34:e23468. [PMID: 32681567 DOI: 10.1002/jcla.23468] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Zheng X, Cui L, Chen M, Soto LA, Graves EE, Rao J. A Near-Infrared Phosphorescent Nanoprobe Enables Quantitative, Longitudinal Imaging of Tumor Hypoxia Dynamics during Radiotherapy. Cancer Res 2019;79:4787-97. [PMID: 31311808 DOI: 10.1158/0008-5472.CAN-19-0530] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
125 Moreau M, Yasmin-Karim S, Kunjachan S, Sinha N, Gremse F, Kumar R, Chow KF, Ngwa W. Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants. Front Oncol 2018;8:56. [PMID: 29594038 DOI: 10.3389/fonc.2018.00056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
126 Sarsarshahi S, Madjd Z, Bozsaky E, Kowaliuk J, Kuess P, Ghahremani MH, Doerr W. An evaluation of the effect of bortezomib on radiation-induced urinary bladder dysfunction. Strahlenther Onkol 2019;195:934-9. [PMID: 31363801 DOI: 10.1007/s00066-019-01497-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
127 Chen Y, Yang J, Fu S, Wu J. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine 2020;15:9407-30. [PMID: 33262595 DOI: 10.2147/IJN.S272902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
128 Baseeruddin Alvi S, P S R, Begum N, Jogdand AB, Veeresh B, Rengan AK. In Situ Nanotransformable Hydrogel for Chemo-Photothermal Therapy of Localized Tumors and Targeted Therapy of Highly Metastatic Tumors. ACS Appl Mater Interfaces 2021;13:55862-78. [PMID: 34788534 DOI: 10.1021/acsami.1c17054] [Reference Citation Analysis]
129 Berzaghi R, Ahktar MA, Islam A, Pedersen BD, Hellevik T, Martinez-Zubiaurre I. Fibroblast-Mediated Immunoregulation of Macrophage Function Is Maintained after Irradiation. Cancers (Basel) 2019;11:E689. [PMID: 31108906 DOI: 10.3390/cancers11050689] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
130 Luen S, Virassamy B, Savas P, Salgado R, Loi S. The genomic landscape of breast cancer and its interaction with host immunity. Breast. 2016;29:241-250. [PMID: 27481651 DOI: 10.1016/j.breast.2016.07.015] [Cited by in Crossref: 104] [Cited by in F6Publishing: 93] [Article Influence: 20.8] [Reference Citation Analysis]
131 Chen HHW, Kuo MT. Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget 2017;8:62742-58. [PMID: 28977985 DOI: 10.18632/oncotarget.18409] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 14.6] [Reference Citation Analysis]
132 Yildirim BA, Guler OC, Kose F, Onal C. The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy. J Obstet Gynaecol 2019;39:695-701. [PMID: 31023114 DOI: 10.1080/01443615.2019.1586852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Feng Y, Wang Z, Yang N, Liu S, Yan J, Song J, Yang S, Zhang Y. Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data. Front Cell Dev Biol 2021;9:724172. [PMID: 34414195 DOI: 10.3389/fcell.2021.724172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Jin J, Zhao Q. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. J Nanobiotechnology 2020;18:75. [PMID: 32408880 DOI: 10.1186/s12951-020-00629-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
135 Vehlow A, Storch K, Matzke D, Cordes N. Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology. Recent Results Cancer Res 2016;198:89-106. [PMID: 27318682 DOI: 10.1007/978-3-662-49651-0_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
136 Dickreuter E, Cordes N. The cancer cell adhesion resistome: mechanisms, targeting and translational approaches. Biol Chem 2017;398:721-35. [PMID: 28002024 DOI: 10.1515/hsz-2016-0326] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
137 Moutabian H, Majdaeen M, Ghahramani-asl R, Yadollahi M, Gharepapagh E, Ataei G, Falahatpour Z, Bagheri H, Farhood B. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02561-7] [Reference Citation Analysis]
138 Silvoniemi A, Suilamo S, Laitinen T, Forsback S, Löyttyniemi E, Vaittinen S, Saunavaara V, Solin O, Grönroos TJ, Minn H. Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer. Eur J Nucl Med Mol Imaging 2018;45:161-9. [PMID: 29075831 DOI: 10.1007/s00259-017-3857-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
139 Meirson T, Gil-Henn H. Targeting invadopodia for blocking breast cancer metastasis. Drug Resist Updat 2018;39:1-17. [PMID: 30075834 DOI: 10.1016/j.drup.2018.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
140 Kim W, Kim MS, Kim HJ, Lee E, Jeong JH, Park I, Jeong YK, Jang WI. Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo. Int J Hyperthermia 2018;34:276-83. [PMID: 28659004 DOI: 10.1080/02656736.2017.1335440] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
141 Hlavata Z, Solinas C, De Silva P, Porcu M, Saba L, Willard-Gallo K, Scartozzi M. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity? Target Oncol 2018;13:113-23. [PMID: 29470785 DOI: 10.1007/s11523-018-0556-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
142 Wang F, Luo R, Xin H, Zhang Y, Córdova Wong BJ, Wang W, Lei J. Hypoxia-stimulated tumor therapy associated with the inhibition of cancer cell stemness. Biomaterials 2020;263:120330. [DOI: 10.1016/j.biomaterials.2020.120330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Li M, Wang Z, Liu X, Song N, Song Y, Shi X, Liu J, Liu J, Yu Z. Adaptable peptide-based therapeutics modulating tumor microenvironment for combinatorial radio-immunotherapy. J Control Release 2021;340:35-47. [PMID: 34699869 DOI: 10.1016/j.jconrel.2021.10.026] [Reference Citation Analysis]
144 Ruan Q, Wang H, Burke LJ, Bridle KR, Li X, Zhao CX, Crawford DHG, Roberts MS, Liang X. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. Int J Cancer 2020;147:1519-27. [PMID: 32010970 DOI: 10.1002/ijc.32899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
145 Zheng R, Li F, Li F, Gong A. Targeting tumor vascularization: promising strategies for vascular normalization. J Cancer Res Clin Oncol 2021;147:2489-505. [PMID: 34148156 DOI: 10.1007/s00432-021-03701-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, Gagnière J, Vazeille E, Bonnet M. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci 2019;20:E4584. [PMID: 31533218 DOI: 10.3390/ijms20184584] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
147 Liu H, Cheng R, Dong X, Zhu S, Zhou R, Yan L, Zhang C, Wang Q, Gu Z, Zhao Y. BiO 2– x Nanosheets as Radiosensitizers with Catalase-Like Activity for Hypoxia Alleviation and Enhancement of the Radiotherapy of Tumors. Inorg Chem 2020;59:3482-93. [DOI: 10.1021/acs.inorgchem.9b03280] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
148 Pourshohod A, Jamalan M, Zeinali M, Ghanemi M, kheirollah A. Enhancement of X-ray radiotherapy by specific delivery of ZHER2 affibody-conjugated gold nanoparticles to HER2-positive malignant cells. Journal of Drug Delivery Science and Technology 2019;52:934-41. [DOI: 10.1016/j.jddst.2019.05.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Jiang X, Zhang B, Zhou Z, Meng L, Sun Z, Xu Y, Xu Q, Yuan A, Yu L, Qian H, Wu J, Hu Y, Liu B. Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine. Drug Deliv 2017;24:1419-28. [PMID: 28937321 DOI: 10.1080/10717544.2017.1378939] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
150 Ma W, Mao Q, Xia W, Dong G, Yu C, Jiang F. Gut Microbiota Shapes the Efficiency of Cancer Therapy. Front Microbiol. 2019;10:1050. [PMID: 31293523 DOI: 10.3389/fmicb.2019.01050] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 19.0] [Reference Citation Analysis]
151 Sheng Y, Chen K, Jiang W, Wu Z, Zhang W, Jing H, Wang L, Qu C, Ren H. PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury. Transl Lung Cancer Res 2021;10:685-98. [PMID: 33718014 DOI: 10.21037/tlcr-20-838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Li K, Li M, Luo Z, Mao Y, Yu Y, He Y, Zhou J, Fei Y, Pei Y, Cai K. Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel. Biochem Biophys Res Commun 2020;526:321-7. [PMID: 32220496 DOI: 10.1016/j.bbrc.2020.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Liu J, Wei C, Tang H, Liu Y, Liu W, Lin C. The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma. Medicine (Baltimore) 2020;99:e18545. [PMID: 31914029 DOI: 10.1097/MD.0000000000018545] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Liu YT, Sun ZJ. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics 2021;11:5365-86. [PMID: 33859752 DOI: 10.7150/thno.58390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
155 Bienkowska KJ, Hanley CJ, Thomas GJ. Cancer-Associated Fibroblasts in Oral Cancer: A Current Perspective on Function and Potential for Therapeutic Targeting. Front Oral Health 2021;2:686337. [PMID: 35048030 DOI: 10.3389/froh.2021.686337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
156 McLaughlin M, Patin EC, Pedersen M, Wilkins A, Dillon MT, Melcher AA, Harrington KJ. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer 2020;20:203-17. [PMID: 32161398 DOI: 10.1038/s41568-020-0246-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 40.0] [Reference Citation Analysis]
157 Zhang Z, Wang L, Ding Y, Wu J, Hu Y, Yuan A. Synergy of hypoxia relief and chromatin remodeling to overcome tumor radiation resistance. Biomater Sci 2020;8:4739-49. [DOI: 10.1039/d0bm00119h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Zhang R, Gao X, Bai H, Ning K. Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare. Front Pharmacol 2020;11:538. [PMID: 32390855 DOI: 10.3389/fphar.2020.00538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
159 Porosnicu I, Butnaru CM, Tiseanu I, Stancu E, Munteanu CVA, Bita BI, Duliu OG, Sima F. Y2O3 Nanoparticles and X-ray Radiation-Induced Effects in Melanoma Cells. Molecules 2021;26:3403. [PMID: 34199757 DOI: 10.3390/molecules26113403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Liu D, Zhang P, Zhao J, Yang L, Wang W. Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis. Biomed Res Int 2021;2021:5587441. [PMID: 34104648 DOI: 10.1155/2021/5587441] [Reference Citation Analysis]
161 Cai S, Xie L, Xu J, Zhou H, Yang C, Tang L, Tian Y, Li M. (-)-Epigallocatechin-3-Gallate (EGCG) Modulates the Composition of the Gut Microbiota to Protect Against Radiation-Induced Intestinal Injury in Mice. Front Oncol 2022;12:848107. [DOI: 10.3389/fonc.2022.848107] [Reference Citation Analysis]
162 Chang Y, Chang PM, Li C, Chan M, Lee Y, Chen M, Hsiao M. Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer. Front Oncol 2022;11:811635. [DOI: 10.3389/fonc.2021.811635] [Reference Citation Analysis]
163 Cardilin T, Almquist J, Jirstrand M, Zimmermann A, Lignet F, El Bawab S, Gabrielsson J. Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents. Cancer Chemother Pharmacol 2019;83:1159-73. [PMID: 30976845 DOI: 10.1007/s00280-019-03829-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Larionova I, Rakina M, Ivanyuk E, Trushchuk Y, Chernyshova A, Denisov E. Radiotherapy resistance: identifying universal biomarkers for various human cancers. J Cancer Res Clin Oncol 2022. [PMID: 35113235 DOI: 10.1007/s00432-022-03923-4] [Reference Citation Analysis]
165 Zhu Y, Wen L, Shao S, Tan Y, Meng T, Yang X, Liu Y, Liu X, Yuan H, Hu F. Inhibition of tumor-promoting stroma to enforce subsequently targeting AT1R on tumor cells by pathological inspired micelles. Biomaterials 2018;161:33-46. [PMID: 29421561 DOI: 10.1016/j.biomaterials.2018.01.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
166 Danielsson F, Fasterius E, Sullivan D, Hases L, Sanli K, Zhang C, Mardinoglu A, Al-Khalili C, Huss M, Uhlén M, Williams C, Lundberg E. Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia. Oncotarget 2018;9:19730-44. [PMID: 29731978 DOI: 10.18632/oncotarget.24808] [Reference Citation Analysis]
167 Leroi N, Lallemand F, Coucke P, Noel A, Martinive P. Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Front Pharmacol 2016;7:78. [PMID: 27064581 DOI: 10.3389/fphar.2016.00078] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
168 Liu C, Liao J, Chen L, Chen J, Ding R, Gong X, Cui C, Pang Z, Zheng W, Song L. The integrated high-resolution reflection-mode photoacoustic and fluorescence confocal microscopy. Photoacoustics 2019;14:12-8. [PMID: 30923675 DOI: 10.1016/j.pacs.2019.02.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
169 Keenan LG, Ibrahim N, Dunne MT, Finn M, Armstrong JG. The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivation. Br J Radiol 2020;93:20190577. [PMID: 31944823 DOI: 10.1259/bjr.20190577] [Reference Citation Analysis]
170 Tang W, Yang Z, He L, Deng L, Fathi P, Zhu S, Li L, Shen B, Wang Z, Jacobson O, Song J, Zou J, Hu P, Wang M, Mu J, Cheng Y, Ma Y, Tang L, Fan W, Chen X. A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy. Nat Commun 2021;12:523. [PMID: 33483518 DOI: 10.1038/s41467-020-20860-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
171 Portella L, Scala S. Ionizing radiation effects on the tumor microenvironment. Semin Oncol 2019;46:254-60. [PMID: 31383368 DOI: 10.1053/j.seminoncol.2019.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
172 Farhood B, Mortezaee K, Goradel NH, Khanlarkhani N, Salehi E, Nashtaei MS, Najafi M, Sahebkar A. Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol 2019;234:5728-40. [PMID: 30317564 DOI: 10.1002/jcp.27442] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 13.5] [Reference Citation Analysis]
173 Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 2019;16:282-95. [PMID: 30778141 DOI: 10.1038/s41575-019-0115-0] [Cited by in Crossref: 102] [Cited by in F6Publishing: 116] [Article Influence: 34.0] [Reference Citation Analysis]
174 Xiong Z, Zhong J, Zhao Z, Chen T. Biocompatible ruthenium polypyridyl complexes as efficient radiosensitizers. Dalton Trans 2019;48:4114-8. [DOI: 10.1039/c9dt00333a] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
175 Song HN, Jin H, Kim JH, Ha IB, Kang KM, Choi HS, Jeong HJ, Kim MY, Kim HJ, Jeong BK. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model. Int J Mol Sci 2021;22:10476. [PMID: 34638817 DOI: 10.3390/ijms221910476] [Reference Citation Analysis]
176 te Riele R, Dronkers E, Wieringa M, De Herdt M, Sewnaik A, Hardillo J, Baatenburg de Jong R. Influence of anemia and BMI on prognosis of laryngeal squamous cell carcinoma: Development of an updated prognostic model. Oral Oncology 2018;78:25-30. [DOI: 10.1016/j.oraloncology.2018.01.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
177 Li H, Wang M, Huang B, Zhu SW, Zhou JJ, Chen DR, Cui R, Zhang M, Sun ZJ. Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis. Nat Commun 2021;12:7149. [PMID: 34887404 DOI: 10.1038/s41467-021-27485-0] [Reference Citation Analysis]
178 Khoshinani HM, Afshar S, Pashaki AS, Mahdavinezhad A, Nikzad S, Najafi R, Amini R, Gholami MH, khoshghadam A, Saidijam M. Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line. Jpn J Radiol 2017;35:664-72. [DOI: 10.1007/s11604-017-0679-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
179 Shin SW, Yang K, Lee M, Moon J, Son A, Kim Y, Choi S, Kim DH, Choi C, Lee N, Park HC. Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments. Int J Mol Sci 2021;22:2637. [PMID: 33807943 DOI: 10.3390/ijms22052637] [Reference Citation Analysis]
180 Panek R, Welsh L, Baker LCJ, Schmidt MA, Wong KH, Riddell AM, Koh DM, Dunlop A, Mcquaid D, d'Arcy JA, Bhide SA, Harrington KJ, Nutting CM, Hopkinson G, Richardson C, Box C, Eccles SA, Leach MO, Robinson SP, Newbold KL. Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. Clin Cancer Res 2017;23:4233-41. [PMID: 28314789 DOI: 10.1158/1078-0432.CCR-16-1209] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
181 Lee P, Gujar S. Potentiating prostate cancer immunotherapy with oncolytic viruses. Nat Rev Urol 2018;15:235-50. [PMID: 29434366 DOI: 10.1038/nrurol.2018.10] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
182 Lee KJ, Shin SH, Lee JH, Ju EJ, Park Y, Hwang JJ, Suh Y, Hong S, Jang SJ, Lee JS, Song SY, Jeong S, Choi EK. A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials 2017;141:136-48. [DOI: 10.1016/j.biomaterials.2017.06.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
183 Wang M, Li H, Huang B, Chen S, Cui R, Sun ZJ, Zhang M, Sun T. An Ultra-Stable, Oxygen-Supply Nanoprobe Emitting in Near-Infrared-II Window to Guide and Enhance Radiotherapy by Promoting Anti-Tumor Immunity. Adv Healthc Mater 2021;10:e2100090. [PMID: 33885213 DOI: 10.1002/adhm.202100090] [Reference Citation Analysis]
184 Serša G, Čemažar M, Markelc B. Blood Flow Modifying and Vascular-Disrupting Effects of Electroporation and Electrochemotherapy. In: Miklavčič D, editor. Handbook of Electroporation. Cham: Springer International Publishing; 2017. pp. 691-705. [DOI: 10.1007/978-3-319-32886-7_165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
185 Liang R, Chen Y, Huo M, Zhang J, Li Y. Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy. Nanoscale Horiz 2019;4:890-901. [DOI: 10.1039/c9nh00008a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
186 Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF. Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer 2017;84:304-14. [PMID: 28863385 DOI: 10.1016/j.ejca.2017.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
187 Ravichandran G, Rengan AK. Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review. ACS Appl Nano Mater 2020;3:9542-59. [DOI: 10.1021/acsanm.0c01785] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
188 Yu P, Han X, Yin L, Hui K, Guo Y, Yuan A, Hu Y, Wu J. Artificial Red Blood Cells Constructed by Replacing Heme with Perfluorodecalin for Hypoxia‐Induced Radioresistance. Adv Therap 2019;2:1900031. [DOI: 10.1002/adtp.201900031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
189 Jiang S, Yu M, Wang H, Han S, Cheng M, Zhang S, Liu J, Wang X, Dong M. 131I-radioisotope modified in PEGylation metal organic frameworks for sensitization in refractory differentiated thyroid cancer treatment. J Biomater Appl 2021;:8853282211029822. [PMID: 34254840 DOI: 10.1177/08853282211029822] [Reference Citation Analysis]
190 Kolberg HC, Hoffmann O, Baumann R. The Abscopal Effect: Could a Phenomenon Described Decades Ago Become Key to Enhancing the Response to Immune Therapies in Breast Cancer? Breast Care (Basel) 2020;15:443-9. [PMID: 33223988 DOI: 10.1159/000511431] [Reference Citation Analysis]
191 Yang Y, Nam GH, Kim GB, Kim YK, Kim IS. Intrinsic cancer vaccination. Adv Drug Deliv Rev 2019;151-152:2-22. [PMID: 31132376 DOI: 10.1016/j.addr.2019.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
192 Thompson E, Smart S, Kinchesh P, Bulte D, Stride E. Magnetic resonance imaging of oxygen microbubbles. Healthc Technol Lett 2019;6:138-42. [PMID: 31832209 DOI: 10.1049/htl.2018.5058] [Reference Citation Analysis]
193 Naz S, Sowers A, Choudhuri R, Wissler M, Gamson J, Mathias A, Cook JA, Mitchell JB. Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo. Clin Cancer Res 2018;24:3994-4005. [PMID: 29716919 DOI: 10.1158/1078-0432.CCR-17-3575] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
194 Levy A, Nigro G, Sansonetti PJ, Deutsch E. Candidate immune biomarkers for radioimmunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017;1868:58-68. [DOI: 10.1016/j.bbcan.2017.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
195 Hossam N, Matboli M, Shehata HH, Aboelhussein MM, Hassan MK, Eissa S. Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 2020;5:455-68. [DOI: 10.1080/23808993.2020.1816136] [Reference Citation Analysis]
196 Carvalho HA, Villar RC. Radiotherapy and immune response: the systemic effects of a local treatment. Clinics (Sao Paulo) 2018;73:e557s. [PMID: 30540123 DOI: 10.6061/clinics/2018/e557s] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
197 Tran TA, Kappelhoff J, Jüstel T, Anderson RR, Purschke M. UV emitting nanoparticles enhance the effect of ionizing radiation in 3D lung cancer spheroids. Int J Radiat Biol 2022;:1-34. [PMID: 35020574 DOI: 10.1080/09553002.2022.2027541] [Reference Citation Analysis]
198 Maurer GD, Heller S, Wanka C, Rieger J, Steinbach JP. Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide. Int J Mol Sci 2019;20:E1061. [PMID: 30823646 DOI: 10.3390/ijms20051061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
199 Meng Z, Chao Y, Zhou X, Liang C, Liu J, Zhang R, Cheng L, Yang K, Pan W, Zhu M, Liu Z. Near-Infrared-Triggered in Situ Gelation System for Repeatedly Enhanced Photothermal Brachytherapy with a Single Dose. ACS Nano 2018;12:9412-22. [DOI: 10.1021/acsnano.8b04544] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 14.3] [Reference Citation Analysis]
200 Huo D, Liu S, Zhang C, He J, Zhou Z, Zhang H, Hu Y. Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy. ACS Nano 2017;11:10159-74. [PMID: 28992409 DOI: 10.1021/acsnano.7b04737] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 17.8] [Reference Citation Analysis]
201 Waller V, Pruschy M. Combined Radiochemotherapy: Metalloproteinases Revisited. Front Oncol 2021;11:676583. [PMID: 34055644 DOI: 10.3389/fonc.2021.676583] [Reference Citation Analysis]
202 Trommer M, Kinsky J, Adams A, Hellmich M, Schlaak M, von Bergwelt-Baildon M, Celik E, Rosenbrock J, Morgenthaler J, Herter JM, Linde P, Mauch C, Theurich S, Marnitz S, Baues C. Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching. Cancers (Basel) 2020;12:E2429. [PMID: 32867046 DOI: 10.3390/cancers12092429] [Reference Citation Analysis]
203 Jiang J, Wang W, Zheng H, Chen X, Liu X, Xie Q, Cai X, Zhang Z, Li R. Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances. Biomaterials 2022;285:121561. [DOI: 10.1016/j.biomaterials.2022.121561] [Reference Citation Analysis]
204 Yu ZK, Xie RL, You R, Liu YP, Chen XY, Chen MY, Huang PY. The role of the bacterial microbiome in the treatment of cancer. BMC Cancer 2021;21:934. [PMID: 34412621 DOI: 10.1186/s12885-021-08664-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Yang K, Hou Y, Zhang Y, Liang H, Sharma A, Zheng W, Wang L, Torres R, Tatebe K, Chmura SJ, Pitroda SP, Gilbert JA, Fu YX, Weichselbaum RR. Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation. J Exp Med 2021;218:e20201915. [PMID: 33496784 DOI: 10.1084/jem.20201915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
206 Victori P, Buffa FM. The many faces of mathematical modelling in oncology. Br J Radiol 2019;92:20180856. [PMID: 30485129 DOI: 10.1259/bjr.20180856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 Kulcenty K, Piotrowski I, Zaleska K, Wichtowski M, Wróblewska J, Murawa D, Suchorska WM. Wound fluids collected postoperatively from patients with breast cancer induce epithelial to mesenchymal transition but intraoperative radiotherapy impairs this effect by activating the radiation-induced bystander effect. Sci Rep 2019;9:7891. [PMID: 31133667 DOI: 10.1038/s41598-019-44412-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
208 Chang H, Wei JW, Tao YL, Ding PR, Xia YF, Gao YH, Xiao WW. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer. Cancer Res Treat 2018;50:1203-13. [PMID: 29268566 DOI: 10.4143/crt.2017.538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
209 Cui Y, Li B, Pollom EL, Horst KC, Li R. Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer. Clin Cancer Res. 2018;24:4754-4762. [PMID: 29921729 DOI: 10.1158/1078-0432.ccr-18-0825] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
210 Celora GL, Bader SB, Hammond EM, Maini PK, Pitt-Francis JM, Byrne HM. DNA-structured mathematical model of cell-cycle progression in cyclic hypoxia. J Theor Biol 2022;:111104. [PMID: 35337794 DOI: 10.1016/j.jtbi.2022.111104] [Reference Citation Analysis]
211 Huang W, Zhang L, Yang M, Wu X, Wang X, Huang W, Yuan L, Pan H, Wang Y, Wang Z, Wu Y, Huang J, Liang H, Li S, Liao L, Liu L, Guan J. Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway. J Exp Clin Cancer Res 2021;40:87. [PMID: 33648530 DOI: 10.1186/s13046-021-01878-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
212 Li H, Liu H, Zhang N, Zhu Z. Involvement of the G-Protein-Coupled Receptor 4 in the Increased Expression of RANK/RANKL/OPG System and Neurotrophins by Nucleus Pulposus Cells under the Degenerated Intervertebral Disc-Like Acidic Microenvironment. Biomed Res Int 2020;2020:1328436. [PMID: 32566653 DOI: 10.1155/2020/1328436] [Reference Citation Analysis]
213 Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. Adv Mater 2017;29:1700996. [DOI: 10.1002/adma.201700996] [Cited by in Crossref: 234] [Cited by in F6Publishing: 209] [Article Influence: 46.8] [Reference Citation Analysis]
214 Tuyaerts S, Van Nuffel AMT, Naert E, Van Dam PA, Vuylsteke P, De Caluwé A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H. PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer. BMC Cancer 2019;19:506. [PMID: 31138229 DOI: 10.1186/s12885-019-5676-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
215 Ni J, Song J, Wang B, Hua H, Zhu H, Guo X, Xiong S, Zhao Y. Dendritic cell vaccine for the effective immunotherapy of breast cancer. Biomed Pharmacother 2020;126:110046. [PMID: 32145586 DOI: 10.1016/j.biopha.2020.110046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
216 Miki S, Imamichi S, Fujimori H, Tomiyama A, Fujimoto K, Satomi K, Matsushita Y, Matsuzaki S, Takahashi M, Ishikawa E, Yamamoto T, Matsumura A, Mukasa A, Nishikawa R, Masutomi K, Narita Y, Masutani M, Ichimura K. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma. Cancer Sci 2018;109:2275-85. [PMID: 29758120 DOI: 10.1111/cas.13637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
217 Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol 2021. [PMID: 34819622 DOI: 10.1038/s41571-021-00579-w] [Reference Citation Analysis]
218 Castro F, Pinto ML, Pereira CL, Serre K, Barbosa MA, Vermaelen K, Gärtner F, Gonçalves RM, De Wever O, Oliveira MJ. Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. Biomaterials 2020;257:120218. [DOI: 10.1016/j.biomaterials.2020.120218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
219 Lennon S, Oweida A, Milner D, Phan AV, Bhatia S, Van Court B, Darragh L, Mueller AC, Raben D, Martínez-Torrecuadrada JL, Pitts TM, Somerset H, Jordan KR, Hansen KC, Williams J, Messersmith WA, Schulick RD, Owens P, Goodman KA, Karam SD. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination. Clin Cancer Res 2019;25:3352-65. [PMID: 30944125 DOI: 10.1158/1078-0432.CCR-18-2811] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
220 Xu T, Ma Y, Yuan Q, Hu H, Hu X, Qian Z, Rolle JK, Gu Y, Li S. Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy. ACS Nano 2020;14:3414-25. [PMID: 32155051 DOI: 10.1021/acsnano.9b09426] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
221 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Harding SM, Benci JL, Irianto J, Discher DE, Minn AJ, Greenberg RA. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 2017;548:466-70. [PMID: 28759889 DOI: 10.1038/nature23470] [Cited by in Crossref: 551] [Cited by in F6Publishing: 497] [Article Influence: 110.2] [Reference Citation Analysis]
223 Tang M, Liu Q, Zhou L, Chen L, Yang X, Yu J, Wang Y, Qiu H. The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer. Invest New Drugs 2019;37:65-75. [DOI: 10.1007/s10637-018-0616-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
224 Sathianathen NJ, Krishna S, Konety BR, Griffith TS. The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer. Immunotherapy 2017;9:1005-18. [PMID: 28971750 DOI: 10.2217/imt-2017-0051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
225 Du C, Zhou M, Jia F, Ruan L, Lu H, Zhang J, Zhu B, Liu X, Chen J, Chai Z, Hu Y. D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy. Biomaterials 2021;269:120642. [PMID: 33440291 DOI: 10.1016/j.biomaterials.2020.120642] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
226 Tian L, Yi X, Dong Z, Xu J, Liang C, Chao Y, Wang Y, Yang K, Liu Z. Calcium Bisphosphonate Nanoparticles with Chelator-Free Radiolabeling to Deplete Tumor-Associated Macrophages for Enhanced Cancer Radioisotope Therapy. ACS Nano 2018;12:11541-51. [PMID: 30359515 DOI: 10.1021/acsnano.8b06699] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 12.8] [Reference Citation Analysis]
227 Gong X, Li X, Jiang T, Xie H, Zhu Z, Zhou F, Zhou C. Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer. J Thorac Oncol 2017;12:1085-97. [PMID: 28478231 DOI: 10.1016/j.jtho.2017.04.014] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 17.8] [Reference Citation Analysis]
228 Shi F, Wang X, Teng F, Kong L, Yu J. Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy. Cancer Biol Ther 2017;18:137-41. [PMID: 28267380 DOI: 10.1080/15384047.2016.1276133] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
229 Wang H, Jia D, Yuan D, Yin X, Yuan F, Wang F, Shi W, Li H, Zhu LM, Fan Q. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy. J Nanobiotechnology 2021;19:138. [PMID: 33985511 DOI: 10.1186/s12951-021-00885-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ashrafizadeh M, Ahmadi Z, Kotla NG, Afshar EG, Samarghandian S, Mandegary A, Pardakhty A, Mohammadinejad R, Sethi G. Nanoparticles Targeting STATs in Cancer Therapy. Cells 2019;8:E1158. [PMID: 31569687 DOI: 10.3390/cells8101158] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
231 Wang Y. Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment. Front Immunol 2020;11:612072. [PMID: 33569059 DOI: 10.3389/fimmu.2020.612072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Sosa Iglesias V, Theys J, Groot AJ, Barbeau LMO, Lemmens A, Yaromina A, Losen M, Houben R, Dubois L, Vooijs M. Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells. Front Oncol 2018;8:460. [PMID: 30464927 DOI: 10.3389/fonc.2018.00460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
233 Dou Y, Liu Y, Zhao F, Guo Y, Li X, Wu M, Chang J, Yu C. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation. Theranostics 2018;8:5870-89. [PMID: 30613268 DOI: 10.7150/thno.27351] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
234 Zhen W, An S, Wang S, Hu W, Li Y, Jiang X, Li J. Precise Subcellular Organelle Targeting for Boosting Endogenous-Stimuli-Mediated Tumor Therapy. Adv Mater 2021;:e2101572. [PMID: 34611949 DOI: 10.1002/adma.202101572] [Reference Citation Analysis]
235 Ji D, Song C, Li Y, Xia J, Wu Y, Jia J, Cui X, Yu S, Gu J. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. J Immunother Cancer 2020;8:e000826. [PMID: 33106387 DOI: 10.1136/jitc-2020-000826] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
236 Lin WC, Chen LH, Hsieh YC, Yang PW, Lai LC, Chuang EY, Lee JM, Tsai MH. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2. Carcinogenesis. 2019;40:883-892. [PMID: 30576425 DOI: 10.1093/carcin/bgy189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
237 Lu K, He C, Guo N, Chan C, Ni K, Lan G, Tang H, Pelizzari C, Fu Y, Spiotto MT, Weichselbaum RR, Lin W. Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy. Nat Biomed Eng 2018;2:600-10. [DOI: 10.1038/s41551-018-0203-4] [Cited by in Crossref: 235] [Cited by in F6Publishing: 208] [Article Influence: 58.8] [Reference Citation Analysis]
238 Sosa Iglesias V, van Hoof SJ, Vaniqui A, Schyns LE, Lieuwes N, Yaromina A, Spiegelberg L, Groot AJ, Verhaegen F, Theys J, Dubois L, Vooijs M. An orthotopic non-small cell lung cancer model for image-guided small animal radiotherapy platforms. Br J Radiol 2019;92:20180476. [PMID: 30465693 DOI: 10.1259/bjr.20180476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
239 Fernández-Nogueira P, Fuster G, Gutierrez-Uzquiza Á, Gascón P, Carbó N, Bragado P. Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis. Cancers (Basel) 2021;13:3146. [PMID: 34201840 DOI: 10.3390/cancers13133146] [Reference Citation Analysis]
240 McNabb E, Al-Mahrouki A, Law N, McKay S, Tarapacki C, Hussein F, Czarnota GJ. Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation. PLoS One 2020;15:e0239456. [PMID: 32976517 DOI: 10.1371/journal.pone.0239456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
241 Cao Z, Liu J. Bacteria and bacterial derivatives as drug carriers for cancer therapy. J Control Release 2020;326:396-407. [PMID: 32681947 DOI: 10.1016/j.jconrel.2020.07.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
242 Kadhim M, Tuncay Cagatay S, Elbakrawy EM. Non-targeted effects of radiation: a personal perspective on the role of exosomes in an evolving paradigm. Int J Radiat Biol 2021;:1-39. [PMID: 34662248 DOI: 10.1080/09553002.2021.1980630] [Reference Citation Analysis]
243 Vāvere AL, Scott PJH. Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook. Semin Nucl Med 2017;47:429-53. [PMID: 28826519 DOI: 10.1053/j.semnuclmed.2017.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
244 Huang J, Li JJ. Cell repopulation, rewiring metabolism, and immune regulation in cancer radiotherapy. Radiation Medicine and Protection 2020;1:24-30. [DOI: 10.1016/j.radmp.2020.02.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 Gil Marques F, Poli E, Malaquias J, Carvalho T, Portêlo A, Ramires A, Aldeia F, Ribeiro RM, Vitorino E, Diegues I, Costa L, Coutinho J, Pina F, Mareel M, Constantino Rosa Santos S. Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues. Radiotherapy and Oncology 2019;141:256-61. [DOI: 10.1016/j.radonc.2019.06.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
246 Derer A, Frey B, Fietkau R, Gaipl US. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors. Cancer Immunol Immunother 2016;65:779-86. [DOI: 10.1007/s00262-015-1771-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
247 D’andrea MA, Reddy GK. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy. American Journal of Clinical Oncology 2020;43:218-28. [DOI: 10.1097/coc.0000000000000651] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Hu ZI, McArthur HL, Ho AY. The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer? Curr Breast Cancer Rep 2017;9:45-51. [PMID: 28344743 DOI: 10.1007/s12609-017-0234-y] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 15.8] [Reference Citation Analysis]
249 Hasegawa H, Vakharia K, Link MJ, Stafford SL, Brown PD, Parney IF, Burns TC, Yan ES, Mahajan A, Laack NN, Pollock BE. The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience. J Neurooncol 2021. [PMID: 34705189 DOI: 10.1007/s11060-021-03882-9] [Reference Citation Analysis]
250 Alcaraz J, Ikemori R, Llorente A, Díaz-Valdivia N, Reguart N, Vizoso M. Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities. Cancers (Basel) 2021;13:3782. [PMID: 34359678 DOI: 10.3390/cancers13153782] [Reference Citation Analysis]
251 Wu CJ, Tsai YT, Lee IJ, Wu PY, Lu LS, Tsao WS, Huang YJ, Chang CC, Ka SM, Tao MH. Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment. Oncoimmunology. 2018;7:e1477459. [PMID: 30228946 DOI: 10.1080/2162402x.2018.1477459] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
252 Cui L, Zhao Y, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L. Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway. Onco Targets Ther 2017;10:5817-26. [PMID: 29263678 DOI: 10.2147/OTT.S150456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
253 Gan GN, Jimeno A. Emerging from their burrow: Hedgehog pathway inhibitors for cancer. Expert Opinion on Investigational Drugs 2016;25:1153-66. [DOI: 10.1080/13543784.2016.1216973] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
254 Kordbacheh T, Honeychurch J, Blackhall F, Faivre-finn C, Illidge T. Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms. Annals of Oncology 2018;29:301-10. [DOI: 10.1093/annonc/mdx790] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
255 Zhang L, Zhao Y, Dai Y, Cheng JN, Gong Z, Feng Y, Sun C, Jia Q, Zhu B. Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. Front Immunol 2018;9:1578. [PMID: 30042763 DOI: 10.3389/fimmu.2018.01578] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
256 Li Y, Cho MH, Lee SS, Lee DE, Cheong H, Choi Y. Hydroxychloroquine-loaded hollow mesoporous silica nanoparticles for enhanced autophagy inhibition and radiation therapy. J Control Release 2020;325:100-10. [PMID: 32621826 DOI: 10.1016/j.jconrel.2020.06.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
257 Ferrisse TM, Rocha AFL, Lança MLA, Silveira HA, Almeida LY, Bufalino A, León JE. Post-radiotherapy recurrence of conventional oral squamous cell carcinoma showing sarcomatoid components: an immunohistochemical study. Autops Case Rep 2021;11:e2020219. [PMID: 34277487 DOI: 10.4322/acr.2020.219] [Reference Citation Analysis]
258 Mein S, Tessonnier T, Kopp B, Harrabi S, Abdollahi A, Debus J, Haberer T, Mairani A. Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions. Adv Radiat Oncol 2021;6:100661. [PMID: 33817410 DOI: 10.1016/j.adro.2021.100661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Meng D, Guo L, Peng L, Zheng L, Xie P, Mei Y, Li C, Peng X, Lang Y, Liu Z, Wang M, Xie D, Shu D, Hu H, Lin S, Li H, Luo F, Sun R, Huang B, Qian C. Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells. Biochemical and Biophysical Research Communications 2020;527:770-7. [DOI: 10.1016/j.bbrc.2020.04.093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
260 Chauhan V, Kanwar SS. Lipopeptide(s) associated with human microbiome as potent cancer drug. Semin Cancer Biol 2021;70:128-33. [PMID: 32574814 DOI: 10.1016/j.semcancer.2020.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T. Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 2018;130:17-38. [PMID: 30009886 DOI: 10.1016/j.addr.2018.07.007] [Cited by in Crossref: 437] [Cited by in F6Publishing: 405] [Article Influence: 109.3] [Reference Citation Analysis]
262 Meng J, Li Y, Wan C, Sun Y, Dai X, Huang J, Hu Y, Gao Y, Wu B, Zhang Z, Jiang K, Xu S, Lovell JF, Hu Y, Wu G, Jin H, Yang K. Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis. JCI Insight 2021;6:e146334. [PMID: 34877934 DOI: 10.1172/jci.insight.146334] [Reference Citation Analysis]
263 Li D, Sedano S, Allen R, Gong J, Cho M, Sharma S. Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life. Cancers (Basel). 2019;11. [PMID: 31216701 DOI: 10.3390/cancers11060841] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
264 Chen Q, Chen M, Liu Z. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses. Chem Soc Rev 2019;48:5506-26. [DOI: 10.1039/c9cs00271e] [Cited by in Crossref: 70] [Cited by in F6Publishing: 17] [Article Influence: 23.3] [Reference Citation Analysis]
265 Chen W, Xie Y, Wang M, Li C. Recent Advances on Rare Earth Upconversion Nanomaterials for Combined Tumor Near-Infrared Photoimmunotherapy. Front Chem 2020;8:596658. [PMID: 33240857 DOI: 10.3389/fchem.2020.596658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Silva VL, Ruiz A, Ali A, Pereira S, Seitsonen J, Ruokolainen J, Furlong F, Coulter J, Al-Jamal WT. Hypoxia-targeted cupric-tirapazamine liposomes potentiate radiotherapy in prostate cancer spheroids. Int J Pharm 2021;607:121018. [PMID: 34416329 DOI: 10.1016/j.ijpharm.2021.121018] [Reference Citation Analysis]
267 Kielbassa K, Vegna S, Ramirez C, Akkari L. Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers. Front Immunol 2019;10:2215. [PMID: 31611871 DOI: 10.3389/fimmu.2019.02215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
268 Jalili-Firoozinezhad S, Prantil-Baun R, Jiang A, Potla R, Mammoto T, Weaver JC, Ferrante TC, Kim HJ, Cabral JMS, Levy O, Ingber DE. Modeling radiation injury-induced cell death and countermeasure drug responses in a human Gut-on-a-Chip. Cell Death Dis 2018;9:223. [PMID: 29445080 DOI: 10.1038/s41419-018-0304-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 20.5] [Reference Citation Analysis]
269 Yang T, Hao L, Cui R, Liu H, Chen J, An J, Qi S, Li Z. Identification of an immune prognostic 11-gene signature for lung adenocarcinoma. PeerJ 2021;9:e10749. [PMID: 33552736 DOI: 10.7717/peerj.10749] [Reference Citation Analysis]
270 Singh B, Patwardhan RS, Jayakumar S, Sharma D, Sandur SK. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells. J Photochem Photobiol B 2020;213:112080. [PMID: 33232882 DOI: 10.1016/j.jphotobiol.2020.112080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
271 Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E. Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer. Acta Oncol 2021;:1-6. [PMID: 34184605 DOI: 10.1080/0284186X.2021.1944663] [Reference Citation Analysis]
272 Funck-Brentano E, Baghad B, Fort M, Aouidad I, Roger A, Beauchet A, Otmezguine Y, Blom A, Longvert C, Boru B, Saiag P. Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy. Int J Cancer 2020;147:1707-14. [PMID: 32083739 DOI: 10.1002/ijc.32934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
273 Kim MS, Lee EJ, Kim JW, Chung US, Koh WG, Keum KC, Koom WS. Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor. Radiat Oncol J 2016;34:230-8. [PMID: 27730800 DOI: 10.3857/roj.2016.01788] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
274 Heong V, Ngoi N, Tan DS. Update on immune checkpoint inhibitors in gynecological cancers. J Gynecol Oncol 2017;28:e20. [PMID: 28028993 DOI: 10.3802/jgo.2017.28.e20] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
275 Liu J, Wang H, Yi X, Chao Y, Geng Y, Xu L, Yang K, Liu Z. pH-Sensitive Dissociable Nanoscale Coordination Polymers with Drug Loading for Synergistically Enhanced Chemoradiotherapy. Adv Funct Mater 2017;27:1703832. [DOI: 10.1002/adfm.201703832] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
276 Hirata E, Sahai E. Tumor Microenvironment and Differential Responses to Therapy. Cold Spring Harb Perspect Med 2017;7:a026781. [PMID: 28213438 DOI: 10.1101/cshperspect.a026781] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 26.0] [Reference Citation Analysis]
277 Dou S, Li R, He N, Zhang M, Jiang W, Ye L, Yang Y, Zhao G, Yang Y, Li J, Chen D, Zhu G. The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication. Front Immunol 2021;12:618367. [PMID: 34552580 DOI: 10.3389/fimmu.2021.618367] [Reference Citation Analysis]
278 Linares J, Marín-Jiménez JA, Badia-Ramentol J, Calon A. Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy. Front Cell Dev Biol 2020;8:621070. [PMID: 33553157 DOI: 10.3389/fcell.2020.621070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
279 Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. J Immunother Cancer 2018;6:6. [PMID: 29375032 DOI: 10.1186/s40425-018-0317-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
280 Wang H, Mu X, He H, Zhang XD. Cancer Radiosensitizers. Trends Pharmacol Sci 2018;39:24-48. [PMID: 29224916 DOI: 10.1016/j.tips.2017.11.003] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 32.4] [Reference Citation Analysis]
281 Huang Z, Wang Y, Yao D, Wu J, Hu Y, Yuan A. Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress. Nat Commun 2021;12:145. [PMID: 33420008 DOI: 10.1038/s41467-020-20243-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
282 Sang W, Xie L, Wang G, Li J, Zhang Z, Li B, Guo S, Deng CX, Dai Y. Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy. Adv Sci (Weinh) 2021;8:2003338. [PMID: 33643804 DOI: 10.1002/advs.202003338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
283 Qi Z, Pei P, Zhang Y, Chen H, Yang S, Liu T, Zhang Y, Yang K. 131I-αPD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer. J Control Release 2022;346:240-9. [PMID: 35469982 DOI: 10.1016/j.jconrel.2022.04.029] [Reference Citation Analysis]
284 Guo D, Xu S, Wang N, Jiang H, Huang Y, Jin X, Xue B, Zhang C, Zhu X. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy. Biomaterials 2017;144:188-98. [DOI: 10.1016/j.biomaterials.2017.08.032] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
285 Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial" by A Dietrich et al. Radiother Oncol 2021;161:261-2. [PMID: 34119587 DOI: 10.1016/j.radonc.2021.06.014] [Reference Citation Analysis]
286 Ellerin BE, Demandante CGN, Martins JT. Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches. Cancer Radiother 2020;24:226-46. [PMID: 32192840 DOI: 10.1016/j.canrad.2020.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Nitta N, Takakusagi Y, Kokuryo D, Shibata S, Tomita A, Higashi T, Aoki I, Harada M. Intratumoral evaluation of 3D microvasculature and nanoparticle distribution using a gadolinium-dendron modified nano-liposomal contrast agent with magnetic resonance micro-imaging. Nanomedicine 2018;14:1315-24. [PMID: 29626524 DOI: 10.1016/j.nano.2018.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
288 Sun H, Sun R, Song X, Gu W, Shao Y. Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity. J Transl Med 2022;20:189. [PMID: 35484557 DOI: 10.1186/s12967-022-03392-w] [Reference Citation Analysis]
289 Stapleton S, Jaffray D, Milosevic M. Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. Adv Drug Deliv Rev 2017;109:119-30. [PMID: 27262923 DOI: 10.1016/j.addr.2016.05.021] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 13.7] [Reference Citation Analysis]
290 Liu Y, Zhou J, Li Q, Li L, Jia Y, Geng F, Zhou J, Yin T. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma. Adv Drug Deliv Rev 2021;172:80-103. [PMID: 33705874 DOI: 10.1016/j.addr.2021.02.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Shen M, Kang Y. Complex interplay between tumor microenvironment and cancer therapy. Front Med 2018;12:426-39. [PMID: 30097962 DOI: 10.1007/s11684-018-0663-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
292 Brindle KM, Izquierdo-garcía JL, Lewis DY, Mair RJ, Wright AJ. Brain Tumor Imaging. JCO 2017;35:2432-8. [DOI: 10.1200/jco.2017.72.7636] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
293 Kennedy P, Lewis S, Bane O, Hectors SJ, Kim E, Schwartz M, Taouli B. Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience. Eur Radiol 2021;31:5791-801. [PMID: 33475773 DOI: 10.1007/s00330-020-07636-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Zeng L, Cao Y, He L, Ding S, Bian XW, Tian G. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy. J Mater Chem B 2021;9:208-27. [PMID: 33215626 DOI: 10.1039/d0tb02294b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
295 Bader SB, Dewhirst MW, Hammond EM. Cyclic Hypoxia: An Update on Its Characteristics, Methods to Measure It and Biological Implications in Cancer. Cancers (Basel) 2020;13:E23. [PMID: 33374581 DOI: 10.3390/cancers13010023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
296 Whitson RJ, Lee A, Urman NM, Mirza A, Yao CY, Brown AS, Li JR, Shankar G, Fry MA, Atwood SX, Lee EY, Hollmig ST, Aasi SZ, Sarin KY, Scott MP, Epstein EH Jr, Tang JY, Oro AE. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med 2018;24:271-81. [PMID: 29400712 DOI: 10.1038/nm.4476] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 11.5] [Reference Citation Analysis]
297 Grimes DR, Jansen M, Macauley RJ, Scott JG, Basanta D. Evidence for hypoxia increasing the tempo of evolution in glioblastoma. Br J Cancer 2020;123:1562-9. [PMID: 32848201 DOI: 10.1038/s41416-020-1021-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
298 Kim WR, Han YD, Min BS. C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy. Ann Surg Oncol 2018;25:3898-905. [PMID: 30288654 DOI: 10.1245/s10434-018-6828-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
299 Zhang Z, Zhou J, Verma V, Liu X, Wu M, Yu J, Chen D. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury. Front Immunol 2021;12:774807. [PMID: 34925345 DOI: 10.3389/fimmu.2021.774807] [Reference Citation Analysis]
300 Tabraue C, Lara PC, De Mirecki-Garrido M, De La Rosa JV, López-Blanco F, Fernández-Pérez L, Boscá L, Castrillo A. LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation. Int J Radiat Oncol Biol Phys 2019;104:913-23. [PMID: 30922944 DOI: 10.1016/j.ijrobp.2019.03.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
301 Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. ACS Nano 2018;12:24-43. [PMID: 29257865 DOI: 10.1021/acsnano.7b05108] [Cited by in Crossref: 119] [Cited by in F6Publishing: 105] [Article Influence: 23.8] [Reference Citation Analysis]
302 Dillon MT, Bergerhoff KF, Pedersen M, Whittock H, Crespo-Rodriguez E, Patin EC, Pearson A, Smith HG, Paget JTE, Patel RR, Foo S, Bozhanova G, Ragulan C, Fontana E, Desai K, Wilkins AC, Sadanandam A, Melcher A, McLaughlin M, Harrington KJ. ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment. Clin Cancer Res 2019;25:3392-403. [PMID: 30770349 DOI: 10.1158/1078-0432.CCR-18-1821] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 18.3] [Reference Citation Analysis]
303 Wu L, Ishigaki Y, Zeng W, Harimoto T, Yin B, Chen Y, Liao S, Liu Y, Sun Y, Zhang X, Liu Y, Liang Y, Sun P, Suzuki T, Song G, Fan Q, Ye D. Generation of hydroxyl radical-activatable ratiometric near-infrared bimodal probes for early monitoring of tumor response to therapy. Nat Commun 2021;12:6145. [PMID: 34686685 DOI: 10.1038/s41467-021-26380-y] [Reference Citation Analysis]
304 Hou J, Li L, Zhu H, Chen H, Wei N, Dai M, Ni Q, Guo X. Association between breast cancer cell migration and radiosensitivity in vitro. Oncol Lett 2019;18:6877-84. [PMID: 31807191 DOI: 10.3892/ol.2019.11027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
305 Cui M, Xiao H, Luo D, Zhang X, Zhao S, Zheng Q, Li Y, Zhao Y, Dong J, Li H, Wang H, Fan S. Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity. Int J Mol Sci 2016;17:E1786. [PMID: 27792172 DOI: 10.3390/ijms17111786] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
306 Zhang C, Liang Z, Ma S, Liu X. Radiotherapy and Cytokine Storm: Risk and Mechanism. Front Oncol 2021;11:670464. [PMID: 34094967 DOI: 10.3389/fonc.2021.670464] [Reference Citation Analysis]
307 Chen S, Yu S, Du Z, Huang X, He M, Long S, Liu J, Lan Y, Yang D, Wang H, Li S, Chen A, Hao Y, Su Y, Wang C, Luo S. Synthesis of Mitochondria-Anchored Nitroimidazoles with a Versatile NIR Fluorophore for Hypoxic Tumor-Targeting Imaging and Chemoradiotherapy. J Med Chem 2021;64:3381-91. [PMID: 33688738 DOI: 10.1021/acs.jmedchem.0c02250] [Reference Citation Analysis]
308 Rey S, Schito L, Koritzinsky M, Wouters BG. Molecular targeting of hypoxia in radiotherapy. Adv Drug Deliv Rev 2017;109:45-62. [PMID: 27771366 DOI: 10.1016/j.addr.2016.10.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
309 Fahim Golestaneh A, Lecker LSM, Schlegel J, Nowrouzi A, Schwager C, Meister S, Weichert W, Debus J, Abdollahi A. Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication. Int J Cancer 2019;144:2774-81. [PMID: 30478850 DOI: 10.1002/ijc.32019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
310 Sabir M, Shah A, Muhammad W, Ali I, Bastian P. A mathematical model of tumor hypoxia targeting in cancer treatment and its numerical simulation. Computers & Mathematics with Applications 2017;74:3250-9. [DOI: 10.1016/j.camwa.2017.08.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
311 Mortezaee K, Parwaie W, Motevaseli E, Mirtavoos-mahyari H, Musa AE, Shabeeb D, Esmaely F, Najafi M, Farhood B. Targets for improving tumor response to radiotherapy. International Immunopharmacology 2019;76:105847. [DOI: 10.1016/j.intimp.2019.105847] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
312 Bian Z, Shi L, Kidder K, Zen K, Garnett-Benson C, Liu Y. Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy. Nat Commun 2021;12:3229. [PMID: 34050181 DOI: 10.1038/s41467-021-23442-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Elbakrawy EM, Mayah A, Hill MA, Kadhim M. Induction of Genomic Instability in a Primary Human Fibroblast Cell Line Following Low-Dose Alpha-Particle Exposure and the Potential Role of Exosomes. Biology (Basel) 2020;10:11. [PMID: 33379152 DOI: 10.3390/biology10010011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 He C, Zhang X, Yan R, Zhao P, Chen Y, Li M, Chen C, Fan T, Lu Y, Wang C, Wu F, Lee RJ, Yang T, Xiang G. Enhancement of cisplatin efficacy by lipid–CaO 2 nanocarrier-mediated comprehensive modulation of the tumor microenvironment. Biomater Sci 2019;7:4260-72. [DOI: 10.1039/c9bm00797k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
315 Gulzar A, He F, Gulzar A, Kuang Y, Zhang F, Gai S, Yang P, Wang C. In situ oxygenating and 808 nm light-sensitized nanocomposite for multimodal imaging and mitochondria-assisted cancer therapy. J Mater Chem B 2021;9:131-46. [PMID: 33226055 DOI: 10.1039/d0tb01967d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Bouleftour W, Rowinski E, Louati S, Sotton S, Wozny AS, Moreno-Acosta P, Mery B, Rodriguez-Lafrasse C, Magne N. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy. Med Sci Monit 2021;27:e934116. [PMID: 34728593 DOI: 10.12659/MSM.934116] [Reference Citation Analysis]
317 Alberti D, Protti N, Franck M, Stefania R, Bortolussi S, Altieri S, Deagostino A, Aime S, Geninatti Crich S. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting. ChemMedChem 2017;12:502-9. [PMID: 28217982 DOI: 10.1002/cmdc.201700039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
318 Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment. Theranostics 2019;9:8073-90. [PMID: 31754382 DOI: 10.7150/thno.37198] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 26.0] [Reference Citation Analysis]
319 Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, Yin LX, Zhang Y, Blackford AL, Drummond MB, Gourin CG, Koch WM, Eisele DW, D'Souza G. Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy. Head Neck 2018;40:1534-47. [PMID: 29542262 DOI: 10.1002/hed.25148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
320 Ohnleiter T, Truntzer P, Antoni D, Guihard S, Elgard A, Noël G. Facteurs pronostiques de la ré-irradiation des cancers des voies aérodigestives supérieures : revue de la littérature. Cancer/Radiothérapie 2017;21:316-38. [DOI: 10.1016/j.canrad.2017.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
321 Rancoule C, Vallard A, Jmour O, Vial N, Guillaume E, Guy J, Magné N. Radiothérapie et immunothérapie. Bulletin du Cancer 2018;105:S92-S100. [DOI: 10.1016/s0007-4551(18)30394-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
322 Sun CY, Zhang BB, Zhou JY. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy. J Mater Chem B 2019;7:4843-53. [PMID: 31389968 DOI: 10.1039/c9tb01115c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
323 Wang X, Zhang Y, Mu X, Tu CR, Chung Y, Tsao SW, Chan GC, Leung WH, Lau YL, Liu Y, Tu W. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment. J Immunother Cancer 2022;10:e003832. [PMID: 35105688 DOI: 10.1136/jitc-2021-003832] [Reference Citation Analysis]
324 Cho O, Noh OK, Oh YT, Chang SJ, Ryu HS, Lee EJ, Chun M. Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer. Tumour Biol 2017;39:1010428317694306. [PMID: 28222668 DOI: 10.1177/1010428317694306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
325 Eguchi T, Sogawa C, Okusha Y, Uchibe K, Iinuma R, Ono K, Nakano K, Murakami J, Itoh M, Arai K, Fujiwara T, Namba Y, Murata Y, Ohyama K, Shimomura M, Okamura H, Takigawa M, Nakatsura T, Kozaki KI, Okamoto K, Calderwood SK. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. PLoS One 2018;13:e0191109. [PMID: 29415026 DOI: 10.1371/journal.pone.0191109] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
326 Zou C, Yang H, Cui L, Cao X, Huang H, Chen T. Potential hazardous effects of printing room PM2.5 exposure include promotion of lung inflammation and subsequent injury. Mol Med Rep 2020;22:3213-24. [PMID: 32945461 DOI: 10.3892/mmr.2020.11399] [Reference Citation Analysis]
327 Ayala Orozco C, Liu D, Li Y, Alemany LB, Pal R, Krishnan S, Tour JM. Visible-Light-Activated Molecular Nanomachines Kill Pancreatic Cancer Cells. ACS Appl Mater Interfaces 2020;12:410-7. [PMID: 31815419 DOI: 10.1021/acsami.9b21497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
328 Jiang LN, Liu YB, Li BH. Lycopene exerts anti-inflammatory effect to inhibit prostate cancer progression. Asian J Androl 2018. [PMID: 30198495 DOI: 10.4103/aja.aja_70_18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
329 Mi Y, Shao Z, Vang J, Kaidar-Person O, Wang AZ. Application of nanotechnology to cancer radiotherapy. Cancer Nanotechnol 2016;7:11. [PMID: 28066513 DOI: 10.1186/s12645-016-0024-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 11.3] [Reference Citation Analysis]
330 de Groot AE, Pienta KJ. Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages. Oncotarget 2018;9:20908-27. [PMID: 29755698 DOI: 10.18632/oncotarget.24556] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
331 Xiang K, Jendrossek V, Matschke J. Oncometabolites and the response to radiotherapy. Radiat Oncol 2020;15:197. [PMID: 32799884 DOI: 10.1186/s13014-020-01638-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
332 Wiechmann S, Saupp E, Schilling D, Heinzlmeir S, Schneider G, Schmid RM, Combs SE, Kuster B, Dobiasch S. Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells. Mol Cell Proteomics 2020;19:1649-63. [PMID: 32651227 DOI: 10.1074/mcp.RA120.002046] [Reference Citation Analysis]
333 Xiao J, He X. Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:8781-94. [PMID: 34849030 DOI: 10.2147/CMAR.S336265] [Reference Citation Analysis]
334 Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Front Immunol 2021;12:773570. [PMID: 34956201 DOI: 10.3389/fimmu.2021.773570] [Reference Citation Analysis]
335 Zou R, Gong Q, Shi Z, Zheng J, Xing J, Liu C, Jiang Z, Wu A. A ZIF-90 nanoplatform loaded with an enzyme-responsive organic small-molecule probe for imaging the hypoxia status of tumor cells. Nanoscale 2020;12:14870-81. [DOI: 10.1039/d0nr02580a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
336 Chen X, Song J, Chen X, Yang H. X-ray-activated nanosystems for theranostic applications. Chem Soc Rev 2019;48:3073-101. [PMID: 31106315 DOI: 10.1039/c8cs00921j] [Cited by in Crossref: 67] [Cited by in F6Publishing: 19] [Article Influence: 22.3] [Reference Citation Analysis]
337 Qin X, Liu J, Xu Y, Li B, Cheng J, Wu X, Zhang J, Liu Z, Ning R, Li Y, Zhang Y, Sun Y, Lu JJ. Mesoporous Bi-Containing Radiosensitizer Loading with DOX to Repolarize Tumor-Associated Macrophages and Elicit Immunogenic Tumor Cell Death to Inhibit Tumor Progression. ACS Appl Mater Interfaces 2020;12:31225-34. [DOI: 10.1021/acsami.0c08074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
338 Capilla-Gonzalez V, Bonsu JM, Redmond KJ, Garcia-Verdugo JM, Quiñones-Hinojosa A. Implications of irradiating the subventricular zone stem cell niche. Stem Cell Res 2016;16:387-96. [PMID: 26921873 DOI: 10.1016/j.scr.2016.02.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
339 Wang C, Wang X, Han A, Wang Y, Jiang H. Proof-of-concept study investigating the role of S100P-RAGE in nasopharyngeal carcinoma. Exp Ther Med 2021;21:470. [PMID: 33767765 DOI: 10.3892/etm.2021.9901] [Reference Citation Analysis]
340 Heymans V, Kunath S, Hajieva P, Moosmann B. Cell Culture Characterization of Prooxidative Chain-Transfer Agents as Novel Cytostatic Drugs. Molecules 2021;26:6743. [PMID: 34771157 DOI: 10.3390/molecules26216743] [Reference Citation Analysis]
341 Yu Z, Wang L, Li X. MiR-3150b-3p inhibits the proliferation and invasion of cervical cancer cells by targeting TNFRSF11a. J Investig Med 2020;68:1166-70. [PMID: 32616510 DOI: 10.1136/jim-2020-001284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Aznar MA, Tinari N, Rullán AJ, Sánchez-Paulete AR, Rodriguez-Ruiz ME, Melero I. Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally. J Immunol 2017;198:31-9. [PMID: 27994166 DOI: 10.4049/jimmunol.1601145] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 20.2] [Reference Citation Analysis]
343 Windisch P, Guckenberger M. Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease. J Thorac Dis 2019;11:S1869-73. [PMID: 31632771 DOI: 10.21037/jtd.2019.08.123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
344 Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y. Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget 2015;6:27537-54. [PMID: 26348470 DOI: 10.18632/oncotarget.4826] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
345 Liao J, Jin H, Li S, Xu L, Peng Z, Wei G, Long J, Guo Y, Kuang M, Zhou Q, Peng S. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 2019;38:454. [PMID: 31694662 DOI: 10.1186/s13046-019-1419-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
346 Yan Y, Kumar AB, Finnes H, Markovic SN, Park S, Dronca RS, Dong H. Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy. Front Immunol 2018;9:1739. [PMID: 30100909 DOI: 10.3389/fimmu.2018.01739] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 20.3] [Reference Citation Analysis]
347 Xu X, Gong X, Wang Y, Li J, Wang H, Wang J, Sha X, Li Y, Zhang Z. Reprogramming Tumor Associated Macrophages toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy. Adv Therap 2020;3:1900181. [DOI: 10.1002/adtp.201900181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
348 Kotowski U, Brkic FF, Koperek O, Nemec SF, Perisanidis C, Altorjai G, Grasl MC, Erovic BM. Accuracy of fine‐needle aspiration cytology in suspicious neck nodes after radiotherapy: Retrospective analysis of 100 patients. Clin Otolaryngol 2019;44:384-8. [DOI: 10.1111/coa.13271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
349 Yao M, Rogers L, Suchowerska N, Choe D, Al-Dabbas MA, Narula RS, Lyons JG, Sved P, Li Z, Dong Q. Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target. Radiother Oncol 2018;128:283-300. [PMID: 29929859 DOI: 10.1016/j.radonc.2018.05.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
350 Tian Y, Tang L, Yi P, Pan Q, Han Y, Shi Y, Rao S, Tan S, Xia L, Lin J, Oyang L, Tang Y, Liang J, Luo X, Liao Q, Wang H, Zhou Y. MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma. J Cancer 2020;11:3976-85. [PMID: 32328201 DOI: 10.7150/jca.42734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
351 Feng LR, Wolff BS, Liwang J, Regan JM, Alshawi S, Raheem S, Saligan LN. Cancerrelated fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction. Int J Mol Med. 2020;45:485-496. [PMID: 31894256 DOI: 10.3892/ijmm.2019.4435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
352 Moreira D, Sampath S, Won H, White SV, Su YL, Alcantara M, Wang C, Lee P, Maghami E, Massarelli E, Kortylewski M. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. J Clin Invest 2021;131:137001. [PMID: 33232304 DOI: 10.1172/JCI137001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
353 Hasan N, Sham NFR, Karim MKA, Fuad SBSA, Hasani NAH, Omar E, Ibahim MJ. Development of custom lead shield and strainer for targeted irradiation for mice in the gamma cell chamber. Sci Rep 2021;11:14559. [PMID: 34267293 DOI: 10.1038/s41598-021-93964-5] [Reference Citation Analysis]
354 Choi SH, Kim AR, Nam JK, Kim JM, Kim JY, Seo HR, Lee HJ, Cho J, Lee YJ. Tumour-vasculature development via endothelial-to-mesenchymal transition after radiotherapy controls CD44v6+ cancer cell and macrophage polarization. Nat Commun 2018;9:5108. [PMID: 30504836 DOI: 10.1038/s41467-018-07470-w] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
355 Hu J, Guan Z, Chen J. Multifunctional biomaterials that modulate oxygen levels in the tumor microenvironment. Cancer Lett 2021;521:39-49. [PMID: 34419500 DOI: 10.1016/j.canlet.2021.08.019] [Reference Citation Analysis]
356 Liu L, Li H, Wang J, Zhang J, Liang XJ, Guo W, Gu Z. Leveraging Macrophages for Cancer Theranostics. Adv Drug Deliv Rev 2022;:114136. [PMID: 35143894 DOI: 10.1016/j.addr.2022.114136] [Reference Citation Analysis]
357 Verma V. Relationship and interactions of curcumin with radiation therapy. World J Clin Oncol 2016; 7(3): 275-283 [PMID: 27298767 DOI: 10.5306/wjco.v7.i3.275] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
358 Cruz-Gregorio A, Martínez-Ramírez I, Pedraza-Chaverri J, Lizano M. Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E182. [PMID: 30764513 DOI: 10.3390/cancers11020182] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
359 Ahmad P, Sana J, Slavik M, Slampa P, Smilek P, Slaby O. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. Dis Markers 2017;2017:8245345. [PMID: 28325958 DOI: 10.1155/2017/8245345] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
360 Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 2020;20:662-80. [PMID: 32753728 DOI: 10.1038/s41568-020-0285-7] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 61.0] [Reference Citation Analysis]
361 Tian L, Wang Y, Sun L, Xu J, Chao Y, Yang K, Wang S, Liu Z. Cerenkov Luminescence-Induced NO Release from 32P-Labeled ZnFe(CN)5NO Nanosheets to Enhance Radioisotope-Immunotherapy. Matter 2019;1:1061-76. [DOI: 10.1016/j.matt.2019.07.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 9.7] [Reference Citation Analysis]
362 Zhang C, Ren J, Hua J, Xia L, He J, Huo D, Hu Y. Multifunctional Bi 2 WO 6 Nanoparticles for CT-Guided Photothermal and Oxygen-free Photodynamic Therapy. ACS Appl Mater Interfaces 2018;10:1132-46. [DOI: 10.1021/acsami.7b16000] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
363 Wang G, Cao P, Fan Y, Tan K. Emerging roles of HSF1 in cancer: Cellular and molecular episodes. Biochim Biophys Acta Rev Cancer 2020;1874:188390. [PMID: 32653364 DOI: 10.1016/j.bbcan.2020.188390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
364 O'Cathail SM, Pokrovska TD, Maughan TS, Fisher KD, Seymour LW, Hawkins MA. Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization. Front Oncol 2017;7:153. [PMID: 28791251 DOI: 10.3389/fonc.2017.00153] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
365 Miller JP, Borde BH, Bordeleau F, Zanotelli MR, LaValley DJ, Parker DJ, Bonassar LJ, Pannullo SC, Reinhart-King CA. Clinical doses of radiation reduce collagen matrix stiffness. APL Bioeng 2018;2:031901. [PMID: 31069314 DOI: 10.1063/1.5018327] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
366 Chen J, Fei X, Wang J, Cai Z. Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy. Pharmacol Res 2020;159:105041. [PMID: 32580030 DOI: 10.1016/j.phrs.2020.105041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
367 Li M, Luo Z, Peng Z, Cai K. Cascade-amplification of therapeutic efficacy: An emerging opportunity in cancer treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2019;11:e1555. [PMID: 31016872 DOI: 10.1002/wnan.1555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
368 Wu P, Li L, Wang H, Ma T, Wu H, Fan X, Yang Z, Chen D, Wang L. Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo. Dig Dis Sci. 2018;63:113-125. [PMID: 29080145 DOI: 10.1007/s10620-017-4818-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
369 Strell C, Stenmark Tullberg A, Jetne Edelmann R, Akslen LA, Malmström P, Fernö M, Holmberg E, Östman A, Karlsson P. Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial. Breast Cancer Res Treat 2021;187:45-55. [PMID: 33661437 DOI: 10.1007/s10549-021-06136-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Deng X, Liang H, Yang W, Shao Z. Polarization and function of tumor-associated macrophages mediate graphene oxide-induced photothermal cancer therapy. J Photochem Photobiol B 2020;208:111913. [PMID: 32473533 DOI: 10.1016/j.jphotobiol.2020.111913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
371 Kohno M, Murakami J, Wu L, Chan ML, Yun Z, Cho BCJ, de Perrot M. Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma. J Immunol 2020;205:2519-31. [PMID: 32948683 DOI: 10.4049/jimmunol.2000487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
372 Pearson YE, Lund AW, Lin AW, Ng CP, Alsuwaidi A, Azzeh S, Gater DL, Teo JC. Non-invasive single-cell biomechanical analysis using live-imaging datasets. J Cell Sci 2016;129:3351-64. [PMID: 27422102 DOI: 10.1242/jcs.191205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
373 Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology 2017;6:e1371896. [PMID: 29209572 DOI: 10.1080/2162402X.2017.1371896] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
374 Donini M, Buti S, Massari F, Mollica V, Rizzo A, Montironi R, Bersanelli M, Santoni M. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions. Expert Rev Anticancer Ther 2020;20:491-501. [PMID: 32479120 DOI: 10.1080/14737140.2020.1770601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
375 Li L, Hamilton L, Montgomery J, Stewart M. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive. J Laryngol Otol 2020;134:460-2. [PMID: 32308160 DOI: 10.1017/S0022215120000729] [Reference Citation Analysis]
376 Gray M, Turnbull AK, Ward C, Meehan J, Martínez-Pérez C, Bonello M, Pang LY, Langdon SP, Kunkler IH, Murray A, Argyle D. Development and characterisation of acquired radioresistant breast cancer cell lines. Radiat Oncol 2019;14:64. [PMID: 30987655 DOI: 10.1186/s13014-019-1268-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
377 Lip H, Amini MA, Zetrini A, Cai P, Abbasi AZ, Bristow RG, Rauth AM, Wu XY. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.02.026] [Reference Citation Analysis]
378 Woo Y, Lee HJ, Kim J, Kang SG, Moon S, Han JA, Jung YM, Jung YJ. Rapamycin Promotes ROS-Mediated Cell Death via Functional Inhibition of xCT Expression in Melanoma Under γ-Irradiation. Front Oncol 2021;11:665420. [PMID: 33959512 DOI: 10.3389/fonc.2021.665420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
379 Barker HE, Paget JTE, Khan AA, Harrington KJ. Erratum: The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 2015;15:509-509. [DOI: 10.1038/nrc3993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
380 Smith V, Mukherjee D, Lunj S, Choudhury A, Hoskin P, West C, Illidge T. The effect of hypoxia on PD-L1 expression in bladder cancer. BMC Cancer 2021;21:1271. [PMID: 34819027 DOI: 10.1186/s12885-021-09009-7] [Reference Citation Analysis]
381 Parida S, Sharma D. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer. Biochim Biophys Acta Rev Cancer 2019;1871:392-405. [PMID: 30981803 DOI: 10.1016/j.bbcan.2019.04.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
382 He W, Kapate N, Shields CW 4th, Mitragotri S. Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases. Adv Drug Deliv Rev 2020;165-166:15-40. [PMID: 31816357 DOI: 10.1016/j.addr.2019.12.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
383 Wu C, Muroski ME, Miska J, Lee-Chang C, Shen Y, Rashidi A, Zhang P, Xiao T, Han Y, Lopez-Rosas A, Cheng Y, Lesniak MS. Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment. Nanomedicine 2019;16:126-37. [PMID: 30553919 DOI: 10.1016/j.nano.2018.11.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
384 Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 2021;44:715-37. [PMID: 33835425 DOI: 10.1007/s13402-021-00602-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
385 Mollica V, Santoni M, Di Nunno V, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Montironi R, Massari F. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Curr Drug Targets 2020;21:1463-75. [PMID: 32160846 DOI: 10.2174/1389450121666200311121540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
386 Schug C, Sievert W, Urnauer S, Müller AM, Schmohl KA, Wechselberger A, Schwenk N, Lauber K, Schwaiger M, Multhoff G, Wagner E, Nelson PJ, Spitzweg C. External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery. Hum Gene Ther 2018;29:1287-300. [PMID: 29724129 DOI: 10.1089/hum.2018.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
387 Wang J, Li Z, Wang Z, Yu Y, Li D, Li B, Ding J. Nanomaterials for Combinational Radio–Immuno Oncotherapy. Adv Funct Mater 2020;30:1910676. [DOI: 10.1002/adfm.201910676] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
388 Totti S, Allenby MC, Dos Santos SB, Mantalaris A, Velliou EG. A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma. RSC Adv 2018;8:20928-40. [DOI: 10.1039/c8ra02633e] [Cited by in Crossref: 11] [Article Influence: 2.8] [Reference Citation Analysis]
389 Bláha P, Feoli C, Agosteo S, Calvaruso M, Cammarata FP, Catalano R, Ciocca M, Cirrone GAP, Conte V, Cuttone G, Facoetti A, Forte GI, Giuffrida L, Magro G, Margarone D, Minafra L, Petringa G, Pucci G, Ricciardi V, Rosa E, Russo G, Manti L. The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives. Front Oncol 2021;11:682647. [PMID: 34262867 DOI: 10.3389/fonc.2021.682647] [Reference Citation Analysis]
390 Makowska A, Lelabi N, Nothbaum C, Shen L, Busson P, Tran TTB, Eble M, Kontny U. Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells. Cells 2021;10:2458. [PMID: 34572108 DOI: 10.3390/cells10092458] [Reference Citation Analysis]
391 Peng L, Wang Y, Fei S, Wei C, Tong F, Wu G, Ma H, Dong X. The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer. Transl Lung Cancer Res 2020;9:745-60. [PMID: 32676336 DOI: 10.21037/tlcr-20-500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
392 Kalinski P, Talmadge JE. Tumor Immuno-Environment in Cancer Progression and Therapy. Adv Exp Med Biol 2017;1036:1-18. [PMID: 29275461 DOI: 10.1007/978-3-319-67577-0_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
393 Yamazaki T, Vanpouille-Box C, Demaria S, Galluzzi L. Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer Treat Res 2020;180:281-96. [PMID: 32215874 DOI: 10.1007/978-3-030-38862-1_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
394 Zhang T, Yu H, Ni C, Zhang T, Liu L, Lv Q, Zhang Z, Wang Z, Wu D, Wu P, Chen G, Wang L, Wei Q, Huang J, Wang X. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer. Sci Rep 2017;7:4866. [PMID: 28687760 DOI: 10.1038/s41598-017-04978-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
395 Vaughan E, Machta J, Walker M, Toumpanakis C, Caplin M, Navalkissoor S. Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: efficacy and prognostic factors for response. Br J Radiol 2018;91:20180041. [PMID: 29513039 DOI: 10.1259/bjr.20180041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
396 Liu S, Li H, Xia L, Xu P, Ding Y, Huo D, Hu Y. Anti-RhoJ antibody functionalized Au@I nanoparticles as CT-guided tumor vessel-targeting radiosensitizers in patient-derived tumor xenograft model. Biomaterials 2017;141:1-12. [PMID: 28666098 DOI: 10.1016/j.biomaterials.2017.06.036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
397 Zhang Z, Wu Z, Xu Y, Lu D, Zhang S. Vascular endothelial growth factor increased the permeability of respiratory barrier in acute respiratory distress syndrome model in mice. Biomed Pharmacother 2019;109:2434-40. [PMID: 30551503 DOI: 10.1016/j.biopha.2018.11.132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
398 Goto T. Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges. Vaccines (Basel) 2019;7:E100. [PMID: 31455032 DOI: 10.3390/vaccines7030100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
399 De Felice M, Tammaro M, Leopardo D, Ianniello GP, Turitto G. Moving towards the Future of Radio-Immunotherapy: Could We “Tailor” the Abscopal Effect on Head and Neck Cancer Patients? Immuno 2021;1:410-23. [DOI: 10.3390/immuno1040029] [Reference Citation Analysis]
400 Zhao P, Ren S, Liu Y, Huang W, Zhang C, He J. PL–W 18 O 49 –TPZ Nanoparticles for Simultaneous Hypoxia-Activated Chemotherapy and Photothermal Therapy. ACS Appl Mater Interfaces 2018;10:3405-13. [DOI: 10.1021/acsami.7b17323] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 11.5] [Reference Citation Analysis]
401 Zheng W, Skowron KB, Namm JP, Burnette B, Fernandez C, Arina A, Liang H, Spiotto MT, Posner MC, Fu YX, Weichselbaum RR. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance. Oncotarget 2016;7:43039-51. [PMID: 27343548 DOI: 10.18632/oncotarget.9915] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
402 Gao Y, Lin Y, Liu T, Chen H, Yang X, Tian C, Du L, Li M. Bioluminescent Probe for Tumor Hypoxia Detection via CYP450 Reductase in Living Animals. Anal Chem 2017;89:12488-93. [DOI: 10.1021/acs.analchem.7b03597] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
403 Yip K, Melcher A, Harrington K, Illidge T, Nobes J, Webster A, Smith D, Lorigan P, Nathan P, Larkin J. Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial. Clin Oncol (R Coll Radiol) 2018;30:201-3. [PMID: 29402599 DOI: 10.1016/j.clon.2018.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Jiang W, Li Q, Zhu Z, Wang Q, Dou J, Zhao Y, Lv W, Zhong F, Yao Y, Zhang G, Liu H, Wang Y, Wang J. Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage Response. ACS Appl Mater Interfaces 2018;10:35734-44. [DOI: 10.1021/acsami.8b10901] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
405 Gerken LRH, Keevend K, Zhang Y, Starsich FHL, Eberhardt C, Panzarasa G, Matter MT, Wichser A, Boss A, Neels A, Herrmann IK. Lanthanide-Doped Hafnia Nanoparticles for Multimodal Theranostics: Tailoring the Physicochemical Properties and Interactions with Biological Entities. ACS Appl Mater Interfaces 2019;11:437-48. [DOI: 10.1021/acsami.8b20334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
406 Dong J, Gao HL, Wang WQ, Yu XJ, Liu L. Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Biochim Biophys Acta Rev Cancer 2021;1875:188484. [PMID: 33246025 DOI: 10.1016/j.bbcan.2020.188484] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
407 Luen SJ, Savas P, Fox SB, Salgado R, Loi S. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer. Pathology 2017;49:141-55. [PMID: 28049579 DOI: 10.1016/j.pathol.2016.10.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 9.8] [Reference Citation Analysis]
408 Peng W, Zhou X, Yan W, Li Y, Du C, Wang X, Shen C, Wang Q, Ying H, Lu X, Xu T, Hu C. Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing. OncoImmunology 2022;11:2026583. [DOI: 10.1080/2162402x.2022.2026583] [Reference Citation Analysis]
409 Higgins MJ, Alipour R, Pope K, Ung KA, Kok DL, Chua MS. QUAD SHOT radiotherapy and doublet immunotherapy in the management of anal mucosal melanoma: A case series of efficacy and toxicity of a novel treatment approach and a review of the literature. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.03.001] [Reference Citation Analysis]
410 Lan Y, Moustafa M, Knoll M, Xu C, Furkel J, Lazorchak A, Yeung TL, Hasheminasab SM, Jenkins MH, Meister S, Yu H, Schlegel J, Marelli B, Tang Z, Qin G, Klein C, Qi J, Zhou C, Locke G, Krunic D, Derner MG, Schwager C, Fontana RE, Kriegsmann K, Jiang F, Rein K, Kriegsmann M, Debus J, Lo KM, Abdollahi A. Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer Cell 2021;39:1388-1403.e10. [PMID: 34506739 DOI: 10.1016/j.ccell.2021.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
411 Huang C, Zheng J, Ma D, Liu N, Zhu C, Li J, Yang R. Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy. J Mater Chem B 2018;6:6424-30. [DOI: 10.1039/c8tb01805g] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 4.8] [Reference Citation Analysis]
412 Wang Z, Tang Y, Tan Y, Wei Q, Yu W. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities. Cell Commun Signal 2019;17:47. [PMID: 31101063 DOI: 10.1186/s12964-019-0362-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
413 Zhou G. Mechanisms underlying FLASH radiotherapy, a novel way to enlarge the differential responses to ionizing radiation between normal and tumor tissues. Radiation Medicine and Protection 2020;1:35-40. [DOI: 10.1016/j.radmp.2020.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
414 Zhu D, Zhu X, Ren S, Lu Y, Zhu H. Manganese dioxide (MnO 2 ) based nanomaterials for cancer therapies and theranostics. Journal of Drug Targeting. [DOI: 10.1080/1061186x.2020.1815209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
415 Choi J, Park J, Cho I, Sheen Y. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer. Radiol Oncol 2022. [PMID: 35390248 DOI: 10.2478/raon-2022-0012] [Reference Citation Analysis]
416 Thanekar AM, Sankaranarayanan SA, Rengan AK. Role of nano-sensitizers in radiation therapy of metastatic tumors. Cancer Treat Res Commun 2021;26:100303. [PMID: 33454575 DOI: 10.1016/j.ctarc.2021.100303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Amin S, Baine MJ, Meza JL, Lin C. Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor. JAMA Netw Open 2020;3:e2015444. [PMID: 32902650 DOI: 10.1001/jamanetworkopen.2020.15444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
418 Liu L, Zhang Z, Zhou L, Hu L, Yin C, Qing D, Huang S, Cai X, Chen Y. Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype. Exp Cell Res 2020;391:111956. [PMID: 32169425 DOI: 10.1016/j.yexcr.2020.111956] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
419 Deng X, Guan W, Qing X, Yang W, Que Y, Tan L, Liang H, Zhang Z, Wang B, Liu X, Zhao Y, Shao Z. Ultrafast Low-Temperature Photothermal Therapy Activates Autophagy and Recovers Immunity for Efficient Antitumor Treatment. ACS Appl Mater Interfaces 2020;12:4265-75. [PMID: 31903741 DOI: 10.1021/acsami.9b19148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
420 Ward TH, Gilbert DC, Higginbotham G, Morris CM, Speirs V, Curtin NJ. Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations. J Pathol Clin Res 2021. [PMID: 34658150 DOI: 10.1002/cjp2.246] [Reference Citation Analysis]
421 Wong DJ, Lee J, Choo SP, Thng CH, Hennedige T. Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series. Immunotherapy 2019;11:167-75. [DOI: 10.2217/imt-2018-0126] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
422 Jiang J, Shen N, Ci T, Tang Z, Gu Z, Li G, Chen X. Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug. Adv Mater 2019;31:1904278. [DOI: 10.1002/adma.201904278] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 14.7] [Reference Citation Analysis]
423 Bao Z, Wang Y, Wang Q, Fang S, Shan X, Wang J, Jiang T. Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution. Front Med 2021;15:551-61. [PMID: 33893983 DOI: 10.1007/s11684-020-0760-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
424 Leary R, Gardner RB, Mockbee C, Roychowdhury DF. Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies. Cureus 2019;11:e4276. [PMID: 31157137 DOI: 10.7759/cureus.4276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
425 Zhou J, Xue C, Hou Y, Li M, Hu Y, Chen Q, Li Y, Li K, Song G, Cai K, Luo Z. Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors. Biomaterials 2019;197:129-45. [PMID: 30641264 DOI: 10.1016/j.biomaterials.2019.01.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
426 Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers (Basel) 2020;12:E957. [PMID: 32294976 DOI: 10.3390/cancers12040957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
427 Durante M, Debus J, Loeffler JS. Physics and biomedical challenges of cancer therapy with accelerated heavy ions. Nat Rev Phys 2021;3:777-90. [PMID: 34870097 DOI: 10.1038/s42254-021-00368-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
428 Sun N, Zhang W, Liu J, Yang X, Chu Q. Propofol Inhibits the Progression of Cervical Cancer by Regulating HOTAIR/miR-129-5p/RPL14 Axis. Onco Targets Ther 2021;14:551-64. [PMID: 33505161 DOI: 10.2147/OTT.S279942] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
429 Kris MG, Faivre-Finn C, Kordbacheh T, Chaft J, Luo J, Tsao A, Swisher S. Making Checkpoint Inhibitors Part of Treatment of Patients With Locally Advanced Lung Cancers: The Time Is Now. Am Soc Clin Oncol Educ Book 2020;40:1-12. [PMID: 32298162 DOI: 10.1200/EDBK_280807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
430 Golubnitschaja O, Yeghiazaryan K, Stricker H, Trog D, Schild HH, Berliner L. Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer 2016;16:357. [PMID: 27277077 DOI: 10.1186/s12885-016-2382-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
431 Koukourakis MI, Giatromanolaki A. Tumor microenvironment, immune response and post-radiotherapy tumor clearance. Clin Transl Oncol 2020;22:2196-205. [PMID: 32445035 DOI: 10.1007/s12094-020-02378-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
432 Seo I, Lee HW, Byun SJ, Park JY, Min H, Lee SH, Lee JS, Kim S, Bae SU. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer. J Immunother Cancer 2021;9:e001610. [PMID: 33692216 DOI: 10.1136/jitc-2020-001610] [Reference Citation Analysis]
433 Chua KLM, Chu PL, Tng DJH, Soo KC, Chua MLK. Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance. Clin Oncol (R Coll Radiol) 2021;33:e469-81. [PMID: 34509347 DOI: 10.1016/j.clon.2021.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Shin PJ, Zhu Z, Camarda R, Bok RA, Zhou AY, Kurhanewicz J, Goga A, Vigneron DB. Cancer recurrence monitoring using hyperpolarized [1-13C]pyruvate metabolic imaging in murine breast cancer model. Magn Reson Imaging 2017;43:105-9. [PMID: 28716678 DOI: 10.1016/j.mri.2017.07.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
435 Du W, Zong Q, Guo R, Ling G, Zhang P. Injectable Nanocomposite Hydrogels for Cancer Therapy. Macromol Biosci 2021;:e2100186. [PMID: 34355522 DOI: 10.1002/mabi.202100186] [Reference Citation Analysis]
436 Cushman TR, Gomez D, Kumar R, Likacheva A, Chang JY, Cadena AP, Paris S, Welsh JW. Combining radiation plus immunotherapy to improve systemic immune response. J Thorac Dis 2018;10:S468-79. [PMID: 29593892 DOI: 10.21037/jtd.2018.01.130] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
437 Knitz MW, Bickett TE, Darragh LB, Oweida AJ, Bhatia S, Van Court B, Bhuvane S, Piper M, Gadwa J, Mueller AC, Nguyen D, Nangia V, Osborne DG, Bai X, Ferrara SE, Boss MK, Goodspeed A, Burchill MA, Tamburini BAJ, Chan ED, Pickering CR, Clambey ET, Karam SD. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis. J Immunother Cancer 2021;9:e001955. [PMID: 33883256 DOI: 10.1136/jitc-2020-001955] [Reference Citation Analysis]
438 Braekeveldt N, Wigerup C, Tadeo I, Beckman S, Sandén C, Jönsson J, Erjefält JS, Berbegall AP, Börjesson A, Backman T, Øra I, Navarro S, Noguera R, Gisselsson D, Påhlman S, Bexell D. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours. Cancer Letters 2016;375:384-9. [DOI: 10.1016/j.canlet.2016.02.046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
439 Jia H, Ren W, Feng Y, Wei T, Guo M, Guo J, Zhao J, Song X, Wang M, Zhao T, Wang H, Feng Z, Tian Z. The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma. Int J Oncol 2018;53:949-60. [PMID: 30015838 DOI: 10.3892/ijo.2018.4473] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
440 Ehling TJ, Klein MK, Smith L, Prescott D, Haney S, Looper J, LaDue T, Brawner W, Fidel J, Shiomitsu K, Green E, Saba C, Turek M, Farrelly J. A prospective, multi-centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma. Vet Comp Oncol 2021. [PMID: 34655275 DOI: 10.1111/vco.12776] [Reference Citation Analysis]
441 Wang H, Lv B, Tang Z, Zhang M, Ge W, Liu Y, He X, Zhao K, Zheng X, He M, Bu W. Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy. Nano Lett 2018;18:5768-74. [PMID: 30052464 DOI: 10.1021/acs.nanolett.8b02409] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
442 Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand? Mol Metab 2020;33:102-21. [PMID: 31399389 DOI: 10.1016/j.molmet.2019.06.026] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 21.0] [Reference Citation Analysis]
443 Wang L, Jiang J, Chen Y, Jia Q, Chu Q. The roles of CC chemokines in response to radiation. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02038-x] [Reference Citation Analysis]
444 Yang B, Chen Y, Shi J. Reactive Oxygen Species (ROS)-Based Nanomedicine. Chem Rev 2019;119:4881-985. [DOI: 10.1021/acs.chemrev.8b00626] [Cited by in Crossref: 465] [Cited by in F6Publishing: 401] [Article Influence: 155.0] [Reference Citation Analysis]
445 Ma LR, Li JX, Tang L, Li RZ, Yang JS, Sun A, Leung EL, Yan PY. Immune checkpoints and immunotherapy in non-small cell lung cancer: Novel study progression, challenges and solutions. Oncol Lett 2021;22:787. [PMID: 34594428 DOI: 10.3892/ol.2021.13048] [Reference Citation Analysis]
446 Zhang Y, Wang Y, Wang J, Liang X. Improved pharmaceutical research and development with AIE-based nanostructures. Mater Horiz 2018;5:799-812. [DOI: 10.1039/c8mh00648b] [Cited by in Crossref: 17] [Article Influence: 4.3] [Reference Citation Analysis]
447 Yoo B, Fuchs BC, Medarova Z. New Directions in the Study and Treatment of Metastatic Cancer. Front Oncol 2018;8:258. [PMID: 30042926 DOI: 10.3389/fonc.2018.00258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
448 Zhou K, Wei Y, Li X, Yang X. MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis. Life Sci 2021;282:119798. [PMID: 34237309 DOI: 10.1016/j.lfs.2021.119798] [Reference Citation Analysis]
449 Li G, Lin H, Tian R, Zhao P, Huang Y, Pang X, Zhao L, Cao B. VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes. J Cancer 2018;9:4049-57. [PMID: 30410610 DOI: 10.7150/jca.25370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
450 Gu X, Dong M, Liu Z, Yang J, Shi Y. MiR-499a-5p Inhibits Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition, and Enhances Radiosensitivity of Cervical Cancer Cells via Targeting eIF4E. Onco Targets Ther 2020;13:2913-24. [PMID: 32308424 DOI: 10.2147/OTT.S241631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
451 Yao T, Cao R, Xiao W, Pan F, Li X. An optical study of drug resistance detection in endometrial cancer cells by dynamic and quantitative phase imaging. J Biophotonics 2019;12:e201800443. [PMID: 30767401 DOI: 10.1002/jbio.201800443] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
452 Fan Y, Tu W, Shen M, Chen X, Ning Y, Li J, Chen T, Wang H, Yin F, Liu Y, Shi X. Targeted Tumor Hypoxia Dual‐Mode CT/MR Imaging and Enhanced Radiation Therapy Using Dendrimer‐Based Nanosensitizers. Adv Funct Mater 2020;30:1909285. [DOI: 10.1002/adfm.201909285] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
453 Darragh LB, Oweida AJ, Karam SD. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment. Front Immunol 2018;9:3154. [PMID: 30766539 DOI: 10.3389/fimmu.2018.03154] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
454 Li X, Zhao Y, Jiang W, Li S, Zhan M, Liu H, Zhang C, Liang H, Liu H, Lu L, Wang Y. Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy. Biomater Sci 2019;7:1335-44. [PMID: 30816393 DOI: 10.1039/c9bm00051h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
455 Hunter B, Crockett C, Faivre-Finn C, Hiley C, Salem A. Re-Irradiation of Recurrent Non-Small Cell Lung Cancer. Semin Radiat Oncol 2021;31:124-32. [PMID: 33610269 DOI: 10.1016/j.semradonc.2020.11.009] [Reference Citation Analysis]
456 Nakamura K, Smyth MJ. Targeting cancer-related inflammation in the era of immunotherapy. Immunol Cell Biol 2017;95:325-32. [PMID: 27999432 DOI: 10.1038/icb.2016.126] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 15.2] [Reference Citation Analysis]
457 Singh P, Eley J, Mahmood N, Bhandary B, Dukic T, Tu KJ, Polf J, Lamichhane N, Mahmood J, Vujaskovic Z, Shukla HD. Therapeutic Efficacy of Variable Biological Effectiveness of Proton Therapy in U-CH2 and MUG-Chor1 Human Chordoma Cell Death. Cancers (Basel) 2021;13:6115. [PMID: 34885223 DOI: 10.3390/cancers13236115] [Reference Citation Analysis]
458 Asna N, Livoff A, Batash R, Debbi R, Schaffer P, Rivkind T, Schaffer M. Radiation therapy and immunotherapy-a potential combination in cancer treatment. Curr Oncol 2018;25:e454-60. [PMID: 30464697 DOI: 10.3747/co.25.4002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
459 Wen H, Tamarov K, Happonen E, Lehto V, Xu W. Inorganic Nanomaterials for Photothermal‐Based Cancer Theranostics. Adv Therap 2021;4:2000207. [DOI: 10.1002/adtp.202000207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
460 Du F, Liu Y. Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer. J Clin Lab Anal 2021;:e24141. [PMID: 34817097 DOI: 10.1002/jcla.24141] [Reference Citation Analysis]
461 Yang W, Zhang F, Deng H, Lin L, Wang S, Kang F, Yu G, Lau J, Tian R, Zhang M, Wang Z, He L, Ma Y, Niu G, Hu S, Chen X. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy. ACS Nano 2020;14:620-31. [PMID: 31877023 DOI: 10.1021/acsnano.9b07212] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 15.7] [Reference Citation Analysis]
462 Sevenich L. Turning "Cold" Into "Hot" Tumors-Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers. Front Oncol 2019;9:163. [PMID: 30941312 DOI: 10.3389/fonc.2019.00163] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
463 Ma Z, Zhang X, Xu L, Liu D, Di S, Li W, Zhang J, Zhang H, Li X, Han J, Yan X. Pterostilbene: Mechanisms of its action as oncostatic agent in cell models and in vivo studies. Pharmacological Research 2019;145:104265. [DOI: 10.1016/j.phrs.2019.104265] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
464 Krisnawan VE, Stanley JA, Schwarz JK, DeNardo DG. Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance. Cancers (Basel) 2020;12:E2916. [PMID: 33050580 DOI: 10.3390/cancers12102916] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
465 Cohen G, Chandran P, Lorsung RM, Tomlinson LE, Sundby M, Burks SR, Frank JA. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel) 2020;12:E350. [PMID: 32033171 DOI: 10.3390/cancers12020350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
466 Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol 2021;162:60-7. [PMID: 34237343 DOI: 10.1016/j.radonc.2021.06.037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Beh CY, Prajnamitra RP, Chen LL, Hsieh PC. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. Molecules 2021;26:5052. [PMID: 34443638 DOI: 10.3390/molecules26165052] [Reference Citation Analysis]
468 Huang Y, Sheng H, Xiao Y, Hu W, Zhang Z, Chen Y, Zhu Z, Wu D, Cao C, Sun J. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Radiother Oncol 2021;162:34-44. [PMID: 34214613 DOI: 10.1016/j.radonc.2021.06.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
469 Li Y, Ni K, Chan C, Guo N, Luo T, Han W, Culbert A, Weichselbaum RR, Lin W. Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade. Advanced Therapeutics 2022;5:2100160. [DOI: 10.1002/adtp.202100160] [Reference Citation Analysis]
470 Wang Y, Deng W, Li N, Neri S, Sharma A, Jiang W, Lin SH. Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions. Front Pharmacol. 2018;9:185. [PMID: 29556198 DOI: 10.3389/fphar.2018.00185] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 33.8] [Reference Citation Analysis]
471 Abraham JA, Yeghiazaryan K, Golubnitschaja O. Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization. Per Med 2016;13:347-60. [PMID: 29749819 DOI: 10.2217/pme-2016-0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
472 Ma T, Liu Y, Wu Q, Luo L, Cui Y, Wang X, Chen X, Tan L, Meng X. Quercetin-Modified Metal-Organic Frameworks for Dual Sensitization of Radiotherapy in Tumor Tissues by Inhibiting the Carbonic Anhydrase IX. ACS Nano 2019;13:4209-19. [PMID: 30933559 DOI: 10.1021/acsnano.8b09221] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
473 Zhou P, Chen D, Zhu B, Chen W, Xie Q, Wang Y, Tan Q, Yuan B, Zuo X, Huang C, Zhu H, Li G. Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma. Front Immunol 2020;11:594212. [PMID: 33552051 DOI: 10.3389/fimmu.2020.594212] [Reference Citation Analysis]
474 Schoenhals JE, Seyedin SN, Tang C, Cortez MA, Niknam S, Tsouko E, Chang JY, Hahn SM, Welsh JW. Preclinical Rationale and Clinical Considerations for Radiotherapy Plus Immunotherapy: Going Beyond Local Control. Cancer J 2016;22:130-7. [PMID: 27111909 DOI: 10.1097/PPO.0000000000000181] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
475 Cohen G, Chandran P, Lorsung RM, Aydin O, Tomlinson LE, Rosenblatt RB, Burks SR, Frank JA. Pulsed-Focused Ultrasound Slows B16 Melanoma and 4T1 Breast Tumor Growth through Differential Tumor Microenvironmental Changes. Cancers (Basel) 2021;13:1546. [PMID: 33801627 DOI: 10.3390/cancers13071546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
476 Chen X, Zhuang X, Zhang Q, Luo Y, Yuan S, Qiao T. Analgecine enhances the anti-tumor response of radiotherapy by increasing apoptosis and cell cycle arrest in non-small cell lung cancer. Oncotarget 2017;8:80730-40. [PMID: 29113340 DOI: 10.18632/oncotarget.19968] [Reference Citation Analysis]
477 Sjoberg HT, Philippou Y, Magnussen AL, Tullis IDC, Bridges E, Chatrian A, Lefebvre J, Tam KH, Murphy EA, Rittscher J, Preise D, Agemy L, Yechezkel T, Smart SC, Kinchesh P, Gilchrist S, Allen DP, Scheiblin DA, Lockett SJ, Wink DA, Lamb AD, Mills IG, Harris A, Muschel RJ, Vojnovic B, Scherz A, Hamdy FC, Bryant RJ. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. Br J Cancer 2021;125:534-46. [PMID: 34155340 DOI: 10.1038/s41416-021-01450-6] [Reference Citation Analysis]
478 Gray M, Turnbull AK, Meehan J, Martínez-Pérez C, Kay C, Pang LY, Argyle DJ. Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines. Front Vet Sci 2020;7:439. [PMID: 32851022 DOI: 10.3389/fvets.2020.00439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Chen X, Takemoto Y, Deng H, Middelhoff M, Friedman RA, Chu TH, Churchill MJ, Ma Y, Nagar KK, Tailor YH, Mukherjee S, Wang TC. Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer. Oncoimmunology 2017;6:e1290034. [PMID: 28405523 DOI: 10.1080/2162402X.2017.1290034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
480 Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, Marguier A, Tochet F, Dosset M, Boustani J, Ravel P, Boidot R, Spehner L, Haicheur-Adjouri N, Marliot F, Pallandre JR, Bonnefoy F, Scripcariu V, Van den Eynde M, Cornillot E, Mirjolet C, Pages F, Adotevi O. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer 2021;9:e002256. [PMID: 34230108 DOI: 10.1136/jitc-2020-002256] [Reference Citation Analysis]
481 Paganetti H. Mechanisms and Review of Clinical Evidence of Variations in Relative Biological Effectiveness in Proton Therapy. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02684-5. [PMID: 34407443 DOI: 10.1016/j.ijrobp.2021.08.015] [Reference Citation Analysis]
482 Rodriguez-Ruiz ME, Garasa S, Rodriguez I, Solorzano JL, Barbes B, Yanguas A, Teijeira A, Etxeberria I, Aristu JJ, Halin C, Melero I, Rouzaut A. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium. Int J Radiat Oncol Biol Phys 2017;97:389-400. [PMID: 28068246 DOI: 10.1016/j.ijrobp.2016.10.043] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
483 Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å. Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy. Adv Radiat Oncol 2018;3:130-8. [PMID: 29904737 DOI: 10.1016/j.adro.2017.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
484 Chen C, Enomoto A, Weng L, Taki T, Shiraki Y, Mii S, Ichihara R, Kanda M, Koike M, Kodera Y, Takahashi M. Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells. Cancer Sci 2020;111:4303-17. [PMID: 32875699 DOI: 10.1111/cas.14637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
485 Nishikawa H, Koyama S. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer 2021;9:e002591. [PMID: 34330764 DOI: 10.1136/jitc-2021-002591] [Reference Citation Analysis]
486 Jahanban-Esfahlan R, de la Guardia M, Ahmadi D, Yousefi B. Modulating tumor hypoxia by nanomedicine for effective cancer therapy. J Cell Physiol 2018;233:2019-31. [PMID: 28198007 DOI: 10.1002/jcp.25859] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 20.0] [Reference Citation Analysis]
487 Zhang S, Long F, Lin H, Wang X, Jiang G, Wang T. Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases. Pharmacol Res 2021;174:105936. [PMID: 34653635 DOI: 10.1016/j.phrs.2021.105936] [Reference Citation Analysis]
488 Manukian G, Bar-Ad V, Lu B, Argiris A, Johnson JM. Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma. Front Oncol 2019;9:122. [PMID: 30895168 DOI: 10.3389/fonc.2019.00122] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
489 Cheng S, Cheadle EJ, Illidge TM. Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response. Cancers (Basel) 2020;12:E2835. [PMID: 33008040 DOI: 10.3390/cancers12102835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Tu J, Tu K, Xu H, Wang L, Yuan X, Qin X, Kong L, Chu Q, Zhang Z. Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy. Eur J Pharm Biopharm 2020;150:96-107. [PMID: 32151726 DOI: 10.1016/j.ejpb.2020.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
491 Cho H, Kim JE, Kim SY, Kim KP, Kim TW, Park JH, Kim JH, Lim SB, Yu CS, Kim JC, Hong YS. Patterns of recurrence in patients with curative resected rectal cancer according to different chemoradiotherapy strategies: Does preoperative chemoradiotherapy lower the risk of peritoneal recurrence? Oncol Lett 2020;20:242. [PMID: 32973956 DOI: 10.3892/ol.2020.12105] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
492 Wang J, Zhang Y, Zhang G, Xiang L, Pang H, Xiong K, Lu Y, Li J, Dai J, Lin S, Fu S. Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer. Drug Deliv 2022;29:588-99. [PMID: 35156493 DOI: 10.1080/10717544.2022.2036871] [Reference Citation Analysis]
493 Her S, Jaffray DA, Allen C. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev. 2017;109:84-101. [PMID: 26712711 DOI: 10.1016/j.addr.2015.12.012] [Cited by in Crossref: 368] [Cited by in F6Publishing: 306] [Article Influence: 52.6] [Reference Citation Analysis]
494 Park M, Kwon J, Kong J, Moon SM, Cho S, Yang KY, Jang WI, Kim MS, Kim Y, Shin US. A Patient-Derived Organoid-Based Radiosensitivity Model for the Prediction of Radiation Responses in Patients with Rectal Cancer. Cancers (Basel) 2021;13:3760. [PMID: 34359661 DOI: 10.3390/cancers13153760] [Reference Citation Analysis]
495 Husband HR, Campagne O, He C, Zhu X, Bianski BM, Baker SJ, Shelat AA, Tinkle CL, Stewart CF. Model-based evaluation of image-guided fractionated whole-brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts. CPT Pharmacometrics Syst Pharmacol 2021;10:599-610. [PMID: 33939327 DOI: 10.1002/psp4.12627] [Reference Citation Analysis]
496 Ryan D, Bodei L. Radioimmunotherapy in Oncology. Curr Radiol Rep 2017;5. [DOI: 10.1007/s40134-017-0258-0] [Reference Citation Analysis]
497 Lu Y, Liu B, Liu Y, Yu X, Cheng G. Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity. Oncol Lett 2020;20:993-1000. [PMID: 32724338 DOI: 10.3892/ol.2020.11684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
498 Bear AS, Vonderheide RH, O'Hara MH. Challenges and Opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell 2020;38:788-802. [PMID: 32946773 DOI: 10.1016/j.ccell.2020.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
499 Lee KW, Wan Y, Li X, Cui X, Li S, Lee CS. Recent Progress of Alkyl Radicals Generation-Based Agents for Biomedical Applications. Adv Healthc Mater 2021;10:e2100055. [PMID: 33738983 DOI: 10.1002/adhm.202100055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
500 Yan D, Zhao Q, Du Z, Li H, Geng R, Yang W, Zhang X, Cao J, Yi N, Zhou J, Tang Z. Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10601-5] [Reference Citation Analysis]
501 Hou X, Chang Y, Yue Y, Wang Z, Ding F, Li Z, Li H, Xu Y, Kong X, Huang F, Guo D, Liu J. Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle. Advanced Science. [DOI: 10.1002/advs.202104349] [Reference Citation Analysis]
502 Webb TE, Davies M, Maher J, Sarker D. The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapy. Clin Transl Radiat Oncol 2020;24:123-6. [PMID: 32875125 DOI: 10.1016/j.ctro.2020.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
503 Challapalli A, Carroll L, Aboagye EO. Molecular mechanisms of hypoxia in cancer. Clin Transl Imaging 2017;5:225-53. [PMID: 28596947 DOI: 10.1007/s40336-017-0231-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 11.6] [Reference Citation Analysis]
504 Oladejo M, Paterson Y, Wood LM. Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies. Front Immunol 2021;12:642316. [PMID: 33936058 DOI: 10.3389/fimmu.2021.642316] [Reference Citation Analysis]
505 Schrand B, Verma B, Levay A, Patel S, Castro I, Benaduce AP, Brenneman R, Umland O, Yagita H, Gilboa E, Ishkanian A. Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation. Cancer Res 2017;77:1310-21. [PMID: 28082399 DOI: 10.1158/0008-5472.CAN-16-2105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
506 Chen Z, Yao N, Zhang S, Song Y, Shao Q, Gu H, Ma J, Chen B, Zhao H, Tian Y. Identification of critical radioresistance genes in esophageal squamous cell carcinoma by whole-exome sequencing. Ann Transl Med 2020;8:998. [PMID: 32953798 DOI: 10.21037/atm-20-5196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
507 Blanco-Fernandez B, Gaspar VM, Engel E, Mano JF. Proteinaceous Hydrogels for Bioengineering Advanced 3D Tumor Models. Adv Sci (Weinh) 2021;8:2003129. [PMID: 33643799 DOI: 10.1002/advs.202003129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
508 Cho O, Chun M, Oh YT, Noh OK, Chang SJ, Ryu HS, Lee EJ. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma. Tumour Biol 2017;39:1010428317733144. [PMID: 29022484 DOI: 10.1177/1010428317734303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
509 Oweida AJ, Mueller AC, Piper M, Milner D, Van Court B, Bhatia S, Phan A, Bickett T, Jordan K, Proia T, Schulick R, Messersmith WA, Del Chiaro M, Clambey E, Gough MJ, Williams J, Hansen K, Goodman K, Karam SD. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunol Immunother 2021;70:989-1000. [PMID: 33097963 DOI: 10.1007/s00262-020-02701-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
510 Broekman ML, Maas SLN, Abels ER, Mempel TR, Krichevsky AM, Breakefield XO. Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol. 2018;14:482-495. [PMID: 29985475 DOI: 10.1038/s41582-018-0025-8] [Cited by in Crossref: 127] [Cited by in F6Publishing: 133] [Article Influence: 42.3] [Reference Citation Analysis]
511 Liu P, Peng Y, Ding J, Zhou W. Fenton Metal Nanomedicines for Imaging-guided Combinatorial Chemodynamic Therapy against Cancer. Asian Journal of Pharmaceutical Sciences 2021. [DOI: 10.1016/j.ajps.2021.10.003] [Reference Citation Analysis]
512 Lee TH, Kim DY, Wu HG, Lee JH, Kim HJ. Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis. Radiat Oncol 2021;16:222. [PMID: 34794471 DOI: 10.1186/s13014-021-01948-6] [Reference Citation Analysis]
513 Weichselbaum RR, Liang H, Deng L, Fu Y. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol 2017;14:365-79. [DOI: 10.1038/nrclinonc.2016.211] [Cited by in Crossref: 394] [Cited by in F6Publishing: 381] [Article Influence: 78.8] [Reference Citation Analysis]
514 Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18:313-322. [PMID: 29449659 DOI: 10.1038/nrc.2018.6] [Cited by in Crossref: 371] [Cited by in F6Publishing: 352] [Article Influence: 92.8] [Reference Citation Analysis]
515 Jatoi I, Benson JR, Kunkler I. Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality? NPJ Breast Cancer 2018;4:8. [PMID: 29644338 DOI: 10.1038/s41523-018-0061-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
516 Demidov V, Maeda A, Sugita M, Madge V, Sadanand S, Flueraru C, Vitkin IA. Preclinical longitudinal imaging of tumor microvascular radiobiological response with functional optical coherence tomography. Sci Rep 2018;8:38. [PMID: 29311686 DOI: 10.1038/s41598-017-18635-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
517 Li W, Han Y, Zhao Z, Ji X, Wang X, Jin J, Wang Q, Guo X, Cheng Z, Lu M, Wang G, Wang Y, Liu H. Oral mucosal mesenchymal stem cell‑derived exosomes: A potential therapeutic target in oral premalignant lesions. Int J Oncol 2019;54:1567-78. [PMID: 30896790 DOI: 10.3892/ijo.2019.4756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
518 Zhang J, Wang H, Suo W, Li Z, Yang C. Penetration Enhancing of an Erythrocyte-Mimicking Nanoplatform via Papaverine for Radiosensitization. Int J Nanomedicine 2021;16:6923-35. [PMID: 34675515 DOI: 10.2147/IJN.S324314] [Reference Citation Analysis]
519 Al-Saafeen BH, Fernandez-Cabezudo MJ, Al-Ramadi BK. Integration of Salmonella into Combination Cancer Therapy. Cancers (Basel) 2021;13:3228. [PMID: 34203478 DOI: 10.3390/cancers13133228] [Reference Citation Analysis]
520 Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R. Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib. Acta Neuropathol 2018;135:779-98. [PMID: 29305721 DOI: 10.1007/s00401-017-1799-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
521 Cheng Y, Li W, Gui R, Wang C, Song J, Wang Z, Wang X, Shen Y, Wang Z, Hao L. Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers. Front Cell Dev Biol 2021;9:671247. [PMID: 34178997 DOI: 10.3389/fcell.2021.671247] [Reference Citation Analysis]
522 Gomes F, Wong M, Battisti NML, Kordbacheh T, Kiderlen M, Greystoke A, Luciani A. Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper. Br J Cancer 2020;123:874-84. [PMID: 32694695 DOI: 10.1038/s41416-020-0986-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Chang L, Zhang Z, Chen F, Zhang W, Song S, Song S. Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α. Med Oncol 2017;34:44. [PMID: 28194716 DOI: 10.1007/s12032-016-0864-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
524 Cytlak UM, Dyer DP, Honeychurch J, Williams KJ, Travis MA, Illidge TM. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nat Rev Immunol 2021. [PMID: 34211187 DOI: 10.1038/s41577-021-00568-1] [Reference Citation Analysis]
525 Duan C, Yang R, Yuan L, Engelbach JA, Tsien CI, Rich KM, Dahiya SM, Johanns TM, Ackerman JJH, Garbow JR. Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth. Int J Radiat Oncol Biol Phys 2019;103:190-4. [PMID: 30171879 DOI: 10.1016/j.ijrobp.2018.08.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
526 Sánchez-Castillo A, Vooijs M, Kampen KR. Linking Serine/Glycine Metabolism to Radiotherapy Resistance. Cancers (Basel) 2021;13:1191. [PMID: 33801846 DOI: 10.3390/cancers13061191] [Reference Citation Analysis]
527 Macmanus M, Hegi-johnson F. Overcoming immunotherapy resistance in NSCLC. The Lancet Oncology 2022. [DOI: 10.1016/s1470-2045(21)00711-7] [Reference Citation Analysis]
528 Irfan M, Delgado RZR, Frias-Lopez J. The Oral Microbiome and Cancer. Front Immunol 2020;11:591088. [PMID: 33193429 DOI: 10.3389/fimmu.2020.591088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
529 Toss MS, Miligy IM, Gorringe KL, AlKawaz A, Mittal K, Aneja R, Ellis IO, Green AR, Roxanis I, Rakha EA. Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study. Mod Pathol 2019;32:1473-85. [PMID: 31175326 DOI: 10.1038/s41379-019-0296-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
530 Kasten BB, Ferrone S, Zinn KR, Buchsbaum DJ. B7-H3-targeted Radioimmunotherapy of Human Cancer. Curr Med Chem 2020;27:4016-38. [PMID: 30836909 DOI: 10.2174/0929867326666190228120908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
531 Muñoz DP, Yannone SM, Daemen A, Sun Y, Vakar-Lopez F, Kawahara M, Freund AM, Rodier F, Wu JD, Desprez PY, Raulet DH, Nelson PS, van 't Veer LJ, Campisi J, Coppé JP. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. JCI Insight 2019;5:124716. [PMID: 31184599 DOI: 10.1172/jci.insight.124716] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
532 Guo SS, Liang YJ, Liu LT, Chen QY, Wen YF, Liu SL, Sun XS, Tang QN, Li XY, Mai HQ, Tang LQ. Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma. Front Pharmacol 2021;12:627935. [PMID: 34512316 DOI: 10.3389/fphar.2021.627935] [Reference Citation Analysis]
533 Fokas E, Ströbel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Rödel C; German Rectal Cancer Study Group. Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. J Natl Cancer Inst 2017;109. [PMID: 29206996 DOI: 10.1093/jnci/djx095] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
534 Piotrowski I, Kulcenty K, Murawa D, Suchorska W. Surgical wound fluids from patients treated with intraoperative radiotherapy induce radiobiological response in breast cancer cells. Med Oncol 2018;36:14. [PMID: 30599057 DOI: 10.1007/s12032-018-1243-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
535 Bhat SA, Kaur R, Chauhan A, Pal A. The microbiome and precision oncology: an emerging paradigm in anticancer therapy. Crit Rev Microbiol 2022;:1-14. [PMID: 35164642 DOI: 10.1080/1040841X.2022.2035313] [Reference Citation Analysis]
536 Myers KV, Amend SR, Pienta KJ. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Mol Cancer 2019;18:94. [PMID: 31088471 DOI: 10.1186/s12943-019-1022-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 24.7] [Reference Citation Analysis]
537 Romano E, Honeychurch J, Illidge TM. Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery? Cancers (Basel) 2021;13:457. [PMID: 33530329 DOI: 10.3390/cancers13030457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
538 Kyu Shim M, Yang S, Sun IC, Kim K. Tumor-Activated Carrier-Free Prodrug Nanoparticles for Targeted Cancer Immunotherapy: Preclinical Evidence for Safe and Effective Drug Delivery. Adv Drug Deliv Rev 2022;:114177. [PMID: 35245568 DOI: 10.1016/j.addr.2022.114177] [Reference Citation Analysis]
539 Khan AA, Paget JT, McLaughlin M, Kyula JN, Wilkinson MJ, Pencavel T, Mansfield D, Roulstone V, Seth R, Halle M, Somaiah N, Boult JKR, Robinson SP, Pandha HS, Vile RG, Melcher AA, Harris PA, Harrington KJ. Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Sci Transl Med 2018;10:eaar2041. [PMID: 29367346 DOI: 10.1126/scitranslmed.aar2041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
540 Yang Y, Liu B, Liu Y, Chen J, Sun Y, Pan X, Xu J, Xu S, Liu Z, Tan W. DNA-Based MXFs to Enhance Radiotherapy and Stimulate Robust Antitumor Immune Responses. Nano Lett 2022. [PMID: 35344667 DOI: 10.1021/acs.nanolett.1c04888] [Reference Citation Analysis]
541 Shen HY, Wei FZ, Liu Q. Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer. World J Clin Cases 2021; 9(16): 3880-3894 [PMID: 34141744 DOI: 10.12998/wjcc.v9.i16.3880] [Reference Citation Analysis]
542 Moon S, Ok Y, Hwang S, Lim YS, Kim HY, Na YJ, Yoon S. A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer. Mar Drugs 2020;18:E498. [PMID: 33003514 DOI: 10.3390/md18100498] [Reference Citation Analysis]
543 Ebersbach C, Beier AK, Thomas C, Erb HHH. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer. Cancers (Basel) 2021;13:4854. [PMID: 34638338 DOI: 10.3390/cancers13194854] [Reference Citation Analysis]
544 Mi Y, Hagan CT 4th, Vincent BG, Wang AZ. Emerging Nano-/Microapproaches for Cancer Immunotherapy. Adv Sci (Weinh) 2019;6:1801847. [PMID: 30937265 DOI: 10.1002/advs.201801847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 17.3] [Reference Citation Analysis]
545 Zhou Z, Lu Z. Molecular imaging of the tumor microenvironment. Advanced Drug Delivery Reviews 2017;113:24-48. [DOI: 10.1016/j.addr.2016.07.012] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 18.4] [Reference Citation Analysis]
546 Loka RS, Yu F, Sletten ET, Nguyen HM. Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity. Chem Commun (Camb) 2017;53:9163-6. [PMID: 28766595 DOI: 10.1039/c7cc04156j] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 6.8] [Reference Citation Analysis]
547 Hellevik T, Berzaghi R, Lode K, Islam A, Martinez-Zubiaurre I. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy. J Transl Med 2021;19:437. [PMID: 34663337 DOI: 10.1186/s12967-021-03112-w] [Reference Citation Analysis]
548 Genji Srinivasulu Y, Yao Q, Goswami N, Xie J. Interfacial engineering of gold nanoclusters for biomedical applications. Mater Horiz 2020;7:2596-618. [DOI: 10.1039/d0mh00827c] [Cited by in Crossref: 30] [Cited by in F6Publishing: 1] [Article Influence: 15.0] [Reference Citation Analysis]
549 Park S, Joung JG, Min YW, Nam JY, Ryu D, Oh D, Park WY, Lee SH, Choi Y, Ahn JS, Ahn MJ, Park K, Sun JM. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma. J Immunother Cancer 2019;7:128. [PMID: 31097034 DOI: 10.1186/s40425-019-0609-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
550 Monzen S, Ueno T, Chiba M, Morino Y, Mariya Y, Wojcik A, Lundholm L. Dose-dependent expression of extracellular microRNAs in HCT116 colorectal cancer cells exposed to high-dose-rate ionising radiation. Mol Clin Oncol 2022;16:19. [PMID: 34881039 DOI: 10.3892/mco.2021.2452] [Reference Citation Analysis]
551 Paderno A, Piazza C, Bresciani L, Vella R, Nicolai P. Microvascular head and neck reconstruction after (chemo)radiation: facts and prejudices. Current Opinion in Otolaryngology & Head and Neck Surgery 2016;24:83-90. [DOI: 10.1097/moo.0000000000000243] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
552 Patwardhan RS, Sharma D, Sandur SK. Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer. Transl Oncol 2022;17:101341. [PMID: 35078017 DOI: 10.1016/j.tranon.2022.101341] [Reference Citation Analysis]
553 Gou S, Liu W, Wang S, Chen G, Chen Z, Qiu L, Zhou X, Wu Y, Qi Y, Gao Y. Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist. Nano Lett 2021;21:9939-50. [PMID: 34779631 DOI: 10.1021/acs.nanolett.1c03243] [Reference Citation Analysis]
554 Nagle PW, Coppes RP. Current and Future Perspectives of the Use of Organoids in Radiobiology. Cells 2020;9:E2649. [PMID: 33317153 DOI: 10.3390/cells9122649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
555 Li JJ. Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy. iScience 2020;23:101215. [PMID: 32512383 DOI: 10.1016/j.isci.2020.101215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
556 Poon DJJ, Tay LM, Ho D, Chua MLK, Chow EK, Yeo ELL. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery. Cancer Lett 2021;511:56-67. [PMID: 33933554 DOI: 10.1016/j.canlet.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
557 Yin T, Xin H, Yu J, Teng F. The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects? Biomark Res 2021;9:22. [PMID: 33789758 DOI: 10.1186/s40364-021-00277-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L. Targeting immune checkpoints in breast cancer: an update of early results. ESMO Open 2017;2:e000255. [PMID: 29177095 DOI: 10.1136/esmoopen-2017-000255] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
559 Yu M, Guo G, Huang L, Deng L, Chang CS, Achyut BR, Canning M, Xu N, Arbab AS, Bollag RJ, Rodriguez PC, Mellor AL, Shi H, Munn DH, Cui Y. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun 2020;11:515. [PMID: 31980601 DOI: 10.1038/s41467-019-14060-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
560 Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch H, Steinbach J, Kotzerke J, Baumann M, Krause M. Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial. Radiotherapy and Oncology 2021;155:285-92. [DOI: 10.1016/j.radonc.2020.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
561 Dhaliwal A, Zheng G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics 2019;9:8091-108. [PMID: 31754383 DOI: 10.7150/thno.37204] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
562 Gridelli C, Ascierto PA, Barberis MC, Felip E, Garon EB, O'brien M, Senan S, Casaluce F, Sgambato A, Papadimitrakopoulou V, De Marinis F. Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology. Expert Opin Biol Ther 2016;16:1479-89. [PMID: 27650132 DOI: 10.1080/14712598.2016.1234602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
563 Fan W, Tang W, Lau J, Shen Z, Xie J, Shi J, Chen X. Breaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer Theranostics. Adv Mater 2019;31:1806381. [DOI: 10.1002/adma.201806381] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
564 Teresa Pinto A, Laranjeiro Pinto M, Patrícia Cardoso A, Monteiro C, Teixeira Pinto M, Filipe Maia A, Castro P, Figueira R, Monteiro A, Marques M. Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities. Sci Rep. 2016;6:18765. [PMID: 26735768 DOI: 10.1038/srep18765] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 15.0] [Reference Citation Analysis]
565 Chua CYX, Ho J, Demaria S, Ferrari M, Grattoni A. Emerging Technologies for Local Cancer Treatment. Adv Therap 2020;3:2000027. [DOI: 10.1002/adtp.202000027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
566 Li B, Jiang C, Pang L, Zou B, Ding M, Sun X, Yu J, Wang L. Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review. Front Immunol 2021;12:627197. [PMID: 33859637 DOI: 10.3389/fimmu.2021.627197] [Reference Citation Analysis]
567 Lee JC, Wu ATH, Chen JH, Huang WY, Lawal B, Mokgautsi N, Huang HS, Ho CL. HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses. Cancers (Basel) 2020;12:E3759. [PMID: 33327484 DOI: 10.3390/cancers12123759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
568 Meng L, Cheng Y, Gan S, Zhang Z, Tong X, Xu L, Jiang X, Zhu Y, Wu J, Yuan A, Hu Y. Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy. Mol Pharm 2018;15:447-57. [PMID: 29261319 DOI: 10.1021/acs.molpharmaceut.7b00808] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
569 Endo H, Okami J, Okuyama H, Nishizawa Y, Imamura F, Inoue M. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations. Oncogene 2017;36:2824-34. [DOI: 10.1038/onc.2016.431] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
570 Rekers NH, Olivo Pimentel V, Yaromina A, Lieuwes NG, Biemans R, Zegers CML, Germeraad WTV, Van Limbergen EJ, Neri D, Dubois LJ, Lambin P. The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses. Oncoimmunology 2018;7:e1414119. [PMID: 29632732 DOI: 10.1080/2162402X.2017.1414119] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
571 Song G, Zheng X, Wang Y, Xia X, Chu S, Rao J. A Magneto-Optical Nanoplatform for Multimodality Imaging of Tumors in Mice. ACS Nano 2019;13:7750-8. [DOI: 10.1021/acsnano.9b01436] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
572 Lindegren A, Schultz I, Sinha I, Cheung L, Khan AA, Tekle M, Wickman M, Halle M. Autologous fat transplantation alters gene expression patterns related to inflammation and hypoxia in the irradiated human breast. Br J Surg 2019;106:563-73. [PMID: 30802303 DOI: 10.1002/bjs.11072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
573 Lacombe J, Zenhausern F. Emergence of miR-34a in radiation therapy. Crit Rev Oncol Hematol 2017;109:69-78. [PMID: 28010900 DOI: 10.1016/j.critrevonc.2016.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
574 Liang T, Tong W, Ma S, Chang P. Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer. Oncoimmunology 2020;9:1773205. [PMID: 32934878 DOI: 10.1080/2162402X.2020.1773205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
575 Krombach J, Hennel R, Brix N, Orth M, Schoetz U, Ernst A, Schuster J, Zuchtriegel G, Reichel CA, Bierschenk S, Sperandio M, Vogl T, Unkel S, Belka C, Lauber K. Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells. Oncoimmunology 2019;8:e1523097. [PMID: 30546963 DOI: 10.1080/2162402X.2018.1523097] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
576 Cho HR, Jeon H, Park CK, Park SH, Choi SH. Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis. Sci Rep 2018;8:16022. [PMID: 30375429 DOI: 10.1038/s41598-018-34242-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
577 Zhou X, You M, Wang F, Wang Z, Gao X, Jing C, Liu J, Guo M, Li J, Luo A, Liu H, Liu Z, Chen C. Multifunctional Graphdiyne-Cerium Oxide Nanozymes Facilitate MicroRNA Delivery and Attenuate Tumor Hypoxia for Highly Efficient Radiotherapy of Esophageal Cancer. Adv Mater 2021;33:e2100556. [PMID: 33949734 DOI: 10.1002/adma.202100556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
578 Zhao X, Shao C. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade. Cancers (Basel) 2020;12:E2762. [PMID: 32992835 DOI: 10.3390/cancers12102762] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
579 Xie Z, Fan T, An J, Choi W, Duo Y, Ge Y, Zhang B, Nie G, Xie N, Zheng T, Chen Y, Zhang H, Kim JS. Emerging combination strategies with phototherapy in cancer nanomedicine. Chem Soc Rev 2020;49:8065-87. [DOI: 10.1039/d0cs00215a] [Cited by in Crossref: 91] [Cited by in F6Publishing: 22] [Article Influence: 45.5] [Reference Citation Analysis]
580 Zhang L, Li M, Zhou Q, Dang M, Tang Y, Wang S, Fu J, Teng Z, Lu G. Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with insitu oxygen generation ability. Acta Pharm Sin B 2020;10:1719-29. [PMID: 33088691 DOI: 10.1016/j.apsb.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
581 Olivo Pimentel V, Marcus D, van der Wiel AM, Lieuwes NG, Biemans R, Lieverse RI, Neri D, Theys J, Yaromina A, Dubois LJ, Lambin P. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy. J Immunother Cancer 2021;9:e001764. [PMID: 33688020 DOI: 10.1136/jitc-2020-001764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
582 Magee K, Marsh IR, Turek MM, Grudzinski J, Aluicio-Sarduy E, Engle JW, Kurzman ID, Zuleger CL, Oseid EA, Jaskowiak C, Albertini MR, Esbona K, Bednarz B, Sondel PM, Weichert JP, Morris ZS, Hernandez R, Vail DM. Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS One 2021;16:e0255798. [PMID: 34383787 DOI: 10.1371/journal.pone.0255798] [Reference Citation Analysis]
583 Lao L, Fan S, Song E. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer. Adv Exp Med Biol 2017;1026:331-70. [PMID: 29282692 DOI: 10.1007/978-981-10-6020-5_16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
584 Alberti D, Michelotti A, Lanfranco A, Protti N, Altieri S, Deagostino A, Geninatti Crich S. In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells. Sci Rep 2020;10:19274. [PMID: 33159147 DOI: 10.1038/s41598-020-76370-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
585 Chen Z, Yu H, Lu W, Shen J, Wang Y, Wang Y. Bone-Seeking Albumin-Nanomedicine for In Vivo Imaging and Therapeutic Monitoring. ACS Biomater Sci Eng 2020;6:647-53. [PMID: 33463196 DOI: 10.1021/acsbiomaterials.9b01195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
586 Possenti L, Mecchi L, Rossoni A, Sangalli V, Bersini S, Cicchetti A, Costantino ML, Candrian C, Arrigoni C, Rancati T, Moretti M. Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective. Cancers (Basel) 2021;13:1182. [PMID: 33803333 DOI: 10.3390/cancers13051182] [Reference Citation Analysis]
587 Zakelj MN, Prevc A, Kranjc S, Cemazar M, Todorovic V, Savarin M, Scancar J, Kosjek T, Groselj B, Strojan P, Sersa G. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep 2019;41:1658-68. [PMID: 30628709 DOI: 10.3892/or.2019.6960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
588 Durante M, Orecchia R, Loeffler JS. Charged-particle therapy in cancer: clinical uses and future perspectives. Nat Rev Clin Oncol 2017;14:483-95. [DOI: 10.1038/nrclinonc.2017.30] [Cited by in Crossref: 189] [Cited by in F6Publishing: 152] [Article Influence: 37.8] [Reference Citation Analysis]
589 Ali MY, Oliva CR, Noman ASM, Allen BG, Goswami PC, Zakharia Y, Monga V, Spitz DR, Buatti JM, Griguer CE. Radioresistance in Glioblastoma and the Development of Radiosensitizers. Cancers (Basel) 2020;12:E2511. [PMID: 32899427 DOI: 10.3390/cancers12092511] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
590 Li J, Luo Y, Pu K. Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy. Angew Chem 2021;133:12792-815. [DOI: 10.1002/ange.202008386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
591 Benna M, Guy JB, Bosacki C, Jmour O, Ben Mrad M, Ogorodniitchouk O, Soltani S, Lan M, Daguenet E, Mery B, Sotton S, Magné N, Vallard A. Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box? Br J Radiol 2020;93:20190147. [PMID: 31971824 DOI: 10.1259/bjr.20190147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
592 Seifert M, Peitzsch C, Gorodetska I, Börner C, Klink B, Dubrovska A. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse. PLoS Comput Biol 2019;15:e1007460. [PMID: 31682594 DOI: 10.1371/journal.pcbi.1007460] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
593 Classen F, Kranz P, Riffkin H, Pompsch M, Wolf A, Göpelt K, Baumann M, Baumann J, Brockmeier U, Metzen E. Autophagy induced by ionizing radiation promotes cell death over survival in human colorectal cancer cells. Experimental Cell Research 2019;374:29-37. [DOI: 10.1016/j.yexcr.2018.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
594 Zhu X, Wang Y, Jiang C, Li X, Sun L, Wang G, Fu X. Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02776-0. [PMID: 34506873 DOI: 10.1016/j.ijrobp.2021.08.041] [Reference Citation Analysis]
595 McMahon SJ, Prise KM. Mechanistic Modelling of Radiation Responses. Cancers (Basel) 2019;11:E205. [PMID: 30744204 DOI: 10.3390/cancers11020205] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
596 Kranjc Brezar S, Mrak V, Bosnjak M, Savarin M, Sersa G, Cemazar M. Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response. Vaccines (Basel) 2020;8:E135. [PMID: 32204304 DOI: 10.3390/vaccines8010135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
597 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
598 Wu K, Chen X, Feng J, Zhang S, Xu Y, Zhang J, Wu Q, You M, Xia B, Ma S. Capilliposide C from Lysimachia capillipes Restores Radiosensitivity in Ionizing Radiation-Resistant Lung Cancer Cells Through Regulation of ERRFI1/EGFR/STAT3 Signaling Pathway. Front Oncol 2021;11:644117. [PMID: 33869036 DOI: 10.3389/fonc.2021.644117] [Reference Citation Analysis]
599 Wang H, Li X, Peng R, Wang Y, Wang J. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis. Semin Cancer Biol 2021;71:21-32. [PMID: 32629077 DOI: 10.1016/j.semcancer.2020.06.018] [Reference Citation Analysis]
600 Bates JE, Morris CG, Milano MT, Yeung AR, Hoppe BS. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database. Radiother Oncol 2019;138:75-9. [PMID: 31252297 DOI: 10.1016/j.radonc.2019.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
601 Basu R, Kopchick JJ. The effects of growth hormone on therapy resistance in cancer. Cancer Drug Resist 2019;2:827-46. [PMID: 32382711 DOI: 10.20517/cdr.2019.27] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
602 Xu M, Zhang C, Zeng Z, Pu K. Semiconducting Polymer Nanoparticles as Activatable Nanomedicines for Combinational Phototherapy. ACS Appl Polym Mater 2021;3:4375-89. [DOI: 10.1021/acsapm.1c00695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
603 Senchukova MA, Makarova EV, Kalinin EA, Tkachev VV, Zubareva EY. MODERN CONCEPTS ON THE ROLE OF HYPOXIA IN THE DEVELOPMENT OF TUMOR RADIORESISTANCE. Sib onkol ž 2020;19:141-7. [DOI: 10.21294/1814-4861-2020-19-6-141-147] [Reference Citation Analysis]
604 Wagner F, Hölig U, Wilczkowski F, Plesca I, Sommer U, Wehner R, Kießler M, Jarosch A, Flecke K, Arsova M, Tunger A, Bogner A, Reißfelder C, Weitz J, Schäkel K, Troost EGC, Krause M, Folprecht G, Bornhäuser M, Bachmann MP, Aust D, Baretton G, Schmitz M. Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer. Front Immunol 2019;10:602. [PMID: 30984181 DOI: 10.3389/fimmu.2019.00602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
605 Liang Y, Peng C, Su N, Li Q, Chen S, Wu D, Wu B, Gao Y, Xu Z, Dan Q, Zheng S, Zhao B, Li Y. Tumor microenvironments self-activated cascade catalytic nanoscale metal organic frameworks as ferroptosis inducer for radiosensitization. Chemical Engineering Journal 2022;437:135309. [DOI: 10.1016/j.cej.2022.135309] [Reference Citation Analysis]
606 Cardoso CM, de Jesus SF, de Souza MG, Santos EM, Santos CKC, Silveira CM, Santos SHS, de Paula AMB, Farias LC, Guimarães ALS. Is HIF1-a deregulated in malignant salivary neoplasms? Gene 2019;701:41-5. [DOI: 10.1016/j.gene.2019.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
607 Bychkov ML, Kirichenko AV, Shulepko MA, Mikhaylova IN, Kirpichnikov MP, Lyukmanova EN. Mambalgin-2 Inhibits Growth, Migration, and Invasion of Metastatic Melanoma Cells by Targeting the Channels Containing an ASIC1a Subunit Whose Up-Regulation Correlates with Poor Survival Prognosis. Biomedicines 2021;9:1324. [PMID: 34680442 DOI: 10.3390/biomedicines9101324] [Reference Citation Analysis]
608 Drebert Z, De Vlieghere E, Bridelance J, De Wever O, De Bosscher K, Bracke M, Beck IM. Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts. Exp Cell Res 2018;362:332-42. [PMID: 29196164 DOI: 10.1016/j.yexcr.2017.11.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
609 Lan Y, Zhang D, Xu C, Hance KW, Marelli B, Qi J, Yu H, Qin G, Sircar A, Hernández VM, Jenkins MH, Fontana RE, Deshpande A, Locke G, Sabzevari H, Radvanyi L, Lo KM. Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β. Sci Transl Med 2018;10:eaan5488. [PMID: 29343622 DOI: 10.1126/scitranslmed.aan5488] [Cited by in Crossref: 176] [Cited by in F6Publishing: 179] [Article Influence: 58.7] [Reference Citation Analysis]
610 Sampath S, Won H, Massarelli E, Li M, Frankel P, Vora N, Vora L, Maghami E, Kortylewski M. Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients. Oncotarget 2018;9:11279-90. [PMID: 29541413 DOI: 10.18632/oncotarget.24397] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
611 Kim JY, Lee JY. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome. Int J Mol Sci 2017;18:E1854. [PMID: 28841148 DOI: 10.3390/ijms18091854] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
612 [DOI: 10.1101/293712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
613 Helfen A, Schnepel A, Rieß J, Stölting M, Gerwing M, Masthoff M, Vogl T, Roth J, Höltke C, Wildgruber M, Eisenblätter M. S100A9-Imaging Enables Estimation of Early Therapy-Mediated Changes in the Inflammatory Tumor Microenvironment. Biomedicines 2021;9:29. [PMID: 33401528 DOI: 10.3390/biomedicines9010029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
614 West MA, Astin R, Moyses HE, Cave J, White D, Levett DZH, Bates A, Brown G, Grocott MPW, Jack S. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acta Oncologica 2019;58:588-95. [DOI: 10.1080/0284186x.2019.1566775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 7.3] [Reference Citation Analysis]
615 Grinde MT, Vik J, Camilio KA, Martinez-Zubiaurre I, Hellevik T. Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts. Sci Rep 2017;7:46714. [PMID: 28440285 DOI: 10.1038/srep46714] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
616 Prezado Y, Jouvion G, Patriarca A, Nauraye C, Guardiola C, Juchaux M, Lamirault C, Labiod D, Jourdain L, Sebrie C, Dendale R, Gonzalez W, Pouzoulet F. Proton minibeam radiation therapy widens the therapeutic index for high-grade gliomas. Sci Rep 2018;8:16479. [PMID: 30405188 DOI: 10.1038/s41598-018-34796-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
617 Ji MT, Nie J, Nie XF, Hu WT, Pei HL, Wan JM, Wang AQ, Zhou GM, Zhang ZL, Chang L, Li BY. 1α,25(OH)2D3 Radiosensitizes Cancer Cells by Activating the NADPH/ROS Pathway. Front Pharmacol 2020;11:945. [PMID: 32848720 DOI: 10.3389/fphar.2020.00945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
618 Dzobo K, Dandara C. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance. OMICS 2020;24:314-39. [PMID: 32496970 DOI: 10.1089/omi.2020.0023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
619 Tong F, Xiong CJ, Wei CH, Wang Y, Liang ZW, Lu H, Pan HJ, Dong JH, Zheng XF, Wu G, Dong XR. Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway. Ther Adv Med Oncol 2020;12:1758835920965853. [PMID: 33193827 DOI: 10.1177/1758835920965853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
620 Naz S, Cook JA, Mitchell JB. Abemaciclib: A multi-functional radiation modifier. Oncotarget 2019;10:1230-2. [PMID: 30815224 DOI: 10.18632/oncotarget.26652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
621 Salem A, Asselin MC, Reymen B, Jackson A, Lambin P, West CML, O'Connor JPB, Faivre-Finn C. Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome. J Natl Cancer Inst 2018;110. [PMID: 28922791 DOI: 10.1093/jnci/djx160] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 18.2] [Reference Citation Analysis]
622 Zolghadr F, Tse N, Loka D, Joun G, Meppat S, Wan V, Zoellner H, Xaymardan M, Farah CS, Lyons JG, Hau E, Patrick E, Seyedasli N. A Wnt-mediated phenotype switch along the epithelial-mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma. Br J Cancer 2021;124:1921-33. [PMID: 33785878 DOI: 10.1038/s41416-021-01352-7] [Reference Citation Analysis]
623 Guo SS, Liu R, Wen YF, Liu LT, Yuan L, Li YX, Li Y, Hao WW, Peng JY, Chen DN, Tang QN, Sun XS, Guo L, Mo HY, Qian CN, Zeng MS, Bei JX, Sun SY, Chen QY, Tang LQ, Mai HQ. Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis. Cancer Lett 2020;468:27-40. [PMID: 31604115 DOI: 10.1016/j.canlet.2019.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
624 Wanigasooriya K, Tyler R, Barros-Silva JD, Sinha Y, Ismail T, Beggs AD. Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors. Cancers (Basel) 2020;12:E1278. [PMID: 32443649 DOI: 10.3390/cancers12051278] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
625 Chen M, Zhou J, Wu C, Zhang W, Long F, Zhou S, Xu J, Wu J, Zou Y, Li S, Shen H. Gut microbiota influenced the xenograft MC38 tumor growth potentially through interfering host lipid and amino acid metabolisms, basing on the integrated analysis of microbiome and metabolomics. Journal of Chromatography B 2022. [DOI: 10.1016/j.jchromb.2022.123136] [Reference Citation Analysis]
626 Park M, Yoon HJ, Kang MC, Kwon J, Lee HW. MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Sci Rep. 2017;7:10932. [PMID: 28883406 DOI: 10.1038/s41598-017-10977-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
627 Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG. Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy. Clin Cancer Res 2018;24:5058-71. [PMID: 29898992 DOI: 10.1158/1078-0432.CCR-17-3427] [Cited by in Crossref: 90] [Cited by in F6Publishing: 49] [Article Influence: 22.5] [Reference Citation Analysis]
628 Talebian H, Monfared AS, Niaki HA, Fattahi S, Bakhtiari E, Changizi V. Investigating the expression level of NF-KB and HIF1A genes among the inhabitants of two different background radiation areas in Ramsar, Iran. J Environ Radioact 2020;220-221:106292. [PMID: 32658641 DOI: 10.1016/j.jenvrad.2020.106292] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
629 Liu Y, Dong Y, Kong L, Shi F, Zhu H, Yu J. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors. J Hematol Oncol. 2018;11:104. [PMID: 30115069 DOI: 10.1186/s13045-018-0647-8] [Cited by in Crossref: 124] [Cited by in F6Publishing: 123] [Article Influence: 31.0] [Reference Citation Analysis]
630 Philippou Y, Sjoberg H, Lamb AD, Camilleri P, Bryant RJ. Harnessing the potential of multimodal radiotherapy in prostate cancer. Nat Rev Urol 2020;17:321-38. [DOI: 10.1038/s41585-020-0310-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
631 Hanna GG, Illidge T. Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future? Clin Oncol (R Coll Radiol) 2016;28:726-31. [PMID: 27519157 DOI: 10.1016/j.clon.2016.07.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
632 Alfonso JCL, Grass GD, Welsh E, Ahmed KA, Teer JK, Pilon-Thomas S, Harrison LB, Cleveland JL, Mulé JJ, Eschrich SA, Torres-Roca JF, Enderling H. Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability. Neoplasia 2021;23:1110-22. [PMID: 34619428 DOI: 10.1016/j.neo.2021.09.003] [Reference Citation Analysis]
633 Labbé M, Hoey C, Ray J, Potiron V, Supiot S, Liu SK, Fradin D. microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation. Mol Cancer 2020;19:63. [PMID: 32293453 DOI: 10.1186/s12943-020-01186-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
634 Mahmood J, Zaveri SR, Murti SC, Alexander AA, Connors CQ, Shukla HD, Vujaskovic Z. Caveolin-1: a novel prognostic biomarker of radioresistance in cancer. Int J Radiat Biol 2016;92:747-53. [PMID: 27623870 DOI: 10.1080/09553002.2016.1222096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
635 Pandey VK, Shankar BS. Radiation-induced augmentation in dendritic cell function is mediated by apoptotic bodies/STAT5/Zbtb46 signaling. Int J Radiat Biol 2020;96:988-98. [PMID: 32396024 DOI: 10.1080/09553002.2020.1767818] [Reference Citation Analysis]
636 Fleischmann M, Diefenhardt M, Nicolas AM, Rödel F, Ghadimi M, Hofheinz R, Greten FR, Rödel C, Fokas E. ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group. Clinical and Translational Radiation Oncology 2022;34:99-106. [DOI: 10.1016/j.ctro.2022.04.003] [Reference Citation Analysis]
637 Li M, Lin L, Guo T, Wu Y, Lin J, Liu Y, Yang K, Hu C. Curcumin Administered in Combination with Glu-GNPs Induces Radiosensitivity in Transplanted Tumor MDA-MB-231-luc Cells in Nude Mice. Biomed Res Int 2021;2021:9262453. [PMID: 34825004 DOI: 10.1155/2021/9262453] [Reference Citation Analysis]
638 Berg TJ, Pietras A. Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.011] [Reference Citation Analysis]
639 Abdou P, Wang Z, Chen Q, Chan A, Zhou DR, Gunadhi V, Gu Z. Advances in engineering local drug delivery systems for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1632. [PMID: 32255276 DOI: 10.1002/wnan.1632] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
640 Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: Targeting cancer treatment. Cancer Letters 2019;452:144-51. [DOI: 10.1016/j.canlet.2019.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
641 Luo Z, Yao X, Li M, Fang D, Fei Y, Cheng Z, Xu Y, Zhu B. Modulating Tumor Physical Microenvironment for Fueling CAR-T Cell Therapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114301] [Reference Citation Analysis]
642 Merrick M, Mimlitz MJ, Weeder C, Akhter H, Bray A, Walther A, Nwakama C, Bamesberger J, Djam H, Abid K, Ekpenyong A. In vitro radiotherapy and chemotherapy alter migration of brain cancer cells before cell death. Biochem Biophys Rep 2021;27:101071. [PMID: 34286111 DOI: 10.1016/j.bbrep.2021.101071] [Reference Citation Analysis]
643 Giuranno L, Ient J, De Ruysscher D, Vooijs MA. Radiation-Induced Lung Injury (RILI). Front Oncol 2019;9:877. [PMID: 31555602 DOI: 10.3389/fonc.2019.00877] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 19.3] [Reference Citation Analysis]
644 Li B, Hao G, Sun B, Gu Z, Xu ZP. Engineering a Therapy‐Induced “Immunogenic Cancer Cell Death” Amplifier to Boost Systemic Tumor Elimination. Adv Funct Mater 2020;30:1909745. [DOI: 10.1002/adfm.201909745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
645 Takahashi J, Nagasawa S. Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review. Int J Mol Sci 2020;21:E9324. [PMID: 33297519 DOI: 10.3390/ijms21239324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
646 Pinto AT, Pinto ML, Velho S, Pinto MT, Cardoso AP, Figueira R, Monteiro A, Marques M, Seruca R, Barbosa MA, Mareel M, Oliveira MJ, Rocha S. Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation. PLoS One 2016;11:e0160891. [PMID: 27513864 DOI: 10.1371/journal.pone.0160891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
647 Li G, Tian Y, Zhu WG. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. Front Cell Dev Biol 2020;8:576946. [PMID: 33117804 DOI: 10.3389/fcell.2020.576946] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
648 Zhou H, Zhang Z, Denney R, Williams JS, Gerberich J, Stojadinovic S, Saha D, Shelton JM, Mason RP. Tumor physiological changes during hypofractionated stereotactic body radiation therapy assessed using multi-parametric magnetic resonance imaging. Oncotarget 2017;8:37464-77. [PMID: 28415581 DOI: 10.18632/oncotarget.16395] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
649 Alinezhad M, Bakhshandeh M, Rostami E, Alimohamadi R, Mosaffa N, Jalali SA. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response. PLoS One 2020;15:e0231507. [PMID: 32287292 DOI: 10.1371/journal.pone.0231507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
650 Pajak B, Siwiak E, Sołtyka M, Priebe A, Zieliński R, Fokt I, Ziemniak M, Jaśkiewicz A, Borowski R, Domoradzki T, Priebe W. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents. Int J Mol Sci 2019;21:E234. [PMID: 31905745 DOI: 10.3390/ijms21010234] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 14.0] [Reference Citation Analysis]
651 Jarzebska N, Karetnikova ES, Markov AG, Kasper M, Rodionov RN, Spieth PM. Scarred Lung. An Update on Radiation-Induced Pulmonary Fibrosis. Front Med (Lausanne) 2020;7:585756. [PMID: 33521012 DOI: 10.3389/fmed.2020.585756] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 Shaked Y. Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects. Nat Rev Clin Oncol 2016;13:611-26. [PMID: 27118493 DOI: 10.1038/nrclinonc.2016.57] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
653 Knops AM, South A, Rodeck U, Martinez-Outschoorn U, Harshyne LA, Johnson J, Luginbuhl AJ, Curry JM. Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Front Oncol 2020;10:565306. [PMID: 33330034 DOI: 10.3389/fonc.2020.565306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
654 He M, Yang T, Wang Y, Wang M, Chen X, Ding D, Zheng Y, Chen H. Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy. Adv Healthc Mater 2021;10:e2002104. [PMID: 33709564 DOI: 10.1002/adhm.202002104] [Reference Citation Analysis]
655 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
656 Yao G, Tang J, Yang X, Zhao Y, Zhou R, Meng R, Zhang S, Dong X, Zhang T, Yang K, Wu G, Xu S. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer. Theranostics 2020;10:11144-58. [PMID: 33042275 DOI: 10.7150/thno.42578] [Reference Citation Analysis]
657 Telarovic I, Wenger RH, Pruschy M. Interfering with Tumor Hypoxia for Radiotherapy Optimization. J Exp Clin Cancer Res 2021;40:197. [PMID: 34154610 DOI: 10.1186/s13046-021-02000-x] [Reference Citation Analysis]
658 Huang Z, Yao D, Ye Q, Jiang H, Gu R, Ji C, Wu J, Hu Y, Yuan A. Zoledronic Acid-Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment. ACS Nano 2021;15:8450-65. [PMID: 33938751 DOI: 10.1021/acsnano.0c10764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Alsahafi E, Begg K, Amelio I, Raulf N, Lucarelli P, Sauter T, Tavassoli M. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis 2019;10:540. [PMID: 31308358 DOI: 10.1038/s41419-019-1769-9] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 38.3] [Reference Citation Analysis]
660 Li W, Nie J, Hu R, Zhao R, Zhu W, Chen X, Li D, Wang L, Hu L. A nanogel sensor for colorimetric fluorescence measurement of ionizing radiation doses. Chem Commun 2019;55:9614-7. [DOI: 10.1039/c9cc03680f] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
661 Stenina-Adognravi O, Muppala S, Gajeton J. Thrombospondins and remodeling of the tumor microenvironment. Vessel Plus 2018;2:30. [PMID: 32984773 DOI: 10.20517/2574-1209.2018.40] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
662 Rakotomalala A, Escande A, Furlan A, Meignan S, Lartigau E. Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of Radiotherapy. Front Endocrinol (Lausanne) 2021;12:742215. [PMID: 34539584 DOI: 10.3389/fendo.2021.742215] [Reference Citation Analysis]
663 Tanić M, Krivokuća A, Čavić M, Mladenović J, Plesinac Karapandžić V, Beck S, Radulović S, Susnjar S, Janković R. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer. Radiat Oncol 2018;13:193. [PMID: 30285791 DOI: 10.1186/s13014-018-1129-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
664 Link B, Torres Crigna A, Hölzel M, Giordano FA, Golubnitschaja O. Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes? J Clin Med 2021;10:5124. [PMID: 34768644 DOI: 10.3390/jcm10215124] [Reference Citation Analysis]
665 Chicas-Sett R, Zafra-Martin J, Morales-Orue I, Castilla-Martinez J, Berenguer-Frances MA, Gonzalez-Rodriguez E, Rodriguez-Abreu D, Couñago F. Immunoradiotherapy as An Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent. Cancers (Basel) 2020;12:E2178. [PMID: 32764371 DOI: 10.3390/cancers12082178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
666 Zhang RX, Li J, Zhang T, Amini MA, He C, Lu B, Ahmed T, Lip H, Rauth AM, Wu XY. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples. Acta Pharmacol Sin 2018;39:825-44. [PMID: 29698389 DOI: 10.1038/aps.2018.33] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
667 Sharma RA, Plummer R, Stock JK, Greenhalgh TA, Ataman O, Kelly S, Clay R, Adams RA, Baird RD, Billingham L, Brown SR, Buckland S, Bulbeck H, Chalmers AJ, Clack G, Cranston AN, Damstrup L, Ferraldeschi R, Forster MD, Golec J, Hagan RM, Hall E, Hanauske AR, Harrington KJ, Haswell T, Hawkins MA, Illidge T, Jones H, Kennedy AS, McDonald F, Melcher T, O'Connor JP, Pollard JR, Saunders MP, Sebag-Montefiore D, Smitt M, Staffurth J, Stratford IJ, Wedge SR; NCRI CTRad Academia-Pharma Joint Working Group. Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol 2016;13:627-42. [PMID: 27245279 DOI: 10.1038/nrclinonc.2016.79] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 22.5] [Reference Citation Analysis]
668 Katakam SK, Pelucchi P, Cocola C, Reinbold R, Vlodavsky I, Greve B, Götte M. Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells. Front Oncol 2020;10:774. [PMID: 32477959 DOI: 10.3389/fonc.2020.00774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
669 Qiao Y, Yang F, Xie T, Du Z, Zhong D, Qi Y, Li Y, Li W, Lu Z, Rao J, Sun Y, Zhou M. Engineered algae: A novel oxygen-generating system for effective treatment of hypoxic cancer. Sci Adv 2020;6:eaba5996. [PMID: 32490207 DOI: 10.1126/sciadv.aba5996] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
670 Chen MX, Liu YM, Li Y, Yang X, Wei WB. Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy. Int J Ophthalmol 2020;13:599-605. [PMID: 32399411 DOI: 10.18240/ijo.2020.04.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
671 Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, Motevaseli E, Mirtavoos-Mahyari H, Eleojo Musa A, Najafi M. TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 2020;155:104745. [PMID: 32145401 DOI: 10.1016/j.phrs.2020.104745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
672 Mirza-Aghazadeh-Attari M, Mohammadzadeh A, Mostavafi S, Mihanfar A, Ghazizadeh S, Sadighparvar S, Gholamzadeh S, Majidinia M, Yousefi B. Melatonin: An important anticancer agent in colorectal cancer. J Cell Physiol 2020;235:804-17. [PMID: 31276205 DOI: 10.1002/jcp.29049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
673 Nagi NMS, Khair YAM, Abdalla AME. Capacity of gold nanoparticles in cancer radiotherapy. Jpn J Radiol 2017;35:555-61. [DOI: 10.1007/s11604-017-0671-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
674 Liu TS, Chen C, Zhou B, Xia BW, Chen ZP, Yan Y. Isobaric tags for relative and absolute quantitation-based quantitative proteomic analysis of X-linked inhibitor of apoptosis and H2AX in etoposide-induced renal cell carcinoma apoptosis. Chin Med J (Engl) 2019;132:2941-9. [PMID: 31855962 DOI: 10.1097/CM9.0000000000000553] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
675 Liu F, Lou J, Hristov D. X-Ray responsive nanoparticles with triggered release of nitrite, a precursor of reactive nitrogen species, for enhanced cancer radiosensitization. Nanoscale 2017;9:14627-34. [DOI: 10.1039/c7nr04684g] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
676 Zhang Q, Chen J, Ma M, Wang H, Chen H. A Bioenvironment-Responsive Versatile Nanoplatform Enabling Rapid Clearance and Effective Tumor Homing for Oxygen-Enhanced Radiotherapy. Chem Mater 2018;30:5412-21. [DOI: 10.1021/acs.chemmater.8b02251] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
677 Fatfat Z, Fatfat M, Gali-Muhtasib H. Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells. World J Clin Oncol 2021; 12(7): 522-543 [PMID: 34367926 DOI: 10.5306/wjco.v12.i7.522] [Reference Citation Analysis]
678 Sundahl N, Duprez F, Ost P, De Neve W, Mareel M. Effects of radiation on the metastatic process. Mol Med 2018;24:16. [PMID: 30134800 DOI: 10.1186/s10020-018-0015-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
679 Hu ZI, Ho AY, McArthur HL. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2017;99:153-164. [PMID: 28816141 DOI: 10.1016/j.ijrobp.2017.05.029] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
680 Rodriguez-Ruiz ME, Yamazaki T, Buqué A, Bloy N, Silva VAO, Stafford L, Sato A, Galluzzi L. Monitoring abscopal responses to radiation in mice. Methods Enzymol 2020;635:111-25. [PMID: 32122540 DOI: 10.1016/bs.mie.2019.04.014] [Reference Citation Analysis]
681 Sun X, Yao F, Zhang H, Li J. Oxygen-generating materials and their biomedical applications: a review. J Mater Sci. [DOI: 10.1007/s10853-022-07229-1] [Reference Citation Analysis]
682 Koerdel K, Spitzner M, Meyer T, Engels N, Krause F, Gaedcke J, Conradi LC, Haubrock M, Beißbarth T, Leha A, Johnsen SA, Ghadimi BM, Rose-John S, Grade M, Wienands J. NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers (Basel) 2021;13:455. [PMID: 33530306 DOI: 10.3390/cancers13030455] [Reference Citation Analysis]
683 Keam SP, Gulati T, Gamell C, Caramia F, Arnau GM, Huang C, Schittenhelm RB, Kleifeld O, Neeson PJ, Williams SG, Haupt Y. Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue. Radiat Environ Biophys 2018;57:241-9. [PMID: 29850926 DOI: 10.1007/s00411-018-0746-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
684 Jarosz-Biej M, Smolarczyk R, Cichoń T, Kułach N. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy. Int J Mol Sci 2019;20:E3212. [PMID: 31261963 DOI: 10.3390/ijms20133212] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 22.7] [Reference Citation Analysis]
685 Ayoub M, Shinde-Jadhav S, Mansure JJ, Alvarez F, Connell T, Seuntjens J, Piccirillo CA, Kassouf W. The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance. Sci Rep 2019;9:6348. [PMID: 31015520 DOI: 10.1038/s41598-019-42864-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
686 Orlova A, Pavlova K, Kurnikov A, Maslennikova A, Myagcheva M, Zakharov E, Skamnitskiy D, Perekatova V, Khilov A, Kovalchuk A, Moiseev A, Turchin I, Razansky D, Subochev P. Noninvasive optoacoustic microangiography reveals dose and size dependency of radiation-induced deep tumor vasculature remodeling. Neoplasia 2022;26:100778. [DOI: 10.1016/j.neo.2022.100778] [Reference Citation Analysis]
687 Rodriguez-Ruiz ME, Rodriguez I, Barbes B, Mayorga L, Sanchez-Paulete AR, Ponz-Sarvise M, Pérez-Gracia JL, Melero I. Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies. Brachytherapy 2017;16:1246-51. [PMID: 28838649 DOI: 10.1016/j.brachy.2017.06.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
688 Mooney B, Abdul-raof N, Tian YI, Xie Y. Restriction of Cancer Metastatic Potential Using Embryonic Stem Cells Encapsulated in Alginate Hydrogel Microstrands. ACS Biomater Sci Eng 2017;3:1769-79. [DOI: 10.1021/acsbiomaterials.7b00237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
689 Gomes AC, Mello AL, Ribeiro MG, Garcia DG, Da Fonseca CO, Salazar MD, Schönthal AH, Quirico-santos T. Perillyl alcohol, a pleiotropic natural compound suitable for brain tumor therapy, targets free radicals. Arch Immunol Ther Exp 2017;65:285-97. [DOI: 10.1007/s00005-017-0459-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
690 Park S, Kim YS, Kim DY, So I, Jeon J. PI3K pathway in prostate cancer: All resistant roads lead to PI3K. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018;1870:198-206. [DOI: 10.1016/j.bbcan.2018.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
691 Liu J, Yang Y, Zhu W, Yi X, Dong Z, Xu X, Chen M, Yang K, Lu G, Jiang L, Liu Z. Nanoscale metal−organic frameworks for combined photodynamic & radiation therapy in cancer treatment. Biomaterials 2016;97:1-9. [DOI: 10.1016/j.biomaterials.2016.04.034] [Cited by in Crossref: 259] [Cited by in F6Publishing: 236] [Article Influence: 43.2] [Reference Citation Analysis]
692 Carlson PM, Mohan M, Patel RB, Birstler J, Nettenstrom L, Sheerar D, Fox K, Rodriguez M, Hoefges A, Hernandez R, Zahm C, Kim K, McNeel DG, Weichert J, Morris ZS, Sondel PM. Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. J Immunol 2021:ji2000656. [PMID: 34261667 DOI: 10.4049/jimmunol.2000656] [Reference Citation Analysis]
693 Piper M, Mueller AC, Karam SD. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy. Mol Carcinog 2020;59:754-65. [PMID: 32363633 DOI: 10.1002/mc.23205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
694 Marampon F, Ciccarelli C, Zani BM. Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation. Int J Mol Sci 2019;20:E2530. [PMID: 31126017 DOI: 10.3390/ijms20102530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
695 Xu J, Saklatvala R, Mittal S, Deshmukh S, Procopio A. Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli-an Industry Perspective. Adv Sci (Weinh) 2020;7:1903394. [PMID: 32328428 DOI: 10.1002/advs.201903394] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
696 Mortezaee K, Najafi M, Farhood B, Ahmadi A, Potes Y, Shabeeb D, Musa AE. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review. Life Sciences 2019;228:228-41. [DOI: 10.1016/j.lfs.2019.05.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
697 Yadav VN, Altshuler D, Kadiyala P, Zamler D, Comba A, Appelman H, Dunn P, Koschmann C, Castro MG, Löwenstein PR. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab. Neuro Oncol 2018;20:1356-67. [PMID: 29660022 DOI: 10.1093/neuonc/noy055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
698 Zhang C, Chen W, Zhang T, Jiang X, Hu Y. Hybrid nanoparticle composites applied to photodynamic therapy: strategies and applications. J Mater Chem B 2020;8:4726-37. [PMID: 32104868 DOI: 10.1039/d0tb00093k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 19.0] [Reference Citation Analysis]
699 Lambin T, Lafon C, Drainville RA, Pioche M, Prat F. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. World J Gastroenterol 2022; 28(13): 1288-1303 [DOI: 10.3748/wjg.v28.i13.1288] [Reference Citation Analysis]
700 Sánchez-Paulete AR, Teijeira A, Cueto FJ, Garasa S, Pérez-Gracia JL, Sánchez-Arráez A, Sancho D, Melero I. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy. Ann Oncol 2017;28:xii44-55. [PMID: 28945841 DOI: 10.1093/annonc/mdx237] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 19.5] [Reference Citation Analysis]
701 Yang Y, Chong Y, Chen M, Dai W, Zhou X, Ji Y, Qiu G, Du X. Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench. J Transl Med 2021;19:170. [PMID: 33902615 DOI: 10.1186/s12967-021-02825-2] [Reference Citation Analysis]
702 Chaouni S, Leduc A, Pouzoulet F, De Marzi L, Megnin-Chanet F, Stefan D, Habrand JL, Sichel F, Laurent C. Biological Effects of Scattered Versus Scanned Proton Beams on Normal Tissues in Total Body Irradiated Mice: Survival, Genotoxicity, Oxidative Stress and Inflammation. Antioxidants (Basel) 2020;9:E1170. [PMID: 33255388 DOI: 10.3390/antiox9121170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
703 Campbell A, Davis LM, Wilkinson SK, Hesketh RL. Emerging Functional Imaging Biomarkers of Tumour Responses to Radiotherapy. Cancers (Basel) 2019;11:E131. [PMID: 30678055 DOI: 10.3390/cancers11020131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
704 Kim N, Lee HH, Lee H, Choi WS, Lee J, Kim HS. Natural killer cells as a promising therapeutic target for cancer immunotherapy. Arch Pharm Res 2019;42:591-606. [DOI: 10.1007/s12272-019-01143-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
705 Shen MJ, Xu LJ, Yang L, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway. Oncotarget 2017;8:80506-20. [PMID: 29113321 DOI: 10.18632/oncotarget.19193] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
706 van Meir H, Nout RA, Welters MJ, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJ, Burggraaf J, van Poelgeest MI, van der Burg SH. Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients. Oncoimmunology 2017;6:e1267095. [PMID: 28344877 DOI: 10.1080/2162402X.2016.1267095] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
707 Yang X, Gao L, Guo Q, Li Y, Ma Y, Yang J, Gong C, Yi C. Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy. Nano Res 2020;13:2579-94. [DOI: 10.1007/s12274-020-2722-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
708 Jank BJ, Lenz T, Haas M, Kadletz-Wanke L, Campion NJ, Schnoell J, Heiduschka G, Macfelda K. Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro. Invest New Drugs 2022. [PMID: 34985593 DOI: 10.1007/s10637-021-01207-1] [Reference Citation Analysis]
709 He K, Zhang S, Shao LL, Yin JC, Wu X, Shao YW, Yuan S, Yu J. Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNA. Cancer Lett 2020;472:108-18. [PMID: 31837443 DOI: 10.1016/j.canlet.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
710 Zhao H, Cheng Y, Dong S, Du J, Gao F, Sun D, Cui J, Ni J, Cai J. Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1. Toxicol Lett 2017;280:116-24. [PMID: 28736328 DOI: 10.1016/j.toxlet.2017.07.891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
711 Najafi M, Shirazi A, Motevaseli E, Rezaeyan AH, Salajegheh A, Rezapoor S. Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacol 2017;25:403-13. [DOI: 10.1007/s10787-017-0332-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
712 Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunol Rev 2017;280:220-30. [PMID: 29027232 DOI: 10.1111/imr.12568] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
713 DuRoss AN, Neufeld MJ, Rana S, Thomas CR Jr, Sun C. Integrating nanomedicine into clinical radiotherapy regimens. Adv Drug Deliv Rev 2019;144:35-56. [PMID: 31279729 DOI: 10.1016/j.addr.2019.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
714 Zhang C, Yan L, Gu Z, Zhao Y. Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy. Chem Sci 2019;10:6932-43. [PMID: 31588260 DOI: 10.1039/c9sc02107h] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 10.7] [Reference Citation Analysis]
715 Zhuang Y, Zhao X, Yuan B, Zeng Z, Chen Y. Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells. J Hepatocell Carcinoma 2021;8:599-611. [PMID: 34178876 DOI: 10.2147/JHC.S300165] [Reference Citation Analysis]
716 Chen Y, Zhang E, Wang Q, Yuan H, Zhuang H, Lang N. Use of dynamic contrast-enhanced MRI for the early assessment of outcome of CyberKnife stereotactic radiosurgery for patients with spinal metastases. Clin Radiol 2021;76:864.e1-6. [PMID: 34404514 DOI: 10.1016/j.crad.2021.07.008] [Reference Citation Analysis]
717 Tian L, Chen Q, Yi X, Chen J, Liang C, Chao Y, Yang K, Liu Z. Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy. Small 2017;13. [PMID: 28544324 DOI: 10.1002/smll.201700640] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
718 Walle T, Martinez Monge R, Cerwenka A, Ajona D, Melero I, Lecanda F. Radiation effects on antitumor immune responses: current perspectives and challenges. Ther Adv Med Oncol 2018;10:1758834017742575. [PMID: 29383033 DOI: 10.1177/1758834017742575] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 21.8] [Reference Citation Analysis]
719 Amugongo LM, Osorio EV, Green A, Cobben D, van Herk M, McWilliam A. Early prediction of tumour-response to radiotherapy in NSCLC patients. Phys Med Biol 2021;66. [PMID: 34644691 DOI: 10.1088/1361-6560/ac2f88] [Reference Citation Analysis]
720 Connor MJ, Shah TT, Horan G, Bevan CL, Winkler M, Ahmed HU. Cytoreductive treatment strategies for de novo metastatic prostate cancer. Nat Rev Clin Oncol 2020;17:168-82. [PMID: 31712648 DOI: 10.1038/s41571-019-0284-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
721 Ghaffari-nazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, Mahmoodi Chalbatani G, Tavakkol-afshari J, Amir Jalali S. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model. International Immunopharmacology 2022;108:108737. [DOI: 10.1016/j.intimp.2022.108737] [Reference Citation Analysis]
722 Zhou T, Peng J, Hao Y, Shi K, Zhou K, Yang Y, Yang C, He X, Chen X, Qian Z. The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure. Bioact Mater 2021;6:697-711. [PMID: 33005832 DOI: 10.1016/j.bioactmat.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
723 Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology 2016;5:e1149674. [PMID: 27471617 DOI: 10.1080/2162402X.2016.1149674] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
724 Milovancev M, Russell DS. Surgical margins in the veterinary cancer patient. Vet Comp Oncol 2017;15:1136-57. [PMID: 28194921 DOI: 10.1111/vco.12284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
725 Yang Z, Zhou X, Zheng E, Wang Y, Liu X, Wang Y, Wang Y, Liu Z, Pei F, Zhang Y, Ren J, Huang Y, Xia L, Guan S, Qin S, Suo F, Shi J, Wang L, He L, Sun L. JFK Is a Hypoxia-Inducible Gene That Functions to Promote Breast Carcinogenesis. Front Cell Dev Biol 2021;9:686737. [PMID: 34336836 DOI: 10.3389/fcell.2021.686737] [Reference Citation Analysis]
726 Sato K, Nitta N, Aoki I, Imai T, Shimokawa T. Repeated photon and C-ion irradiations in vivo have different impact on alteration of tumor characteristics. Sci Rep 2018;8:1458. [PMID: 29362374 DOI: 10.1038/s41598-018-19422-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
727 Zhao X, Li J, Zheng L, Yang Q, Chen X, Chen X, Yu Y, Li F, Cui J, Sun J. Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer. Front Mol Biosci 2022;9:786864. [DOI: 10.3389/fmolb.2022.786864] [Reference Citation Analysis]
728 Li M, Yang Y, Xu C, Wei J, Liu Y, Cun X, Yu Q, Tang X, Yin S, Zhang Z, He Q. Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy. AAPS J 2019;21:18. [PMID: 30635795 DOI: 10.1208/s12248-018-0289-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
729 Zhang Y, Liu J, Yu Y, Chen S, Huang F, Yang C, Chang J, Yang L, Fan S, Liu J. Enhanced radiotherapy using photothermal therapy based on dual-sensitizer of gold nanoparticles with acid-induced aggregation. Nanomedicine 2020;29:102241. [PMID: 32565227 DOI: 10.1016/j.nano.2020.102241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
730 Kosinsky Y, Dovedi SJ, Peskov K, Voronova V, Chu L, Tomkinson H, Al-Huniti N, Stanski DR, Helmlinger G. Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model. J Immunother Cancer 2018;6:17. [PMID: 29486799 DOI: 10.1186/s40425-018-0327-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
731 Scutti JAB. Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). Int J Oncol 2018;52:1041-56. [PMID: 29484440 DOI: 10.3892/ijo.2018.4283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
732 Wang T, Wang J, Ren W, Chen S, Cheng YF, Zhang XM. CircRNA-0008717 promotes cell proliferation, migration, and invasion by regulating miR-203/Slug in esophageal cancer cells. Ann Transl Med 2020;8:999. [PMID: 32953799 DOI: 10.21037/atm-20-5205]